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Neutrophil leucocytes constitute the principal
cellular defence against microorganisms and are essential
for life. Neutrophils enter the oral cavity
predominantly via the gingival crevice, where little is
known of their function. Phagocytic and microbicidal
activity of gingival crevicular neutrophils has been
reported in limited studies and the purpose of the
present investigation was to extend the study of
neutrophils collected from the gingival crevice.
The high proportion of neutrophils found in the
crevice confirmed previous work. Many contained
intracellular bacteria and the majority stained positively
for alkaline phosphatase. More detailed studies were
undertaken of two main components of the oxygen-dependent
microbicidal system.
Nitroblue tetrazolium (NBT) dye reduction was used
as an indirect assay of neutrophil metabolism and
superoxide anion production, and the enzyme myeloperoxidase
(MPO) was assayed as a specific factor contributing to
microbicidal activity. Crevicular neutrophils
consistently showed significantly higher NBT reduction
than neutrophils from peripheral blood, illustrating
their ability to respond to local bacterial stimuli.
There was a positive correlation between blood and
crevicular neutrophil values for NBT reduction, which may
ii
therefore provide a predictive assay of crevicular
neutrophil function.
Nitroblue tetrazolium was used as a marker to
isolate the reducing activity of whole saliva. This
activity was located in the bacterial fraction, so that
there is a need for caution when bacteria are used as
cell stimulants in NBT tests.
Myeloperoxidase was present in the crevicular
neutrophils of all subjects examined but enzyme activity
was variable, being absent in one study group. It is
possible that neutrophils migrate selectively into the
gingival crevice. There was a positive correlation
between the degree of gingival inflammation measured
clinically and MPO activity. Also, the crevicular
enzyme was shown to be altered by the in vivo administra¬
tion of antibiotics, significantly more so than the blood
enzyme in the case of cefaclor, a chlorinated
cephalosporin.
When the NBT and MPO assays were applied to
crevicular cells from patients with neutrophil dysfunction
(neutropenia, leukaemia and chronic granulomatous disease),
their sensitivity to both disease and treatment was
apparent.
Studies of crevicular neutrophils may therefore
provide information relevant to understanding the
aetiology and pathogenesis of periodontal disease, and
iii
may also provide an accessible source of neutrophils by
which to monitor host defence mechanisms in patients
with disorders of neutrophil production and function.
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CHAPTER 1
GENERAL REVIEW AND INTRODUCTION
1
PHAGOCYTIC CELLS
Those mammalian cells regarded as committed
phagocytes, and an integral part of normal host defence
mechanisms, are the monocytes/macrophages and the
neutrophil and eosinophil polymorphonuclear leucocytes.
Many other cell types, such as fibroblasts and epithelial
cells (Wolff and Konrad, 1972; Tripathi and Tripathi,
1982), have been shown to be capable of internalising
particles or bacteria, but the essential distinction is
the ability of committed phagocytes to respond rapidly to
a bacterial stimulus, and following phagocytosis, to kill
the organisms. Specialisation is shown by the increased
efficiency of this system if the organisms have been
opsonised with antibody or activated complement, for
which the phagocytes have surface receptors. Other
non-specific mechanisms also facilitate attachment. In
the case of monocyte or macrophage activity, phagocytosis
may be an integral part of its role in immunological, as
opposed to strictly inflammatory, processes.
This vital protective response to external attack
was first described and placed in biological perspective
by the zoologist Metchnikoff 100 years ago. He
observed wandering cells in starfish larvae, and how
they localised round the site of an injected thorn
2
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(Metchnikoff, 0., 1918 ). Subsequently he developed his
theory of phagocytosis, although it is clear that much
experimentation had already been undertaken (Metchnikoff,
1880; Karnovsky, 1981), and that the studies of other
zoologists such as Haeckel (1862) provided additional
inspiration. The first comprehensive account of this
cellular defence mechanism, based particularly on
experiments with Daphnia (Metchnikoff, 1884), was
followed by recognition of its importance by others and
a request for further information, and thus extended
experimentation. An editorial footnote to a paper
published by invitation in Annales de l'Institut Pasteur
(Metschnikoff, 1887) noted: "A raison de 1'interSt et
de 1'attention qu'excite en ce moment la nouvelle thdorie
des phagocytes de M. Metschnikoff, nous avon demande S.
1'auteur de vouloir bien l'exposer lui-meme dans ces
Annales".
Metchnikoff argued that phagocytosis as a protective
phenomenon had developed in complex animals (from
crustaceans to man) directly from the feeding mechanisms
of protozoans and sponges. This was further emphasised
by Hofmeister's work, demonstrating the presence of
proteolytic enzymes, chemically similar, both in
■k
Mme Olga Metchnikoff was the zoologist's wife, and her
biography, originally published in 1918 in French, was
translated into English by the family friend,
Sir Roy Lankester.
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phagocytic cells and the digestive tract of invertebrates
and vertebrates. Between these two, in developmental
terms, he cited the work of Ranvier on the resorption of
dead nerve fibres, and Kowalesky's work on phagocytic
leucocytes involved in the complex metamorphosis of fly
larvae. Phagocytic-like activity is now recognised as
a widespread biological phenomenon in tissue repair, but
is marked in being a very much slower process than the
classical neutrophil or macrophage-bacterial interaction.
For example, chick embryonic retinal pigment epithelium
takes about two hours to phagocytose latex particles, in
vitro, although for some species these cells may exhibit
a pre-uptake latent period of 12 hours (Tsunematsu et
al. , 1981) .
The vertebrate immune system appears to be
considerably more sophisticated than that of invertebrates,
and the phylogenetic origins have been much investigated
in recent years (Wright, 1976; Warr et al., 1977).
Invertebrates rely principally on less specific defence
mechanisms such as phagocytosis (Bang, 1973; Cheng,
1975; Rowley, 1981), even though "phagocytes" comprise only
about 1% of the total circulating blood cell population
(Endean, 1960). Furthermore, while there are variations
between species, the naturally occurring haemagglutinins are
not effective as opsonins (Rowley and Ratcliffe, 1980).
Little is known of killing activity in invertebrate
4
phagocytes, but it appears that the oxygen-dependent
pathways, for example involving myeloperoxidase, are
poorly developed (Rowley, A.F., personal communication).
Metchnikoff's studies allowed him to theorise on
the development of phagocytic systems, in part due to the
incredible range of his experimental models. Beyond the
observations in Daphnia, he studied anthrax, cholera,
erysipelas, malaria, typhus and other infections in
experimental animals (Metschnikoff, 1887) . He showed,
for example, that "microphages" were ineffectual in
limiting anthrax infection in mice, guinea pigs and
rabbits, but that the "macrophages of the spleen"
appeared better able to cope. The ability of host cell
populations to deal with anthrax bacilli was markedly
enhanced, however, after a "weak vaccine" had been
injected by the method of Pasteur, Chamberland and Roux.
With erysipelas infection, Metchnikoff demonstrated the
late arrival of macrophages in the inflammatory site, and
how they effectively phagocytosed debris and effete
microphages. He also demonstrated that bacteria may
remain viable for protracted periods within phagocytic
cells. Metchnikoff was fortunate in having enlightened
patrons in this work, for example Prince Oldenbourg who
took a keen interest in his typhus studies.
Metchnikoff and his colleagues were clearly
prodigious workers, as pointed out by Binnie in the
5
preface to his English translation of Metchnikoff's book,
•k
"Immunity in Infective Diseases" (1905) . The work
includes chapters on plant immune mechanisms, touches on
reproductive biology and gives a guide to regimes of
immunisation.
While Metchnikoff's work was criticised by some
contemporaries who saw humoral mechanisms of immunity as
all-important, he himself fully realised the significance
of serum factors, both per se and as a vital adjunct to
phagocytic function. For example, in his book, among
many others he cited the work of Bordet, Pfeiffer and, above
all, Ehrlich. He made reference to the typhoid
immunisation studies of Wright, who did much to consolidate
the cellular/humoral basis of effective phagocytosis
(Wright and Douglas, 1903).
*
Originally published in 1901, in French.
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NEUTROPHIL HOMEOSTASIS
Metchnikoff's "microphages" are now referred to as
granulocytes or polymorphonuclear leucocytes and are
basophilic, eosinophilic or neutrophilic. Neutrophils
constitute the largest circulating human leucocyte
population, in a ratio of approximately 1:1000 with
erythrocytes. The neutrophils are, of course, the
phagocytes of primary cellular defence. They are the
progeny of marrow stem cells,which mature to band and
segmented forms over a period of about ten days before
being released into the circulation (Klebanoff and Clark,
1978: 74-75). The marrow compartment is divided into
the precursor pool and the mature granulocyte reserve,
from which population functional cells pass into the
vascular space (Fig. 1.1). In a normal healthy adult
approximately 1 x 1011 granulocytes pass into the
circulation per day and there the cells also exist as
two "pools" in equilibrium. The circulating pool is
that from which granulocytes are sampled by venepuncture;
the more slowly moving marginating pool close to the
vessel walls is the origin of cells which pass into the
tissues, presumably under the influence of chemotactic
factors. It is known that the granulocytes remain in
the circulation for only a matter of hours, but how long
they remain in the tissue compartment is not known
(Klebanoff and Clark, 1978: 74-75). Indeed, the size
7
FIG. 1.1: Neutrophil homeostasis. Neutrophils are
produced and mature in the bone marrow, from where they
pass into the circulation and thence to the tissues.
The relative proportions of cells migrating to different
anatomical sites are unknown.
G.t.£ = Genital tract, female.
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and precise areas of migration are yet to be fully
determined, and some examples of known tissue sites are
illustrated in Fig. 1.1. While neutrophils and other
leucocytes can be sampled from accessible secretions (e.g.
colostrum) and exudates (e.g. gingival crevicular fluid),
some workers have also attempted to estimate their
proportions in connective tissue cells in an experimental
system (Darcy and Dean, 1981).
The control of neutrophil production in the marrow is
only now being elucidated. Detailed studies of cyclical
neutropenia in Grey Collie dogs provided data regarding
the time scale of cell production (Dale, Ailing et al.,
1972; Dale, Ward et al., 1972). In recent years
interest has focused on so-called colony stimulating
factors (CSF), a group of glycoproteins produced by the
monocyte-macrophage system and possibly also by
lymphocytes (Foster et al., 1968; Chervenick and Boggs,
1970; Golde et al., 1972; Baker and Galbraith, 1979;
Gordon and Gordon-Smith, 1980; Hartmann et al., 1981).
They induce DNA synthesis and cell proliferation at least
in vitro and probably in vivo (Moore and Williams, 1973).
Control of granulopoeisis is thus effected via a number
of negative feedback loops. In addition, there is a
recent report suggesting that bacterial clearance rates
may also regulate and influence granulocyte production
(Hartmann et al. , 1981) . •• Neutrophils themselves do not
re-enter the circulation after passing into the tissues,
9
but this does not preclude the possible regulatory
products of bacteria or even neutrophil-derived
substances from the tissue site returning to the
circulation.
Neutrophils comprise approximately 75% of the
leucocytes sampled by venepuncture, the absolute count
being on average higher in women than men, and higher in
the afternoon than the morning (Bain and England, 19 75) .
These authors also demonstrated a significant correlation
between the peripheral blood neutrophil and monocyte
counts, so supporting the hypothesis of a linked
regulatory mechanism of production and release. However,
as illustrated in Fig. 1.1, the circulating pool of
granulocytes, while in equilibrium with the marginating
pool, may not be identical to it at any given time point.
The functional goal of neutrophils is to reach tissue
sites in order to confront bacteria and it has been
demonstrated experimentally that peripheral blood
measurements of cell numbers do not accurately correlate
with either the number of cells being produced or the
number migrating to infected sites (Hartmann et al.,
1981) .
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ANTIMICROBIAL FUNCTION OF NEUTROPHILS
The vital importance of an intact host defence
system is epitomised in studies of the neutrophil.
Defects of normal function are associated with recurrent,
severe or protracted infections, while neutropenia is
life-threatening, even in this antibiotic era. Over
the past 25 years, although the neutrophil has received
less attention by researchers than the lymphocyte, a
voluminous literature on all aspects of neutrophil
function has been produced. In the wake of these
original reports have appeared reviews relating to those
principal activities into which neutrophil physiology and
pathology are by convention divided, i.e. chemotaxis
(Wilkinson, 1979), phagocytosis (Stossel, 1974a,b,c),
microbicidal activity (Klebanoff, 1975; Block et al.,
1980; Root and Cohen, 1981; Segal, 1981) and functional
abnormalities (Tauber, 1981). Investigations have
reached a stage which allows the formulation of totally
comprehensive reviews of the neutrophil literature
(Murphy, 1976; Klebanoff and Clark, 1978).
Metschnikoff (1887) may have been the first to
record the phenomenon of in vivo phagocytosis in man, in
cells from the buccal cavity. He deduced that they had
probably migrated from the pharyngeal tonsils and used
this evidence in the development of his theory concerning
the evolution of phagocytic defences in sites of primary
11
bacterial challenge.
Phagocytosis like chemotaxis depends on the
integrity of microfilaments (e.g. actin and myosin) and
the microtubular system as well as the complex
interaction of electrolytes with these (Stossel, 1974;
Klebanoff and Clark, 1978: 126-132). The phagocytic
process operates effectively both in aerobic and
anaerobic conditions although killing is generally
impaired in the latter (McRipley and Sbarra, 1967a;
Mandell, 1974; Ingham et al. , 1981). However, it has
become apparent that the many variables involved in
phagocyte-microbial interaction, for example serum
factors, pH, bacterial species and strain-specific
surface characteristics, and oxygen tension, are of
paramount importance in determining the outcome. Thus many
experimental results are equivocal, and some anaerobes
for example have been shown to profoundly influence their
own phagocytosis and killing (Tofte et al., 1980).
Some recent studies have demonstrated that
neutrophils have a considerable potential for
extracellular killing of bacteria (Henson, 1980; Sips
and Hamers, 1981), but the classical bactericidal events
occur intracellularly, following phagocytosis (Klebanoff
and Clark, 1978: Chs. 4 & 7).
The "respiratory burst" in neutrophils (De Chatelet,
1975; Klebanoff, 1975; Rossi et al., 1977) is the key
12
to subsequent microbicidal events, and may be initiated
even before phagolysosomal formation is complete. This
very complex and imperfectly understood area of neutrophil
function centres around membrane-associated events
(Elsbach, 19 77; Henson, 19 80) . The energy requirement
is obtained principally by anaerobic glycolysis, since
neutrophils possess very few mitochondria (Elsbach, 1972;
Klebanoff and Clark, 1978: 191-192). As a result of the
respiratory burst, essential to which is the four-stage
reduction of oxygen to water, a number of reactive
molecules, ions and radicals are produced. For example,
hydrogen peroxide, H202, (Klebanoff, 1975), superoxide
anion (Babior et al., 1973; Johnston et al., 1975), the
hydroxyl radical (Johnston et al., 1975), and singlet'
oxygen species (Krinsky, 1974; Allen, 1979) have all
been shown to be bactericidal individually and may
interact to potentiate killing (Allen, 1979). In
addition, a powerful oxidising system is established if
primary granule-associated myeloperoxidase interacts with
halide and hydrogen peroxide (Klebanoff and Hamon, 1972;
Sbarra et al., 1977). The consensus of opinion is that
all these mechanisms are the basis of bacterial killing
by neutrophils (Block et al., 1980), but recent work has
suggested that the reactive oxygen species may be
incidental to the sequence of reduction of oxygen to
water. Reactive oxygen species also produce an
environment for alternative killing mechanisms and modify
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the intravacuolar pH (Segal, Geisow et al., 1981;
Segal, 1983). It may be, of course, that all types of
mechanism operate simultaneously to improve killing
efficiency.
The bactericidal armamentarium of the neutrophil
also includes the cytoplasmic granules and their contents.
These were described in detail, including histochemistry
and drawings made from microscopic observations, by
contemporaries of Metchnikoff (Kanthack and Hardy, 1894).
Once again there appears to have been a hiatus of over
half a century before the work of Hirsch and Cohn
regenerated interest in this area (Cohn and Hirsch, 1960;
Hirsch and Cohn, 1960). Two populations of granules
were described: azurophil (primary) and specific
(secondary). In the mature neutrophil specific granules
outnumber azurophil granules by approximately 2-3:1
(Klebanoff and Clark, 1978: 13-29), but species
differences in granule proportions and constituents exist
(Klebanoff and Clark, 1978: 29-35), which means that
antibacterial mechanisms of neutrophils in animals and
man are not always comparable. For example, only
chicken neutrophils have lysozyme at levels similar to
humans. Guinea pig neutrophils, often used in
experimentation, contain approximately 10% as much
myeloperoxidase as the human cell; chicken neutrophils
have none (Rausch and Moore, 1975). Specific granules
contain lactoferrin and about half of the cell's lysozyme
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(Leffel and Spitznagel, 1972). Bactericidal activities
of these agents are independent of oxygen. The
azurophil granules contain the remainder of the lysozyme
and the myeloperoxidase (Schultz et al. , 1965). The
lysosomes are a distinct population of granules
containing the acid hydrolases (Segal et al., 1980). The
neutral proteases and cationic proteins are also granule-
associated (Spitznagel and Chi, 1963; Olsson and Venge,
1972; Elsbach, 1977; Klebanoff and Clark, 1978: 455-
463) .
A much less researched area of neutrophil function
is the digestion and degradation of bacteria following
killing. The rate at which some constituents are removed
has been studied, particularly lipids (Elsbach, 1972).
The role of polyelectrolytes in controlling degradation
has recently received attention (Ginsburg et al., 1976;
Ginsburg and Quie, 19 80) .
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OTHER ACTIVITIES OF NEUTROPHILS
From clinical evidence alone, it is apparent that
the neutrophil is of paramount importance, both in
controlling pathogens and maintaining an equilibrium with
respect to the commensal flora. This balance is
delicate, and in the immunologically uncompromised
individual, few clinical problems arise. However,
there is increasing evidence that some forms of tissue
damage may be mediated by, or caused by neutrophil
activities.
It is important to maintain a perspective between
host defence and destructive activities of neutrophils.
Extracellular lysosomal enzyme release is no longer
considered to be the result of post-phagocytic cytolysis
alone but as a factor contributing to the inflammatory
process both destructively and beneficially. For
example, it has been suggested that pulmonary injury may
be caused by non-specific immunological enhancement of
neutrophil phagocytic activity (Lanser and Saba, 1981),
as well as by bronchoalveolar lavage fluids containing
high levels of potentially destructive lysosomal
hydrolases (Henson, 19 80) . Neutrophils contain
collagenase (Lazarus et al., 1968) which may contribute
to connective tissue breakdown, and in human periodontal
disease this may be highly significant in conjunction
with tissue damage caused by other lysosomal enzymes and
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immunological mechanisms (Page and Schroeder, 1981).
The role of extracellular enzyme release in tissue
destruction has been reviewed (Murphy, 1976: 177-199;
Henson, 1980). Much of this activity in the
inflammatory site may be essential to the degradation
and removal of endogenous and exogenous debris (Henson,
1980). Furthermore, myeloperoxidase-mediated killing,
traditionally considered to operate intracellularly, has
been shown to be extremely effective extracellularly
(Odeberg et al., 1974; Sips and Hamers, 1981). Thus
there is evidence for both destructive and protective
sequelae to enzyme release, although the final outcome
will also be determined by the extracellular buffering
capacity (Henson, 1980), and the potential for the
neutrophils themselves to inactivate existing enzymes
(Voetman et al., 1981).
Finally, neutrophils may limit tumour growth (Clark
and Klebanoff, 1975; Sendo et ad., 1981) , and contribute
to such physiological processes as collagenolysis in the




Gross functional disorders of neutrophils are
uncommon; that is, those which inevitably produce
significant clinical problems. With increasing interest
and sophistication in dissecting out the complex pathways
of activity, the role of neutrophil dysfunction in the
pathogenesis of common diseases will be elucidated
(Segal, 1981).
The most dramatic clinical manifestations,
illustrating the vital role of neutrophils in host
defence, occur in patients with agranulocytosis, which
may be acquired, e.g. following drug therapy (Harkness,
1981). Relative neutrophil depletion in the circulating
pool or neutropenia exists in various forms, the most
documented, apart from the effects of cytotoxic
drugs, being the congenital cyclical neutropenias (Baehner,
1978), which result from a defect in stem cell
proliferation. In such patients recurrent clinical
infections, with advanced periodontal disease and oral
ulcers, coincide with the neutropenic state. Other
forms of neutropenia have been described, such as chronic
benign neutropenia (Stahlie, 1956; Cutting and Lang,
196 4) , and syndromes of neutropenia with other
immunological dysfunctions (e.g. Bjorksten and Lundmark,
1976) .
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Defective neutrophil function has recently been
comprehensively reviewed (Tauber, 1981). Lesions may be
classified in terms of the established division of
neutrophil functions (chemotaxis, phagocytosis, granule
function, oxidative metabolism and killing), and
examples in all these areas are documented. One of the
most studied, but rare conditions, is that of chronic
granulomatous disease (CGD) first described by Berendes
et al. (1957) and which may result from an absence or
inactivity of the membrane-associated cytochrome b
essential for the respiratory burst (Segal and Jones,
1980). This prevents bacterial killing via the
oxidative pathways, except in the case of some catalase
negative bacteria which provide the neutrophils with
hydrogen peroxide. The inability of CGD neutrophils to
reduce nitroblue tetrazolium (NBT) after stimulation is a
useful diagnostic test, and has been applied to prenatal
diagnosis (Newburger et al., 1979).
Myeloperoxidase (MPO) is central to the oxidative
killing mechanism of neutrophils (Klebanoff, 1975) and
certainly each cell contains a large amount of this haem
protein (Venge et al., 1978). With improved screening
techniques, symptomless MPO-deficient patients have been
identified; thus the precise role and importance of MPO
is less certain (Parry et al., 1981). Clinical signs of
deficiency may only appear when enzyme activity is less
than about 10% of normal, partly because nature provides
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more enzyme than is necessary, and partly because other
compensatory mechanisms operate (Harkness, 1980).
The Chediak-Higashi syndrome occurs both in animals
and man. It is associated with abnormal granule function,
and increased susceptibility to infection (Wolff et al.,
1972). Other biochemical defects in neutrophil function,
such as glucose-6-phosphate dehydrogenase deficiency,
exist and all these and the above conditions have been
reviewed in considerable detail (Klebanoff and Clark,
1978) .
There is a vast literature relating to acquired
defects of neutrophil function, for example those caused
by tobacco smoke (Corberand et al., 1980), alcohol
(Brayton et al., 1970), fluoride (Gabler and Leong,
1979), antimicrobial drugs (Finch, 1980; Gnarpe and
Belsheim, 1981), the contraceptive pill (Kvarstein and
Gj0nnaess, 1981) and other steroid drugs (MacGregor et
al., 1974; Klempner and Gallin, 1978a). Neutrophil
function may be depressed by bacterial infection (Helium
and Solberg, 1977; Repine et al., 1976) . Direct
inhibition of chemotaxis has been demonstrated in relation
to particular-pathogenic organisms (Shurin et al., 1979;
Adamu and Sperry, 1981). Abnormalities are also
associated with some primary disease states, for example
diabetes mellitus (Mowat and Baum, 1971; Repine et al.,
1980) .
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Functional problems arise in granulocytic leukaemia
and other myeloproliferative states, as a result of the
neoplasia, the antimitotic chemotherapy, infection or
antimicrobial chemotherapy (Baehner et al., 1973;
Odeberg et al., 1975; Humbert et al., 1976; Pinkerton
and Robinson, 1976). Finally, it should be mentioned
that not all drug effects are adverse; some may in fact
enhance neutrophil function (Renz et al., 1974; Raeburn
1982; Grant et al., 1983).
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CONCLUDING REMARKS
Metchnikoff and others at the end of the 19th
century formulated theories of inflammation and immunity
which have largely stood the test of time. Surprisingly,
little progress was made regarding neutrophil function
for about half a century, but in the past 25 years, there
has been an enormous expansion of interest. Although
considerable advances have been made, aided by electron
microscopy and sophisticated biochemical and immunological
techniques, much is still to be discovered especially in
understanding the genetic basis and aetiology of
functional neutrophil disorders. Recent evidence has
suggested that a suppression of granulopoeisis by
T-lymphocyte subsets may be responsible for some forms of
neutropenia (Bogby, 1981). The biochemical lesion of
chronic granulomatous disease has almost been elucidated
and this condition may well be suited to genetic
engineering should that become practicable (Segal, 1981).
The kinetics of neutrophil migration are now
generally understood, but the fate of cells in the tissues
is far less certain (Fig. 1.1). It is not clear whether
or not the vast numbers of neutrophils which pass into
the tissues daily are "wasted". A more teleological
view, based on the evidence from severe deficiency states,
is that the migration of functional cells holds the body's
commensal population of bacteria in balance. Thus, in
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neutropenia, congenital or acquired, and in chronic
granulomatous disease, commensal organisms often cause
clinical infections, for example in the mouth, lungs, gut
and skin. Constant migration also establishes "pathways"
for the subsequent release of even larger numbers of
neutrophils if challenge by pathogens ensues. An
appreciation of neutrophil physiology in tissue sites,
exudates and secretions is thus central to achieving a
complete understanding of their in vivo significance, and
their role in the aetiology and pathogenesis of
inflammatory conditions, such as chronic periodontitis.
Most knowledge will be gained by comparison of cells
sampled from more than one compartment. Neutrophils do
not return to the circulation once in the tissues but in
the case of bacterial infection, peripheral blood
neutrophils will exhibit increased NBT reduction, despite
the stimulus being peripheral (Park et al., 1968). This
implies that there must be some signalling system at the
inflammatory site which has metabolic consequences
(Harkness, 1981; Hartmann et al., 1981).
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AIMS OF THIS STUDY
The purpose of this study was to investigate some
functional characteristics of gingival crevicular
neutrophils both to increase understanding of their
presumed protective role in the aetiology of human
periodontal disease and as a model of cellular migration.
The following investigations were proposed:
1) To collect crevicular neutrophils by a method
suitable for cell quantitation, including differential
counting, vitality testing, determining in vivo phagocytosis
and performing basic histochemical tests.
2) To examine the integrity of the respiratory burst by
nitroblue tetrazolium (NBT) reduction and compare this to
activity in peripheral blood neutrophils.
The reducing activity of human saliva was also studied.
3) To investigate the presence and activity of
myeloperoxidase (MPO) as an enzyme specifically related to
microbicidal function. The influence of two antibiotics
on MPO activity was studied in both crevicular and
peripheral blood neutrophils.
4) To apply the above assays to a small group of patients






Leucocytes in the Oral Cavity
The principal function of the neutrophil as an
essential antimicrobial system has been outlined in the
previous chapter. For the healthy individual in whom
no additional bacterial challenge exists, neutrophils
marginate in small blood vessels and pass via the tissues
onto mucosal surfaces. Thus, in secretions and exudates
they limit the activity of commensal bacteria and
contribute to the maintenance of host-microbial
equilibrium.
The oral cavity is a site of such neutrophil-
bacterial interaction, being extremely complex in that
both anaerobic and aerobic habitats exist, with
anatomical features as physically varied as, for example,
the ventral surface of the tongue, periodontal pockets
and the enamel tooth crowns. Finally, saliva and
crevicular fluid, both extremely variable in constitution,
further modify these interactions.
The presence of leucocytes in the oral cavity was
noted by Metschnikoff (1887) who deduced that they
originated from the tonsillar tissues. Some years later
Mendel (1916), having demonstrated the presence of
leucocytes, concluded that the gingival pocket may be
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regarded as a 'lymphatic sac'. Lacquer (1911) showed,
however, both morphologically and cytochemically that
these cells were polymorphonuclear leucocytes. As with
the study of functional characteristics of peripheral
blood neutrophils, several decades separated these early
observations from subsequent investigations on oral
leucocytes. Hagerman and Arnim (1954) commented that
epithelial cells and polymorphonuclear leucocytes were
present in smears of gingival crevicular material from
clinically healthy sites.
The gingival crevice is the principal route for
entry of leucocytes into the oral cavity (Sharry and
Krasse, 1960; Schiott and Loe, 1970) and the majority
are neutrophilic polymorphonuclear leucocytes (Klinkhamer,
1963; Attstrom, 1970; Raeste, 1972a). The rate of
entry of cells into the oral cavity as measured in
saliva is approximately 1 x 105 cells per second in a
fully dentate subject (Klinkhamer, 1963). Lower counts
are obtainable from totally edentulous subjects with
clinically healthy mucosa (Raeste, 1976). Initial
studies of oral leucocytes were limited to salivary
cells, collected by a mouth rinsing technique using
buffered saline, which were shown to be 90% neutrophils
and 10% unidentified mononuclear cells (Klinkhamer, 1963).
Wright (1968), however, recorded only 58% neutrophils with
very small percentages of' other myeloid cells but 38%
lymphocytes. More thorough methodology using a Millipore
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filter technique for collection (Raeste and Calonius,
1971) showed that 98-99% of salivary leucocytes were
neutrophils (Raeste, 1972a).
The first clinical application of salivary cell
counting was to develop an objective measurement of
gingival tissue inflammation. The rate of cell
migration into the oral cavity, or the orogranulocyte
migratory rate (OMR), was shown to correlate well with
the inflammatory state. The oral migratory rate index
(OMRI) was developed and accounted for the number of
teeth present, a factor which would obviously govern the
potential for cell migration (Klinkhamer, 1968a).
Skougaard et al. (1969), and subsequently Woolweaver et
al. (1972), demonstrated a positive correlation between
OMR and the Gingival Index of Loe and Silness (1963).
Other workers failed to confirm this either in children
(Cox et al., 1974) or in adults (Hase and Reade, 1979).
Once neutrophils enter the saliva, their functional
characteristics alter and over the past decade, with an
increasing awareness of their role in the aetiology of
periodontal disease, attention has been focused on more
detailed aspects of their function. Cells in saliva, a
hypotonic environment, tend to exhibit progressive
degeneration (Sharry and Krasse, 1960; Raeste and
Calonius, 1971; Raeste, 1972b) to an extent that may
result in their being mistaken for mononuclear cells
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(Raeste and Calonius, 1971). However, contact with
saliva may increase some aspects of neutrophil function
in vitro (Sela et al., 1981; Ginsburg, personal
communication) and such effects may be relevant to local
host-bacterial interactions. The majority of studies
are now conducted on leucocytes collected directly from
the gingival crevice especially since a variety of simple,
reliable sampling techniques have become available
(Cimasoni et al., 1977) .
Leucocytes in Gingival Crevicular Fluid
Sueda et al. (1969) collected gingival crevicular
fluid with filter paper strips. This did not permit
quantitation and a more precise method was described by
which crevicular material was removed with a sterile
platinum loop (Lange and Schroeder, 1971). The two
methods were then combined to examine eukaryote cells and
bacteria in the gingival crevice (Lange et al., 1972) .
Attstrom (1970) described a technique for examining cells
which were adherent to Styroflex film and he reported a
differential count of 97% neutrophils, with 2% monocytes
and 1% lymphocytes. These results accorded with those
of Raeste (1972a) for saliva, and also with those of
Egelberg (1963) who collected gingival crevicular fluid
with a capillary tube. These techniques permitted
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quantitation as did that described by Hershon (1971), in
which enzymes were assayed from crevicular fluid,
collected in absorbent paper points. However, only
small sample volumes were available when the gingivae
were clinically healthy. A custom-built acrylic
appliance was devised by Takamori (1963) and modified by
Oppenheim (1970), with internal channels along the buccal
and palatal margins to fit a dental arch precisely.
Fluid was collected by means of a pump method, now used
extensively in cellular and enzyme studies (Cimasoni,
1974; Kowashi et al. , 1980) . The disadvantage of this
device is the technical expertise required and the
inconvenience of having to construct one for each subject.
The rinsing method of Skapski and Lehner (1976) employed
a 50 n-1 microsyringe to introduce small volumes of Hank's
balanced salt solution into the gingival crevice and
then to re-aspirate the washings. The differential cell
count was performed on Leishman stained samples and shown
to be 91.5% neutrophils and 8.5% mononuclear cells.
Viability of the fresh cell sample dispersed in a Neubauer
chamber, by Trypan blue dye exclusion (McLimans et al.,
1957; Fallon et al. , 1962) increased from 81% for cells
in the initial washings to 99% in later samples. The
lower viability was ascribed to the early washings
containing exhausted and degenerating leucocytes. This
technique, sometimes in modified form, has been widely
used for the more recent, detailed studies of crevicular
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neutrophils, including one study in rats (Ramamurthy et
al., 1979). Wilton et al. (1976) reported a differential
count of 91% neutrophils and 8.8% mononuclear cells in
man, which was almost identical to that of Skapski and
Lehner (1976). They proceeded to show that the
mononuclear population comprised 24% T lymphocytes, 58% B
lymphocytes and 18% monocytes. Cell counts in human
gingival washings were reported as approximately 1 x 10s
neutrophils/ml; 85-87% were viable as tested with Trypan
blue (Wilton et al., 1977a,b). Similar values were
reported by Murray and Patters (1980), although they
recorded cell numbers per site sampled. Scully (1982)
found that 83% of crevicular neutrophils were viable and
that approximately 20% showed evidence of in vivo
phagocytosis. One of the difficulties with this washing
technique is the lack of precise quantitation. For the
original method devised by Skapski and Lehner (1976),
Challacombe et al. (1978) calculated a dilution factor of
between 1 in 20 and 1 in 50. Recovery of transfused
neutrophils from gingival crevices in Rhesus monkeys
showed that the concentration of cells was higher than
that of peripheral venous blood, so supporting the view
that there is a positive migration of cells, presumably
under chemotactic stimulus (Scully and Challacombe, 1979).
Finally, one study of crevicular neutrophils in beagle
dogs utilised the acrylic appliance technique of Oppenheim
(1970) combined with the aspiration method. The results
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were similar to those in man, i.e. 86% of the cells were
neutrophils, 8% mononuclear cells, with epithelial cells
and debris comprising the remainder (Kraal and Bowles,
1977) .
Gingival crevicular cells resemble peripheral blood
neutrophils more closely than those from saliva when
studied morphologically (Lange and Schroeder, 1971;
Raeste, personal communication). This is perhaps not
surprising since they have emerged into the crevicular
fluid after a short passage from the gingival capillaries,
through the connective tissue and junctional epithelium.
The rate of flow of gingival crevicular fluid in dogs has
been shown to vary directly with the clinical degree of
inflammation, but this relationship is less precise for
the migrating neutrophils (Attstrom and Egelberg, 1970;
Attstrom, Graf-de-Beer et al. , 1975). More recently,
evidence has been presented to demonstrate that in humans
also crevicular fluid and neutrophils enter the oral
cavity under independent control (Kowashi et al., 1980).
The leucocyte count was shown to vary with the
inflammatory state of the gingival tissues (Attstrom,
1970; Scully and Challacombe, 1979) and to reflect
systemic influences, e.g. as in diabetes (Ramamurthy et
al., 1979) .
In the classical concept of an inflammatory response,
neutrophils migrate under the influence of chemotactic
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stimuli. Clearly, the bacteria, their components and
products in the crevice and saliva constitute an adequate
and effective stimulus (Tempel et al., 1970; Lindhe and
Hellden, 1972; Hellden et al., 1973; Kraal and Loesche,
1974; Lindhe and Socransky, 1979; Scully and
Challacombe, 1979; Ginsburg and Quie, 1980).
Humoral Components of Crevicular Fluid
Complement components are also present in the
gingival tissue (Brandtzaeg, 1973; Genco et al., 1974)
and crevicular fluid (Shillitoe and Lehner, 1972).
Activation occurs in the crevice (Attstrom, Laurel et al.,
1975) and this may lead to subsequent tissue destruction
via immunological responses (Allison et al., 1976).
Equally it is likely to enhance neutrophil adherence via
C5a (Gallin, 1980), chemotaxis via C5a des arg (Wilkinson
and Lackie, 1979) and the binding of bacteria to
neutrophils followed by phagocytosis and killing via C3b
(Lay and Nussenzweig, 1968; Klebanoff and Clark, 1978).
Crevicular fluid also contains immunoglobulins,
principally IgG, which may further facilitate the
antimicrobial activity of neutrophils in this site
(Shillitoe and Lehner, 1972; Challacombe et al., 1978).
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Gingival Crevicular Neutrophil Function
The first dynamic studies of crevicular neutrophils
were undertaken to investigate the possible protective
role of these cells in periodontal disease and dental
caries. Electron microscopic studies in particular had
shown that neutrophils in the crevicular region could
phagocytose bacteria in vivo (Schroeder, 1970; Frank and
Cimasoni, 1972; Garant, 1976) and the conclusion drawn
from these observations was that they appeared to wall
off plaque bacteria from the gingival tissue (Attstrom,
1975; Garant, 1976; Newman, 1980). It has already been
mentioned that freshly stained preparations of crevicular
cells show evidence of phagocytosis (Scully, 1982). In
vitro studies in the same laboratory demonstrated that
crevicular neutrophils from clinically healthy sites were
less able to phagocytose Candida albicans blastospores
than peripheral blood neutrophils, although killing was
equally effective (Wilton et al., 1977a). It was also
shown that the decreased phagocytosis was probably due to
impaired C3b receptor function (Wilton et al., 1977b) ,
possibly induced by the exudate itself. In patients
with early or advanced periodontal disease, crevicular
neutrophil viability and phagocytic capacity for latex
particles were high (Murray and Patters, 1980).
Phagocytosis, however, was markedly impaired in cells
from patients with juvenile periodontitis, isolated from
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diseased sites only. The latter finding was consistent
with data from peripheral blood neutrophil studies in
sufferers from this aggressive, early onset form of
periodontitis (Cianciola et al., 1977; Clark et al.,
19 77; Lavine et al., 19 79) .
The bacteria usually associated with dental caries,
both in animals and man, are the various serotypes of
Streptococcus mutans (Fitzgerald and Keyes, 1960;
Loesche et al., 1975). Serotype c is most frequently
isolated in human caries (Duany et al., 1972) and in
Rhesus monkeys fed a sucrose-rich diet (Lehner et al.,
1975). It was hypothesised that crevicular neutrophils
might form an important component of the defence
mechanisms against these bacteria (Scully and Lehner,
1979a). Experimental evidence from subsequent in vitro
studies supported this hypothesis both in Rhesus monkeys
(Scully, 1980a) and man (Scully, 1982). The peripheral
blood neutrophil phagocytic and bactericidal capacities
exceeded those of crevicular cells, which were greater
than those of salivary neutrophils. These experiments
were conducted using streptococci opsonised with specific
antisera. It had already been demonstrated that
immunisation of monkeys with formalinised Streptococcus
mutans, serotype c, induced a significant protection
against caries (Lehner et al., 1975) . One mechanism for
such protection may be the induction of opsonising IgG
antibodies, which facilitate phagocytosis and killing of
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the streptococci both in the crevice and on the tooth
surface (Lehner et al. , 1976). Experiments using sera
from serotype c immunised Rhesus monkeys showed that
phagocytosis and killing were increased in comparison to
that with non-immune serum, not only for that serotype,
but for types e, a and d as well, presumably due to
antigenic cross-reactivity (Scully and Lehner, 1979b).
The cumulative evidence suggests that crevicular
neutrophils are functional, albeit in a reduced form as
compared to those from peripheral venous blood. They
appear to be more functional than salivary cells,
although a recent study has demonstrated the reverse with
respect to phagocytosis of Candida albicans and Salmonella
typhi via complement receptors (Sela et al., 1981).
The limited number of studies of gingival crevicular
neutrophils to date has therefore been in two groups, i.e.
the specific and detailed work which relates to the
protective immunological responses in dental caries and
the investigations of neutrophil function which may bear
relevance to the aetiology of periodontitis. With regard
to the latter, neutrophils were mostly challenged with
inert particles (latex) or Candida albicans, so that much
work is required to determine how neutrophils respond to
commensal bacteria which exist in periodontal pockets,
particularly to those anaerobes implicated in destructive
disease (van Palenstein Helderman, 1981) . It has been
suggested that variations in function of crevicular as
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compared to peripheral blood cells may be a general
feature of cells in an inflammatory exudate (Wilton et
al. , 1977a,b). Therefore it is relevant to investigate
the gingival crevicular neutrophils further for possible
relevance to the aetiology and pathogenesis of
periodontal disease and also as a model of phagocytic
cells migrating to primary sites of confrontation with
commensal and pathogenic bacteria.
The first requirement in the present study was
therefore to establish a suitable technique for collecting
cells in gingival crevicular fluid, and subsequently to
perform a series of basic investigations from which it
would be possible to conduct more detailed functional
studies.




an assessment of in vivo phagocytosis
basic histochemistry, exemplified by neutrophil
alkaline phosphatase (NAP) determination
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MATERIALS AND METHODS
Collection of Cells in Crevicular Fluid
Initially, serial washings were attempted as
described by Skapski and Lehner (1976) but using 1 ml or
2 ml disposable plastic syringes, with gauge 25 needles.
Although some cells were collected in this way, the
syringe and needle hub volumes were so large as to result
in considerable loss of material. Subsequently, a 50 jj.1
gas-tight Hamilton syringe (Hamilton Products, Bonaduz,
Switzerland) was used as in the original method (Skapski
and Lehner, 19 76) . Two needles were tested: a fixed
needle/syringe unit (Hamilton No. 705-N) and a removable
Hamilton, Luer-lock needle with appropriate fitting on
the syringe (No. KF-7265). Both the fixed needle and
removable needle (gauge 26, internal diameter 0.15 mm,
with a 12° bevel) provided flexibility and the long,
shallow bevel allowed penetration of the healthy gingival
crevice without apparent trauma.
To summarise the method of collection, 10 jj.1
aliquots of physiological rinsing fluid (PBS) were
introduced into the gingival crevice being sampled by
insinuating the bevelled needle tip along the dry tooth
surface. By slowly withdrawing the plunger, diluted
crevicular fluid containing cells was obtained. By
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repeating the process several times and pooling
washings from several sites, sufficient cells could be
obtained for a number of investigations.
Cell Viability-
Viability was assessed in leucocyte suspensions
from interproximal sites in 10 subjects with no evidence
of gingivitis according to the Gingival Index of
inflammation (GI < 0.2; Loe and Silness, 1963). The
investigation was repeated in a further five subjects
with clinical gingivitis of varying degrees (GI = 1.0-3.0).
The first two washings were discarded so as to remove the
heavy contamination of epithelial cells, bacteria and
possibly old leucocytes in the free crevicular fluid.
It was thus hoped that subsequent washings would contain
marginating cells. Subsequent aspirates were mixed on a
clean microscope slide with 0.5% Trypan blue dye (British
Drug Houses, Poole, England), a coverslip gently applied,
and the preparation immediately examined at magnification
x 312.5 with a Zeiss RA microscope (Carl Zeiss
(Oberkochen) Ltd., London). Viability was determined as
a percentage by scoring the number of leucocytes excluding
the dye per 100 cells counted 10 times per subject. This
method readily permits distinction between vital (clear)




This was the single most important item of
equipment for the basic investigations, including
histochemistry. The cytocentrifuge (Shandon Southern
Products Ltd., Cheshire) allows relatively small numbers
of cells in small volumes of fluid to be concentrated
into a monolayer within a 6 mm diameter circle on a
standard glass microscope slide. The bulk of the
suspending fluid passes out radially into an absorbent
filter paper strip placed between the glass slide and
the centrifuge well (Fig. 2.1). The manufacturers
recommend that the minimum volume used is 0.1 ml. Any
less causes the cell collecting area to be incompletely
filled. This was borne out by experience. For
leucocyte preparations the manufacturers suggest
centrifugation speeds of approximately 1500 rpm for 5-10
minutes. However, a series of preparations was made of
gingival cells collected from one donor (29 years of age,
male), centrifuged for various speeds and for varying
times in order to determine the optimum cycle to maintain
morphological quality for examination. Preparations
were stained routinely with Leishman stain.
Morphological integrity was scored subjectively as
follows:
, 0 = complete disruption of cells








FIG. 2.1: The cvtocentrifuge well
assembly. Twelve of these are
accommodated within the centrifuge head.
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2 = < 50% of cells well preserved, the majority
distorted
3 = 50-75% of cells well preserved
4 = overall maintenance of cell morphology
Effect of Storage
Once a suitable cytocentrifugation cycle had been
determined, the possibility of storing the cells was
investigated. Cells were collected and maintained in
the plastic tubes at 37°C in a water bath, at 4°C in a
refrigerator, or standing on the laboratory bench at room
temperature (approximately 20-22°C). These were
maintained for varying time periods before spinning onto
glass and morphological assessment was made as before.
Cell Number, Differential Leucocyte Count and in vivo
Phagocytosis
To determine these three parameters, cytocentrifuge
preparations of crevicular washings were made as follows.
Fifty microlitres of rinsing fluid were placed into a 2 ml
cylindrical plastic tube (Searle, High Wycombe, Bucks.),
and 20 serial samples were added. From this final
dilution, 0.1 ml was placed in the base of a cytocentrifuge
41
well and the glass slide preparation made by centrifugation
at 400 rpm for 5 minutes. The slides were stained
immediately with Leishman stain.
Cell number
The cytocentrifuge is not recommended for
quantitation. The manufacturers quote the results of
comparing microscopic field counts of sheep erythrocytes
to spectrophotometric density, from centrifugation volumes
of 0.2 ml. To determine whether a reasonably accurate
count was possible, the following method was employed.
The 0.1 ml cell sample was spun onto a glass slide and
stained as described above. The preparation was examined
at x 500 magnification with oil immersion. By traversing
the total 6 mm diameter several times it was possible to
determine that this diameter constituted 14 complete
fields. The edge of the preparation was not always
precisely demarcated. The following area calculation
was performed:
a) Diameter of one field of view = 1 unit
b) Diameter of total preparation = 14 units
Ilr2 = area of circle
.*. Area of one field of view = II x 0.52 =
3.141 x 0.25 = 0.7853 units
Area of total preparation = n x 72 =
3.141 x 49 = 153.94
.*. Ratio of total area to one field of view area
= - 195-988
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Thus approximately 196 field areas constituted the total.
Assuming an even distribution of cells within the
total area of the preparation made from 0.1 ml of fluid,
a calculation for the cell concentration was performed:
cell count/field x 196 x 10 = total number of cells/ml
This was tested for preparations from ten healthy adult
subjects with differing states of gingival health. Ten
random field counts were made per subject in order to
establish a mean value; the standard error of the mean
was calculated from the standard deviation.
Simultaneously, counts were performed using a
standard laboratory Neubauer counting chamber (Gallenkamp,
East Kilbride, Glasgow) for five of the subjects.
An additional set of results was calculated from
washings taken from two healthy young children to
determine any obvious differences between these and the
adults. These results were not included in the overall
analysis.
Differential leucocyte count
From the same cytocentrifuge preparation it was
possible to perform a differential leucocyte count. Five
random counts, each of 100 leucocytes per slide, were
made. Two preparations were made for each subject so
allowing a mean count of 1,000 cells to be obtained.
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Differentiation was based on standard nuclear and
cytoplasmic morphology and staining, according to a
standard text (McDonald, Dodds and Cruickshank, 1970).
The clinical state of the tissues from which the cells
were obtained was noted. Care was required because
there was a tendency for nucleated epithelial cells with
contracted cytoplasm to resemble large lymphocytes.
Neutrophil granulocytes with severe degeneration
exhibited rounded nuclei and were thus subject to
confusion with mononuclear cells. This phenomenon has
already been described for neutrophils in saliva (Raeste
and Calonius, 1971). On careful examination, however,
the nuclear staining between cell types was quite
different.
Further differential counting was performed on
cytocentrifuge preparations stained by the combined
method for non-specific and chloroacetate esterases
(Appendix 1). This method is used routinely in the
Haematology Department of the Western General Hospital,
Edinburgh and is based on individual reactions of
neutrophils and monocytes. With a-naphthyl butyrate as
substrate, the reaction is strong in monocytes and weak
in neutrophils but, using naphthol AS-D chloroacetate,
the reverse occurs. Lymphocytes are non-reactive. The
reaction principle is based on the hydrolysis of a
synthetic substrate (an ester derivative of naphthalene)
by the leucocyte esterases. A naphthyl compound is
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liberated which reacts rapidly with a diazonium salt to
produce a coloured precipitate in the cell cytoplasm
(Moloney, McPherson and Fliegelman, 1960; Li, Lam and
Yam, 1973; Cline, 1981). The method is considerably
more complex than that for Leishman stain, so that a
series of counts using each method was performed on five
subjects and compared.
In vivo phagocytosis
It was found that standard Romanowsky staining
(Leishman stain) permitted an assessment of in vivo
phagocytosis in crevicular exudate neutrophils.
Controversy exists regarding the accuracy of microscopic
evaluation of phagocytosis since it is possible to
mistake extracellular, adherent bacteria for intracellular
organisms. However, the method is widely used and, with
care and experience, can be reliable (Klebanoff and Clark,
1978: 163-166). In this study only one observer was
involved so that errors in judgement would be consistent.
Bacteria were recorded as intracellular only if the
outline of a phagocytic vacuole was visible. Mean values
were determined from 10 fields.
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The Relative Maturity of Crevicular Neutrophils
An additional investigation was conducted into the
state of neutrophils in the gingival crevice to determine
if the cells in the first washings were in fact
degenerating forms. It is possible to establish the
relative maturity of cells from their nuclear morphology
using the Arneth-Cooke count as described by Britton
(1969). Five stages for peripheral blood neutrophils
are described, from juvenile to fully segmented forms,
based on the extent of nuclear segmentation.
From five healthy adult subjects a cytocentrifuge
preparation was made of the pooled first washings of
five crevices. Three subsequent washings from the same
crevices were discarded, and the fifth washings were
again pooled, centrifuged onto glass and stained. The
Arneth-Cooke counts were performed at x 500 magnification
and compared. An additional category was included to
allow for recording of degenerating cells which are not
normally seen in peripheral blood films.
Neutrophil Alkaline Phosphatase (NAP)
The histochemical test reaction for NAP depends on a
diazo-dye coupling. That is, the substrate (naphthol
AS-MX phosphate) is hydrolysed by the alkaline phosphatase
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to aryl naphtholamide and phosphate. The aryl
naphtholamide is coupled to a diazonium salt to form an
insoluble precipitate which can be seen microscopically.
The test method employed was that of the Haematology
Laboratory, Western General Hospital, Edinburgh, which is
based on the method of Kaplow (1963) (see Appendix 2).
Freshly prepared films from peripheral venous blood and
crevicular washings from six healthy adult subjects with
no clinical evidence of gingivitis were prepared in order
to determine whether crevicular neutrophils exhibited NAP,
and if so how this related to peripheral blood NAP. The
results were expressed as a percentage of cells staining
positively for NAP and a score ascribed according to
intensity, as described by Cline (1981); see Table 2.1.
Thus, for 100 cells, all positive, a maximum score of
400 was possible.
TABLE 2.1:
CRITERIA FOR NAP SCORING
Percentage of cyto- Intensity of
Score per cell plasmic staining staining
0 0 0








The viability of crevicular neutrophils for the ten
subjects with no clinical evidence of gingivitis, mean
age 28.7 years, and the five with gingivitis, mean age
26.6 years, is shown in Table 2.2. The mean percentage
cell viability was 75.8 ± sem 1.2 and 74.8 ± sem 0.6
Figure 2.2 shows the progressive degenerative change
in one glass-adherent cell. This was photographed while
being observed during one of the viability assessments.
It can be seen that the cell became enlarged and
distorted as the blue dye entered the cytoplasm and
nucleus.
The standard error of a percentage is calculated from
the formula
However, this can only be applied to a single value and
not to each of ten constituent counts from which a
final mean was obtained for each subject in Table 2.2.
Neither would there have been an indication of any
possible variation between the ten counts of 100 cells.
To allow for this, errors of percentage figures are
quoted as standard errors of the mean (sem) throughout.
This gives larger error values than the SE %.
As an example, the SE % calculated on the mean viability
of 78.7% for the first subject in Table 2.2 was 1.29, in
contrast to 1.76 for the sem (p = 78.7, q = 21.3, n = 1000).
respectively There was no sex difference
*
p = percentage vital cells
q = 100—p
n = total number of counts





















































































































































































































































the neutrophil of the
Trypan blue dye.
x 750.
The photographs V7ere taken
at intervals of 2 min.
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Operation of the Cytocentrifuge
The subjective assessment of the morphological
integrity of neutrophils following various centrifugation
cycles is shown in Table 2.3. Very slow speeds produced
poor quality cells and low yields, particularly when the
time was short. On the other hand, the speed recommended
by the manufacturers (1500 rpm) produced equally poor
results for these exudate cells. The best morphological
appearances were produced by a cycle of 400 rpm for 5
minutes and almost as good by 500 rpm for 5 minutes. The
slightly slower speed, however, subsequently proved to be
more consistently reliable.
In order to determine if a longer centrifugation
time would improve the yield, speeds of 200 and 300 rpm
were used for up to 15 minutes in a subsequent experiment.
The cell yield improved but morphological appearances did
not. All subsequent preparations were therefore made by
a centrifugation cycle of 400 rpm for 5 minutes. At
this rotation speed, the g force was calculated to be
14.3 according to the standard formula:
_ g
g = 1118 x 10 x r x rpm2, where r = radius of
extended centrifuge head in cm.
g = 1118 x 10 ® x 8 x 4002 = 14.3
Figures 2.3a and b show examples of neutrophil
preparations produced under these conditions, and Fig. 2.3c
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TABLE 2.3:
RESULTS OF INVESTIGATION TO DETERMINE THE OPTIMUM CENTRIFUGATION









































































Centrifugation cycle for a)
and b) =400 rpm for 5 min;
for c) = 200 rpm for 5 min.
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an example in which considerable cellular disruption has
occurred.
Effect of Storage
The effect of storing the cells in the collecting
tubes at three temperatures over varying time periods is
shown in Table 2.4. Clearly the preservation of cellular
morphology was not affected by storage or the temperature
of storage up to 30 minutes. Beyond that time,
progressive degeneration occurred at all temperatures,
this being most marked at 4°C. Based on these findings
in subsequent work every endeavour was made to minimise
the interval between collection of cells and experimenta¬
tion.
Cell Number, Differential Leucocyte Count and
in vivo Phagocytosis
Crevicular cell numbers, differential leucocyte
count and in vivo phagocytosis were all determined from
the same cytocentrifuge preparations.
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TABLE 2.4:
EFFECT OF STORAGE OF CELLS AT 37°C, 4°C AND ROOM TEMPERATURE
(RT = 20-22°C), PRIOR TO CENTRIFUGATION AT 400 RPM FOR 5 MINUTES
Quality of Preparation
Time of Storage
(min) 37 °C 4 °C RT
10 4 4 4
30 4 4 4
60 3 2 3
120 2 1 3
360 2 1 1
TABLE 2.5:
CREVICULAR NEUTROPHIL COUNTS FROM ONE FEMALE SUBJECT, AGED 34 YEARS
Cell count/ml















Table 2.5 shows a worked example for one subject of
the calculation for mean neutrophil numbers/ml washings.
Table 2.6 shows a comparison for the mean counts of five
subjects between this microscopic method and that using
the traditional counting chamber. It is apparent that
the former procedure gave neither consistently higher nor
lower values than the traditional method, and the values
for each method were similar in magnitude. Statistical
comparison of the mean figure for the microscopic method
with the single figure obtained from the traditional
method was as follows:
Valuei - Value 2 _ t
sem for micro method
For 9 degrees of freedom, the significance level was
obtained from tables. The results are shown in Table 2.6.
In only one case was a statistically significant difference
noted.
The mean values for the counts as performed by the
microscopic method for the ten subjects with differing
clinical gingivitis are shown in the composite Table 2.7.
Clearly the values were extremely variable with, in most
cases, large standard errors of the mean. No
relationship was apparent between sex or age and count, or
indeed the Gingival Index.
TABLE2.6: CREVICULARNEUTROPHILCOUNTSFORVES BJECTSDE ERMINEDBYTH"MICROSCOPIC" METHODANDHAEMOCY OMETER/COUNTINGCHAMBER Subject Age (yrs) 34 17 23 29 24Sex F F F M MMicroscopic±sem 33,516±2,131 96,122±2,51 56,448±6,211 44,820±6,084 135,240±9,825
Neutrophilcount/ml
NeubauerChambtval e 30,0001.6499 90,0002.44 65,0001.3769 45,0000.0295 120,0000.7687
Significance P NS 0̂.05(ji
cn
NS NS NS


































































































































































































5.5±1 2 72.2±14 0
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The two small healthy boys had low cell counts, one
particularly so. The differential count was similar to
that for the adults, with a very high score for in vivo
phagocytosis for one (Table 2.7).
Differential leucocyte count
The differential white cell counts as determined by
the cytocentrifuge preparations of the same ten subjects
are shown in Table 2.7. The vast majority of leucocytes
in all cases were neutrophils with a very small
proportion of mononuclear cells. In one adult, and one
of the small children, the neutrophils constituted 100%
of the leucocytic population. It is important to note
that the standard errors were small for each subject and
the overall group means, which was not the case for the
total cell counts. There was no correlation between
the differential count and either the inflammatory state
of the gingival tissues or the total cell count for each
individual.
For the five subjects in whom the differential count
was repeated on a separate occasion and compared with
that using the esterase staining characteristics, the
results are presented in Table 2.8. In all cases, the
proportion of neutrophils identified by the more specific
staining method was higher, suggesting that with the
Leishman stained preparations, in which reliance was
TABLE2.8: COMPARISONFTWSTAININGMETHODSIDETERMINATIONDIFFE E IALLEUC CYTECOU FROMGINGIVALCREVICULARWASHINGSIIVESUBJECTS DifferentialCount-LeishmanStai %mean±SD Neutrophils 92.6±1.8 92.8±1.4 89.6±0.9 95.4±1.9 97.3±1.8Monocytes/ MacrophagesLymphocyt s 4.9±2 2 5.1±3 9.3±3 1 4.6±1 8 2.3±1 22.5±1 2.1±1 6 1.1±4 0.4±9SubjectNo. 1 2 3 4 5
DifferentialCount-EsteraseStai ing %mean±SD Neutrophils 98.8±0.9 99.0±1.5 97.8±1.6 100 99.1±0.8Monocytes/ Macrophages 1.2±0 8 1.0±1 1.5±4 0.8±9















placed on morphological and granular characteristics,
some neutrophils were scored as mononuclear cells.
Figure 2.4 shows the clear distinction between
granulocytes and a monocyte in a preparation stained for
esterase activity.
In vivo phagocytosis
Figure 2.5a illustrates the extracellular adherence
of bacteria to the surface of a neutrophil, while Fig.
2.5b shows bacteria within a phagocytic vacuole. Only
examples of the latter were scored as evidence of
phagocytosis in vivo. The values are also given in
Table 2.7 and demonstrate a wide variation within and
between individuals. The results demonstrate that
neutrophils within the crevicular exudate have
considerable phagocytic capacity.
The Relative Maturity of Crevicular Neutrophils
For the five subjects studied, the results of
Arneth-Cooke counts are shown in Table 2.9, as means for
the group. For the 100 cells counted according to the
method, it is interesting that, apart from approximately
5% degenerating forms in the first washings collected,
the count was very close to that given for a peripheral
blood film (Britton, 1969). In the fifth washing, the
small number of degenerating forms was still present, but
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FIG. 2.4: Cytocentrifuge preparation of crevicular
neutrophils stained for esterase activity. The
green/blue stained granulocytes are clearly
distinguished from the single macrophage,
x 750
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FIG. 2.5a: Bacterial adherence to the surface of
a crevicular neutrophil.
Leishman stain. x 1890.
FIG. 2.5b: Intracellular bacteria in crevicular
neutrophils, demonstrating in vivo phagocytosis.
Leishman stain. x 1890.
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TABLE 2.9:
MATURITY OF GINGIVAL CREVICULAR NEUTROPHILS
Arneth-Cooke Counts from Five Adult Subjects
(mean % cells in each category ± sem)
Washing No. I II III IV V Degenerate
cells
1 13 ±4 23 ±6 45 ±6 13 ±5 1 ± 2 5±3
5 25 ±7 32 ±5 23 ±5 15 ±6 1 ± 2 4±4
Normal peripheral
blood neutrophils* 10 25 47 16 2
★
Figures taken from Britton, C.J.C. (1969)
TABLE 2.10:
PERCENTAGE OF POSITIVE CELLS STAINING FOR NAP AND TOTAL SCORES FOR




Sex (yrs) % +ve cells Score % +ve cells Score
F 34 69 133 75 113
F 28 51 78 87 168
M 46 64 94 76 132
M 30 58 91 82 156
M 29 67 138 79 143
M 40 68 142 95 187
Mean 63 113 82 150
a considerable 'left shift' had occurred, indicating that
less mature forms were entering the crevice.
Neutrophil Alkaline Phosphatase (NAP)
Both peripheral blood and gingival crevicular
neutrophils stained positively for NAP. An example of a
positively staining neutrophil in a peripheral venous
blood film is shown in Fig. 2.6a, to which was ascribed
a score of 2. Figure 2.6b shows a preparation of
crevicular neutrophils exhibiting a range of positive
staining. For the six healthy subjects studied, the
percentage positive cells and scores ascribed in each
neutrophil population are shown in Table 2.10. A higher
proportion of crevicular neutrophils stained for NAP and
generally more intensely, although the variation was
considerable. Application of Student's 't' test to
the means for the percentage positive cells and also for
the scores showed no significant difference between the
two cell populations (t = 1.006 and 1.08 respectively,
p > 0.1). Linear regression analysis of the blood on
crevicular values demonstrated no significance in either
percentage positivity or total scores. As an example,
Fig. 2.7 shows the results from one subject studied.
The difference in distribution of staining intensity
between the two cell populations within one subject is
apparent, although this is not accounted for by standard
statistical analysis.
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FIG. 2.6a: Peripheral venous blood film stained for
alkaline phosphatase. Neutrophil shows positive
staining, score 2. x 1200.
FIG. 2.6b: Crevicular neutrophils stained for
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FIG. 2.7: Distribution of NAP scores for peripheral
blood and crevicular neutrophils from one healthy-
adult male subject (age 40 years).
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DISCUSSION
To minimise the theoretical risk of cross infection,
it was desirable to develop a crevicular fluid collecting
technique using entirely disposable materials. However,
for purely technical reasons, the best cell recovery was
obtained using a fixed needle 50 |il Hamilton syringe as
originally described by Skapski and Lehner (1976). The
design of the needle eliminates the problems of dead space
and also the turbulence arising from sections of widely
differing diameters, which could cause cellular distortion.
The manufacturers describe specific cleaning procedures
which were extended by always rinsing the syringe and plunger
in disinfectant (Chloros; ICI Ltd., Birtley, Co. Durham),
then strong detergent (Decon; Decon Laboratories Ltd.,
Hove, Sussex), followed by rinsing in water after use.
By such a regime it was hoped that any risk of contamination
or cross-infection would be minimised.
The viability of the majority of crevicular neutrophils
as determined by Trypan blue dye exclusion confirmed
previous studies on human subjects (Skapski and Lehner,
1976; Scully, 1982). The presence of clinically evident
gingivitis did not influence the proportion of cells
excluding dye. Skapski and Lehner (1976) reported a
further increase in viability with decreasing cell yields
by rinsing successively 12 times at each site. In the
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present study the first two washings were discarded in
order to remove the likelihood of including old,
degenerating cells, but subsequent washings were not
examined individually for cell viability.
One of the initial aims of this study was to explore
the possibility of developing a rapid, simple screening
test based on the collection of crevicular exudate
neutrophils. By making glass slide preparations with
the cytocentrifuge, this objective was realised, at least
in part. It was clear that crevicular neutrophils are
fragile, and 'gentle' centrifugation was required to
preserve their morphology. Too low a speed did not
provide sufficient force to place the cells onto the
glass, particularly if the cycle time was short. On
the other hand, too high a speed (e.g. that actually
recommended by the manufacturer) resulted in the cells
being 'smashed' against the glass slide and grossly
distorted, irrespective of the cycle time. Thus, the
conditions deemed most appropriate resulted in a
centrifugation force of 14 g , which is considerably less
than the 8 3 g used by Skapski and Lehner (1976) .
Despite the apparent cell fragility described above,
storage for up to 30 minutes was possible between 4°C
and 37°C with no loss of morphological integrity. This
was a potentially important point, if in subsequent tests
the cells were to be held prior to use. Crevicular fluid
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is a complex exudate containing electrolytes, ions and
proteins (Cimasoni, 1974); they probably contribute to
the maintenance of cellular homeostasis.
From a single cytocentrifuge preparation, three
parameters were measured: the total cell count, the
differential leucocyte count and in vivo phagocytosis.
The neutrophil count as determined from the calculation
described, although simplistic, appeared as accurate as
the traditional 'wet' counting chamber method which is
also error-prone. This was verified by statistical
analysis. The counts reported were consistent with
those of Wilton et al. (1977a,b) who reported equally
large standard errors using a counting chamber. No
correlation between the inflammatory state of the gingivae
and the cell count was demonstrable. This confirms the
unsuitability of using the migrating cell numbers as an
index of clinical inflammation (Hase and Reade, 1979).
In the classical description of an inflammatory
response, neutrophil granulocytes are eventually
superseded, usually after some hours, by macrophages.
This can be demonstrated artificially in the skin window
as described by Rebuck and Crowley (1955). In the
gingival crevicular exudate, however, this does not
happen, and the proportion of neutrophils is consistently
high. From the same Leishman stained preparations in
this study, the proportion of neutrophils in crevicular
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fluid washings was shown to be approximately 97%, which
confirms the findings of others (Egelberg, 1963;
Attstrom, 1970; Raeste, 1972a; Wilton et al., 1977b).
Apart from the very low proportion of neutrophils
reported by Wright (1968), which was based on cells
collected from saliva, other studies on cells obtained
directly from the crevice have put the differential
neutrophil count at approximately 90% (Skapski and
Lehner, 1976; Wilton et al., 1976). These workers also
employed standard Romanowsky staining techniques. An
explanation for the difference may be in the small
proportion of neutrophils that are starting to undergo
degenerative changes, seen more dramatically in salivary
cells (Raeste and Calonius, 1971). Thus, these cells
with rounding nuclei may be scored as mononuclear cells.
In addition, epithelial cells with contracted cytoplasm,
present in large numbers in the crevice, may resemble
monocytes. Finally, there is the possibility that
slight trauma, produced by the collecting procedure but
undetected clinically, could result in additional
extravasation of neutrophils and mononuclear cells. The
combined method for non-specific and chloroacetate esters
employed in this study served to resolve the issue.
Although there is no suggestion of a statistically
significant difference between the mean differential
counts shown in Table 2.8 for the five subjects studied
(t = 0.18; p > 0.1), it is clear that with the Leishman
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staining method a proportion of neutrophils were being
scored as mononuclear cells.
The conclusion to be drawn is that 'the' leucocyte
of the gingival crevice is the neutrophil granulocyte.
It may be hypothesised that mononuclear leucocytes are
present only accidentally, perhaps as a result of chance
extravasation, of microscopic tissue damage produced
during food impaction, or of the micro-ulceration of
chronic sub-clinical inflammation. Histological
examination of gingival tissue has revealed that
mononuclear leucocytes as well as neutrophils are a
prominent and distinctive feature during all stages of
chronic gingivitis and periodontitis. This infiltration
is restricted largely to the connective tissue and to a
limited extent the epithelium, but there is no evidence
that the monocytes or macrophages and lymphocytes are en
passage to the crevice, as are the neutrophils (Page and
Schroeder, 1976; Page and Schroeder, 1982: 251-260).
Almost a quarter of the cells in the samples studied
showed evidence of in vivo phagocytosis having occurred,
so confirming the findings of others (Attstrom, 1970;
Scully, 1980b). There was considerable variation both
within and between individuals, but these findings support
the hypothesis that crevicular neutrophils fulfil a
protective role. The left-shift in blood, according to
Arneth-Cooke counts, is often associated with infection
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and this example may be considered analogous. Many
cells had bacteria adhering to the surface or the
perimeter as shown in Fig. 2.5a. Since the fate of
crevicular cells is to be shed into saliva and swallowed,
this phenomenon must also be considered as a non-specific,
protective response. No correlation was shown between
the percentage of neutrophils exhibiting in vivo
phagocytosis and cell count for the test group, but the
possibility of phagocytosis occurring is likely to be
increased if the potential for bacterial-neutrophil
collisions increases within certain, unknown numerical
limits. Other factors such as opsonisation must also be
important. This may help to explain the high proportion
of cells containing bacteria in one of the children with
a concomitant low crevicular neutrophil count.
Alkaline phosphatase was assayed histochemically to
determine the feasibility of this type of investigation
in crevicular neutrophils. The enzyme was demonstrable
and more so than in peripheral venous blood neutrophils
collected simultaneously. This finding is consistent
with the fact that NAP is often raised (in peripheral
blood cells) during leucocytosis of severe infection,
among other clinical conditions. The gingival crevice
is a site of active confrontation between phagocytes and
bacteria, and this finding complements that of the
Arneth-Cooke counts. Controversy exists as to the
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physiological function of alkaline phosphatase, there
being less of the enzyme in human neutrophils than in
many other species (Rausch and Moore, 1975). The
localisation within the cell is also disputed (Klebanoff
and Clark, 1978: 48-49). Some workers have isolated it
in the specific granule fraction (Bainton et al. , 1971)
while others claim its presence in the membrane-associated
fraction (e.g. Spitznagel et al., 1974). Further
controversy arises because available data suggest that
NAP expression is related directly to maturation
(Pedersen and Hayhoe, 1971; Scott et al., 1982) although
others argue that the relationship is an inverse one
(Williams, 1975; Mishler and Williams, 1980). Thus,
the results presented here could be interpreted according
to either hypothesis.
The NAP scoring system being semi-subjective, leads
to wide variation in standard haematological practice so
that control patients are always required when testing
for suspected defects, as occurs classically in chronic
myeloid leukaemia. The blood values obtained were
comparable to those of a standard haematology laboratory
(G. Stockdill, personal communication). Crevicular
neutrophil values seemed to be higher than those for
blood, although possibly due to the small sample number,
the differences were not statistically significant.
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SUMMARY
It has been demonstrated that neutrophils are
readily collected in gingival crevicular washings in
large numbers. From cytocentrifuge preparations
carefully executed, total counts, differential counts
and an estimate of phagocytic function and basic
histochemical assays can be performed. The results of
all these studies indicate a functional, far from
expired, population of continuously migrating neutrophils
that are readily available for further investigation.
CHAPTER 3
NITROBLUE TETRAZOLIUM REDUCTION BY BLOOD AND




Circulating neutrophils are in transit between
their production site in the bone marrow and functional
challenge sites in the tissues, exudates and secretions.
In addition to the 'physiological' role, there clearly
exists, in terms of number, an enormous phagocytic
cellular potential to meet the demands of a localised or
systemic microbial invasion. Unless confronted by some
particulate or soluble antigenic stimulus, neutrophils
exhibit little metabolic activity, having very few
mitochondria, sparse endoplasmic reticulum and being
incapable of mitosis (Klebanoff and Clark, 1978: 191-
192). Each cell, however, has an enormous reserve and
stimulation of the cell membrane, which may be the
result of phagocytosis, produces an outstanding increase
in metabolic activity, and a concomitant increase in
cellular oxygen consumption. It is this 'metabolic
burst' or 'respiratory burst' that is central to




The neutrophil performs a range of functions which
require it to produce and expend energy, for example
cellular adherence, chemotaxis, phagocytosis and any
membrane mobilising activities. As stated above, few
mitochondria are seen in mature neutrophils and thus
oxidative phosphorylation accounts for a small proportion
of ATP production, over 99.9% being produced by anaerobic
glycolysis (Sbarra and Karnovsky, 1959; Jemelin and
Frei, 1970; Stjernholm and Manak, 1970; Klebanoff and
Clark, 1978: 339). During glycolysis, via the Embden-
Meyerhof pathway there is a net production of two ATP
molecules (four less two utilized in phosphorylation
reactions) resulting in the generation of lactate. The
lactate may contribute to bactericidal systems either
directly, or indirectly by reducing the pH in the
phagolysosome (Hirsch and Cohn, 1960) . Some authors
have recently suggested, however, that this is of little
significance (Murphy, 1976: 171; van Zwieten et al. , 1981).
The principal energy source is thus glucose or its
storage form glycogen, which comprises 1-2% of the wet
weight of the human neutrophil (Klebanoff and Clark, 1978:
327). Glucose, whether exogenous in origin or
endogenous from glycogenolysis, is degraded anaerobically
to pyruvate and lactate. Following glucose-6-phosphate
formation, the pathway may be direct glycolysis to
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lactate or via the hexose monophosphate shunt (HMPS).
The HMPS, or pentose cycle, is a series of reactions by
which pentose sugars are produced as the basis of
nucleotide synthesis or more importantly in the case of
the neutrophil, to be returned to the glycolytic pathway.
Of vital importance, however, is that during this
process the cell generates NADPH, essential for reducing
reactions central to microbicidal systems (Fig. 3.1).
There is thus a crucial link between energy
metabolism and the metabolic 'diversion' created for
the specific functions of this cell.
The HMPS is dependent upon the availability of
NADP+, generated from, for example, the glutathione
system (Fig. 3.1). In the resting state glucose
utilisation via the HMPS accounts for only 5% of the
total (Beck, 1958a; Stjernholm and Manak, 1970)
whereas with phagocytosis this rises to nearly 40%
(Stjernholm and Manak, 1970). By contrast, direct
glycolysis predominates as the major pathway in the
resting cell (Beck, 1958b) and increases only slightly
during phagocytosis (Stjernholm and Manak, 1970).
Inhibition of the glycolytic pathways results in
inhibition of phagocytosis (Elsbach, 1972).
Phagocytosis proceeds normally in anaerobic conditions
although bacterial killing is impaired (Selvaraj and




FIG. 3.1: The link between glycolysis, HMPS, the
generation of NADP and the initiation of the oxygen-
dependent microbicidal pathway. Adapted from
Klebanoff and Clark, 1978: Figs. 6.11, 6.13 and 6.19.
Key to enzymes:
1- Pyruvate kinase
2- NADH-linked lactate dehydrogenase
3- NADPH-linked lactate dehydrogenase







integrity depends upon an intact oxygen-dependent system
which, as stated above, is crucially linked to the HMPS.
The enzyme which forms this link via which molecular
oxygen is reduced to water, is the membrane-associated
oxidase. This will be considered in the next section.
The Metabolic Burst
Fifty years ago it was observed that canine
neutrophils challenged with Sarcina lutea exhibited an
increase in oxygen consumption (Baldridge and Gerard,
1933) and this phenomenon has been confirmed by other
groups of workers (Sbarra and Karnovsky, 1959; Cohn and
Morse, 1960). Non particulate stimuli which are
surface active, also produce this effect, but without a
classical phagocytic response (Goetzel and Austen, 1974;
Schell-Frederick, 1974; Rossi et ad., 1977) . The
increase in oxygen uptake is extremely rapid, occurring
within seconds of membrane stimulation (Patriarca et al.,
1971; Rossi et ad., 1972; Segal and Coade, 1978) and is
sustained for several minutes (De Chatelet et al., 1972;
Segal and Coade, 1978; Romeo £t al., 1979) . The
subsequent fate of the oxygen is entirely dependent on
initial triggering of the neutrophil membrane, and the
associated activity of an oxidase enzyme (De Chatelet,
1978). Oxygen consumption is governed to some extent
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by the nature of the stimulus (Klebanoff and Clark, 1978:
284), but it is unaffected by cyanide, so demonstrating
that the cytochrome system is not responsible for the
metabolic burst (Sbarra and Karnovsky, 1959) . The
consensus view is that the key enzyme is an NADH or
NADPH oxidase and intense efforts have been directed
towards identifying its precise localisation (see
reviews by Karnovsky, 1973; Klebanoff, 1975; De
Chatelet, 1978).
Over the past few years several neutrophil enzymes,
such as myeloperoxidase, NADPH oxidase, NADH oxidase and
amino acid oxidase, have been proposed as candidates
for the oxidase (Klebanoff and Clark, 1978: 352-361).
Klebanoff and Clark (1978) clearly favoured either
myeloperoxidase or an NADPH oxidase. In their review,
they stated "Conclusive evidence for the presence of a
distinct NADPH oxidase would be its purification and
the elucidation of its structure and properties. This
has not yet been reported." (Klebanoff and Clark, 1978:
361). It should be repeated that whatever the nature of
the oxidase, it must provide the essential link with the
activation of the HMPS, and Klebanoff and Clark (1978:
362) stated that NADPH oxidase would meet these criteria.
Research activity into the nature, localisation,
properties and function of the NADPH oxidase has been
intensive over the past few years (Babior, 1983). There
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are various reasons for the degree of interest in this
single aspect of phagocytic cell function, among which
are the relevant ease of cell collection and functional
investigations, but more importantly there is a clear
observable relationship between a molecular and
biochemical function, as well as dysfunction producing
dramatic clinical disease. The rare hereditary and
debilitating chronic granulomatous disease (CGD) and
leucocyte glucose-6-phosphate dehydrogenase deficiencies
are directly related to dysfunction in the NADPH oxidase
and related HMPS.
Although Iyer and Quastel (1963) described the
principle of the oxidase reaction, it transpired that
they were probably measuring myeloperoxidase activity,
since they studied resting cells. NADPH oxidase only
becomes stimulated in conjunction with the HMPS on
stimulation of the neutrophil. The actual identification
was made in a series of studies by Rossi and his colleagues
(Rossi and Zatti, 1964; Patriarca et al., 1971;
Patriarca et al., 1975; Romeo et al., 1979), and their
findings have been confirmed by other workers (De Chatelet
et al., 1975; Babior et al., 1976; Suzuki and Kakinuma,
1983). The oxidase also appears to require specific
divalent cations for optimum function (Green et al., 1983).
The essential function of the oxidase is to catalyse the
reaction:
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NADPH + 202 NADP+ + 202*~ + H+
By further reduction, this ultimately results in the
production of water when the cell is stimulated with an
appropriate agent (Babior et al., 1976; Suzuki and
Lehrer, 1980).
Various studies have indicated that the NADPH
oxidase is concentrated within the plasma membrane of
the neutrophil (Briggs et al., 1975; De Wald et al.,
1979; Badwey et al., 1980) and that, following
stimulation, it can also be detected in the membranes of
the phagolysosomes both in guinea pig (Bellavite et al.,
1982; Tsunawaki et al., 1983) and human neutrophils
(Borregaard, Heiple et al., 1983). This phenomenon
incidentally is not limited to eukaryote cells
(Dechartellier et al., 1983).
The precise composition of the NADPH oxidase has not
been finally elucidated, partly due to technical
difficulties, so that most of the information collected
has been based on studying the effects and properties of
the oxidase system. Considerable interest and intense
study have been applied to a few putative components.
Foremost of these is a low potential cytochrome b, present
in plasma membranes of human neutrophils, but absent from
neutrophils of patients with chronic granulomatous
disease (Segal and Jones, 1978, 1980; Cross et al., 1981).
Segal's group has in fact done most to elucidate many of
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the properties of this unusual cytochrome and a recent
paper has reviewed the state of knowledge (Segal, 1983).
The cytochrome, which is only found in phagocytic cells
I
(Segal, Goldstone et al. , 1981), has the lowest mid-point
potential at -245 mV of any mammalian cytochrome so far
studied (Cross et al., 1981). Evidence has also been
presented for the participation of a flavin, specifically
FAD (Babior and Peters, 1981; Cross et al., 1982).
Segal (1983) thus believes that the cytochrome
the terminal component of the electron transport chain
which results in the reduction of molecular oxygen to
the superoxide anion, and his group have proposed the




> FAD > cytochrome 2 45 **
NADP +
(Cross et al., 1982)
Babior (1983), however, argues against the involvement of
the b cytochrome, suggesting that the kinetics of its
reduction are inconsistent with those of superoxide
production in human cells. He favours the participation
of a quinone, quoting the evidence of other workers
(Sloan et al., 1981; Crawford and Schneider, 19^2).
Segal (1983) does not share this view and experimental
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evidence has been presented to suggest that neutrophil
ubiquinone is present in the small mitochondrial fraction,
and thus is not a participant in NADPH oxidase function
(Cross et al., 1983). Clearly the question of precise
composition remains to be totally clarified, but there
is general agreement, as stated previously, that NADPH
is the superoxide-generating electron donor as simply
depicted in Fig. 3.1. It is also supposed that the
ensuing reduction of oxygen is the basis for the oxygen-
dependent microbicidal system (Babior et al., 1975;
Klebanoff, 1975) . Thus a number of ionic species and
radicals participate directly or indirectly in bringing
about bacterial killing by some form of oxidation process.
Superoxide anion, the perhydroxyl radical, the hydroxyl
ion, various singlet oxygen species, hydrogen peroxide
and myeloperoxidase-mediated oxidations are all implicated
and illustrated in Fig. 3.2 (for review see Klebanoff and
Clark, 1978: 409-446). The myeloperoxidase system will
be the subject of detailed discussion in chapter 4 but is
dependent upon a supply of substrate, principally hydrogen



















FIG. 3.2: Several radicals and ionic species are
produced in the phagocytic vacuole as a result of
the membrane-associated reduction of molecular oxygen.
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Superoxide Anion
The first reduction product of electron transfer to
oxygen is the perhydroxyl radical (H02) or its ionised
state the superoxide anion (02 ) . The pKa of the
reaction
HO2 H+ + Oj" is 4.8,
so that at neutral pH the superoxide anion predominates
(Klebanoff and Clark, 1978: 289). This highly reactive
anion may be formed by a large number of biochemical
mechanisms (Fridovich, 1972) but was first shown to be
produced in human neutrophils by Babior and his colleagues
(1973). In fact, nearly 30 reaction mechanisms have been
proposed as resulting in superoxide production and at
least a third of these may be feasible in neutrophils
(Klebanoff and Clark, 1978: 290). The generation of
perhydroxyl rather than superoxide has recently been
proposed (Allen, 1979) but refuted by Roos, Hamers et al.
(1983). The superoxide anion may of course either lose
an electron and act as a reductant so being converted to
oxygen, or gain an electron so acting as an oxidant and
itself being reduced to hydrogen peroxide (Klebanoff and
Clark, 1978: 289). Furthermore, the interaction of two
superoxide ions leads to a dismutation reaction:
Or + 02"~ + 2H+ > 02 + H202
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which proceeds rapidly under the influence of the enzyme
superoxide dismutase (Fridovich, 1972; 1975). There
are distinct forms of dismutases varying in the divalent
ion metallic content (Klebanoff and Clark, 1978: 291-293),
and these are widespread in aerobic mammalian cells. It
has been suggested that the principal functions of the
dismutase, rather than the generation of hydrogen peroxide
per se, are to protect the cell against the toxic effects
of oxygen radicals (McCord et ad., 1971) , a concept that
is receiving close scrutiny at present.
The production of superoxide by human and animal
neutrophils has been studied extensively and shown to be
markedly increased by the phagocytosis of latex particles
(Babior et al., 1973) , bacteria (Curnutte and Babior,
1974) and zymosan (Rosen and Klebanoff, 1976). In
addition, soluble stimuli which perturb the neutrophil
membrane, may also induce superoxide production. Examples
of these are fluoride (Curnutte and Babior, 1975) and
phorbol myristate acetate (De Chatelet et ad., 1976).
There is evidence that a significant proportion of the
oxygen consumed on cellular stimulation is converted to
superoxide (Curnutte and Babior, 1974; Weening et al.,
1974), although its actual presence in phagocytic
vacuoles is speculative. The acidic pH of the vacuole
would favour dismutation to hydrogen peroxide,
particularly in the presence of superoxide dismutase;
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In one study approximately 50% of the hydrogen peroxide
produced during phagocytosis was shown to be derived
from the dismutation of superoxide (Root and Metcalf,
1977). More recently, the generation of superoxide in
neutrophils has been in dispute, in the sense that it may
not be an invariable product of electron transport to
molecular oxygen. The grounds for controversy are based
on essentially technical considerations. The standard
method by which superoxide is assayed depends upon the
reduction of ferricytochrome c by whole cells, and the
inhibition of this reaction by superoxide dismutase
(Babior et al., 1973). The principle of the reaction is
as follows:
or + Cyt c (Fe3+) ^ 02 + Cyt c (Fe2+),
so that oxygen is regenerated. In 1979, two conflicting
reports were published, one of which upheld this reaction
(Babior, 1979) and one which reported no such activity in
stimulated neutrophils (Segal and Meshulam, 1979). The
nature of the stimulant is of prime importance. It has
been shown that latex is a poor generator of superoxide
(Weening et al., 1975; Curnutte and Tauber, 1983),
although the respiratory burst is activated (Curnutte and
Tauber, 1983). In another report the soluble stimulant,
N-formylmethionyl-leucyl-phenylalanine (FMLP), was far
more effective in stimulating neutrophils to produce
superoxide than opsonised zymosan (West et al., 1983).
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These authors also suggested that other mechanisms may
exist by which ferricytochrome c is reduced. Clearly,
in vivo and in vitro, different stimuli may differentially
trigger the univalent reduction of oxygen to superoxide or
a two electron donation to produce hydrogen peroxide
(Curnutte and Tauber, 1983). This view is shared by
others who believe that the physiological end product of
the oxidase system is hydrogen peroxide and not superoxide
or the perhydroxyl radical (Roos et al. , 1982; Roos,
Hamers et al., 1983).
Measurement of Superoxide Anion
As stated above, the standard assay for superoxide
depends upon the reduction of ferricytochrome c and more
importantly, given the possible reduction by agents other
than superoxide, the inhibition of this reduction by
extraneous superoxide dismutase (Babior et al., 1973;
Weening et al., 1975; Babior and Cohen, 1981). As with
other such measurements of neutrophil function, superoxide
production by stimulated or phagocytosing neutrophils is
markedly greater than that for resting cells (Klebanoff
and Clark, 1978: 297-298). The generation of superoxide
anion may be monitored over a fixed time period or
continuously, but it has been pointed out that the
ferricytochrome c does not enter the cells. Therefore,
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these assays only detect the superoxide which is released
into the extracellular medium, with the result that an
unknown proportion may be undetected (Babior and Cohen,
1981). An indirect assay of superoxide production is
possible by utilising the intracellular reduction of a
soluble dye, nitroblue tetrazolium (NBT).
Nitroblue Tetrazolium Reduction
The historical development of tetrazolium salts and
their applications in oxidoreductase histochemistry have
been described in detail by Pearse (1972: 880-920). The
first compound, prepared almost 90 years ago, was triphenyl
tetrazolium chloride, and subsequent development through
the first half of the 20th century was slow. However,
after the Second World War, there was a demand for more
sensitive agents and a second group of tetrazolium agents
became available, neotetrazolium, blue tetrazolium and
iodophenyl-nitrophenyl substituted tetrazolium chloride.
These were quickly applied to histochemical methods and
widely used for nearly ten years. One of these,
neotetrazolium chloride, was used in a series of
sophisticated experiments to determine the metabolic
response of rat peritoneal exudate cells (60-70%
neutrophils) to brucella organisms (Shaffer et al., 1953).
These workers were not able to use nitroblue tetrazolium,
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as stated erroneously by Klebanoff and Clark (1978: 308),
because it was developed along with others in the next
generation of compounds, between 1956 and 1963 (Pearse,
1972: 882).
Other compounds have since followed in attempts to
increase sensitivity and quality of staining, which
depend on a number of factors, particularly the redox
potential, substantivity for protein and lipid solubility.
The half-wave potential of a tetrazolium salt indicates
the theoretical ease of reduction to a coloured formazan,
so that nitroblue tetrazolium with an value of -50 mV,
at pH 7.2, is easily reduced and particularly useful in
biological systems, since its other properties are also
favourable. NBT is a substantive ditetrazole, and more
fully described as 2,2'-di-p-nitro-phenyl-5,5'-diphenyl-
3,3'—(3,3*-dimethoxy-4,4'-biphenylene) ditetrazolium
chloride (Tsou et al., 1956).
The reduction of a tetrazolium salt involves the
acceptance of electrons from an oxidised substrate or
intermediate electron carrier with a conversion to a
coloured formazan. In dehydrogenase histochemistry-,
under the influence of a tetrazolium reductase or
diaphorase (Pearse, 1972: 907), the reaction would be:
NAD(P)H + tetrazolium salt ± NAD(P)+ + formazan
Unless there is depletion of the pyridine nucleotide via
*Affinity of the tetrazolium salt as defined by chemical thermo¬
dynamics .
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a different pathway, this reaction will proceed to the
right, since formazans are not reoxidised in biological
systems. As Pearse (1972: 917) states, given the
relative redox potentials of the biological mechanisms
under investigation and the tetrazolium salts, particularly
those more recently developed, there is every reason to
suppose that electrons will flow from the former to the
latter. With manipulation of this chemistry, and
choosing an appropriate combination of other properties in
the system, tetrazolium salt reduction has been applied to
the intersection of electron transfer in plant tissues as
well as prokaryotic and eukaryotic cells.
Nitroblue Tetrazolium Reduction in Neutrophils
Neutrophil leucocytes, particularly stimulated cells,
clearly possess the potential for reduction of tetrazolium
salts. Shaffer and his colleagues (1953) demonstrated
this with neotetrazolium (NT) and similar results were
subsequently published to confirm their findings, and all
demonstrated that the neutrophil leucocyte was the most
reactive of all human peripheral blood cells (Marcuse and
Cochran, 1961). However the newer nitroblue tetrazolium
(NBT) offered increased sensitivity (for example,
E| NBT - 50 mV, NT - -170 mV) with the production of an
intense blue or black formazan.
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In 1960 Quaglino and Hayhoe employed an acetone
fixation method with NBT to demonstrate dehydrogenases
in leucocytes, but one year later a method was described
using NBT in a supra-vital system (Balogh and Cohen, 1961) .
In 1966, Baehner and Nathan reported a lack of NBT
reduction by neutrophils from patients with CGD and
published a more complete account the following year
(Baehner and Nathan, 1967). This heralded a period of
intense interest and activity in clinical applications of
NBT testing. Initially a number of workers confirmed
the results of Baehner and Nathan (Windhorst et aJL. , 1967;
Park et al., 1969; Gifford and Malawista, 1970), but
attention soon focused on the possibility of using NBT
reduction as a marker for bacterial infection (Park et
al., 1968). A number of studies were encouraging
(Freeman and King, 1972a; Wollman et al., 1972;
Freeman et al., 19 73) , but others drew attention to
difficulties (Matula and Paterson, 1971; Gordon et al.,
1973) and considered the test unreliable (Segal et al.,
1973; Segal, 1974; Steigbigel et al., 1974).
Subsequently a series of reviews has been published in
an attempt to provide a balanced appraisal of NBT tests
(Editorial, Lancet, 1971; Gordon and Rowan, 1973; Segal,
1974; Ward, 1974; Klebanoff and Clark, 1978: 308-316).
Many potential problems have been discussed in these
reviews. For example the anticoagulant used following blood
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collection may influence the results (Gordon et al.,
1973; Helium and Solberg, 1973; Bjorksten, 1974). The
concentration of NBT used in a test may be sufficiently
high as to be toxic to the neutrophils (De Chatelet and
Shirley, 1975). Drug therapy may influence the neutrophil
response. For example some authors have reported that
steroids depress NBT reduction (Mandell et al., 1970)
whilst others have found no effect (Wollman et al., 1972).
With respect to using NBT tests for diagnosing clinical
infections, extensive lists have been produced documenting
situations in which both false negative results (normal or
low values in the presence of bacterial infection) and
false positive results (increased values in the absence of
infection) may occur. Klebanoff and Clark (1978: 314-
315) cite 11 circumstances in which the former may be seen
and 31 of the latter. Current practice with respect to
the diagnosis of bacterial infection is to use an NBT test
only in conjunction with other investigative procedures.
It has been emphasised that there is no such thing as the
NBT test (Freeman and King, 1975), and each laboratory
must establish a method and determine normal values and
ranges for that method. In clinical immunology the test
is, however, invaluable for diagnosing the existence of
CGD and this will be discussed further in chapter 5.
When CGD is suspected, the so-called "stimulated" NBT test,
devised by Park and Good (1970) is virtually confirmatory.
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Unstimulated neutrophils from a healthy donor with
no bacterial infection reduce NBT to a very limited
extent. Positive cells occur for a number of reasons.
For example NBT may diffuse through the plasma membrane,
or heparin-formazan complexes may be formed which can be
phagocytosed (Segal and Levi, 1973). Metabolic
stimulation may occur as a result of the test system, e.g.
when cells are adherent to glass (Gifford and Malawista,
1970). Park and Good's stimulated test was designed to
override these factors by producing a definitive challenge
to the cells, which is clearly seen in normal neutrophils
and clearly absent in neutrophils from a patient with CGD.
After Baehner and Nathan (1966) triggered interest in
NBT tests, they have been developed broadly along two
lines. Semi-quantitative histochemical techniques as
first described by Park et al. (1968) employ an incubation
of cells with NBT, followed by glass slide preparation, so
that the percentage of positive cells can be counted
microscopically. This approach is technically simple,
but care is needed to avoid cell clumping during
incubation (Ward, 1974). Many variations of this test
and modifications have been described (Preisig and Hitzig,
1971; Freeman and King, 1972b; Gordon et al., 1973;
Gordon et al., 1 975; Babior and Cohen, 1981) . A method
which permits the use of small cell numbers was described
by Gifford and Malawista (1970). As mentioned above, the
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cells are permitted to adhere to a glass slide before
being challenged and variations on this technique have
also been published (Gifford and Malawista, 1972; Repine
et al., 1979; Babior and Cohen, 1981).
The other technique is spectrophotometric and is
therefore fully quantitative (Baehner and Nathan, 1968).
This provides a precise measure of the total NBT reduction
by a given number of cells, but requires more sophisticated
equipment. Recently a miniaturised quantitative test was
described, which permits the rapid processing of multiple
tests (Hofstaetter and Brammsen, 1981; Pick et al. , 1981).
Since the initial promise of a universally acceptable
NBT test for monitoring and diagnosing infection was not
fulfilled, the review articles of the mid-1970s were
followed by a much reduced rate of publication on this
subject, largely devoted to laboratory research, and in
particular the reduction mechanism.
The principle of NBT reduction is common to all these
techniques and variations, and any established test should
demonstrate an increase in reduction by normal neutrophils
when stimulated.
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Mechanism of Nitroblue Tetrazolium Reduction by
Neutrophils
Over the past 15 years uncertainty has prevailed as
to the precise mechanism of NBT reduction in neutrophils.
It has always been apparent that the source of electrons
which effect the reduction must centre on the membrane
oxidase, and thus the metabolic or respiratory burst.
The discussion and debate as to the nature of that
oxidase has been described earlier in this chapter.
The formazan of reduced NBT first appears in the
phagocytic vacuoles and later in the cytoplasm (Nathan
et al. , 1969). The associated cyanide-insensitive
enzyme or enzymes can be isolated from both the soluble
and membrane fractions of neutrophils (Humbert et al.,
1973; De Chatelet et al., 1974; Segal and Peters, 1977).
Over ten years ago it was demonstrated that solubilised
fractions of human neutrophils contained several NBT-
reducing pyridine nucleotide diaphorases (Holmes and
Good, 1972) , and recent studies using polyacrylamide gel
electrophoresis have confirmed this (Phillips ejt al. ,
1982). These latter authors point out that this approach
is limited in that the considerable membrane-associated
enzyme activity is lost, as may be enzyme co-factors, as
a result of the experimental procedure.
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From the studies on cell sonicates it would appear
that a direct reduction of NBT is possible by reduced NAD
or NADP and in disrupted cells may therefore be oxygen
independent. However, in intact human cells there
appears to be an absolute requirement for oxygen and
Baehner's group have proposed a scheme for NBT reduction
which depends upon a functional respiratory burst oxidase
(Baehner et al., 1975).
+ SOD





SOD = superoxide dismutase
They also showed the NBT reductase activity to be located
in the microsomal cell fraction (Baehner, 1975). Oxygen
is as essential for the operation of this mechanism as for
HMPS activity, hydrogen peroxide production and
iodinization.
NBT can be reduced directly by the superoxide anion
(Rajogopalan and Handler, 1964; Beauchamp and Fridovich,
1971) and very efficiently with an intermediate electron
carrier (Nishikimi et al., 1972). Indirect evidence comes
from the observation that superoxide dismutase blocks NBT
reduction (Curnutte and Babior,.1974) although this activity
may be less specific (reviewed by Klebanoff and Clark, 1978:
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309). There is ample evidence to support the contention
by Baehner's group (Baehner et. al., 1975) that superoxide
anion generation is essential for NBT reduction in vivo.
This is perhaps an illustration of a controversy brought
about by extrapolation of data obtained from separated
enzyme fractions and comparing this to experiments on
whole cells. The evidence from each side is impressive,
remembering that there is a long tradition of using
tetrazolium salt reduction in dehydrogenase histochemistry
(Pearse, 1972). The two hypotheses are not however
mutually exclusive, as Klebanoff and Clark (1978: 309)
have concluded in their presentation of a reaction for
NBT reduction:
Flavoprotein
NAD (P) H + 02 ^ NAD(P) + of + H
02 + NBT > 02 + Formazan
This is depicted in an expanded form to indicate the
metabolic events in Fig. 3.3.
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Mechanisms whereby NBT may be reduced to its formazan.
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The Present Study
Nitroblue tetrazolium reduction must be seen as an
indirect assay of the respiratory burst linked with
oxygen-dependent microbicidal systems. At the time of
starting this work, there were no data regarding the NBT
reducing activity of exudate neutrophils, and no metabolic
studies of any kind on gingival crevicular cells. One
study, published in Japanese, had reported reduced NBT
reduction by peripheral blood neutrophils in patients with
periodontal disease and concluded that this was the result
of some suppressive serum factor (Kusunoki, 1977).
The conditions under which an NBT test are conducted
must be standardised by each laboratory. In this study
a suitable test method for peripheral blood neutrophils
was established first, so that the results obtained could
be compared with those published by other workers. Having
developed a test for blood neutrophils and demonstrated
its integrity in a "stimulated" system, it was then
possible to proceed to a method for gingival neutrophils.
Finally, a chance observation during the course of these
experiments revealed the strong NBT-reducing property of
whole human saliva which contains large numbers of
neutrophils, and this was also investigated.
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NITROBLUE TETRAZOLIUM REDUCTION TEST FOR
PERIPHERAL BLOOD NEUTROPHILS
Introduction
Initially several attempts were made to establish a
"glass-adherent cell" type of test based on the method of
Gifford and Malawista (1970). It proved difficult to
obtain satisfactory preparations of formazan-containing
neutrophils and therefore an alternative approach was
tried.
In routine haematological screening of patients,-
2.5 ml of peripheral blood are collected in a plastic
tube anticoagulated with ethylenediamine tetra-acetic acid
(EDTA) (Stayne Laboratories Ltd., England), and an
automated system is used for cell counting and determining
haematological indices. For convenience and economy, it
was therefore proposed to use these tubes for the
histochemical NBT test, similar in principle to that of
Park et al. (1968). A low molecular weight dextran
solution was incorporated in the reaction for two
reasons. Firstly, some erythrocyte sedimentation would
occur, thus giving a "cleaner" preparation of leucocytes,
which should not require further purification for the
purpose of this test. Secondly, Freeman and King (1972c)
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had stated that a whole blood method is more reliable than
one in which a full separation is performed, but that EDTA
as anticoagulant produces low and inconsistent results.
Stuart and Simpson (1970) however, showed that a sucrose
polymer, Ficoll, would reverse the cell membrane lesion
induced by the EDTA, and this was confirmed by others
(Gordon et al., 1973). A dilute dextran/sugar solution
might be supposed to have a similarly restoring effect on
the neutrophil membranes.
Materials and Methods
As a starting point for the development of the test,
peripheral venous blood (PVB) was collected from healthy
young volunteers (both male and female aged 20-35 years).
The NBT used throughout all experiments was that
produced by Sigma Chemical Co. Ltd., USA. Each vacuum
sealed phial (product code 840-10) contained 1 mg
nitroblue tetrazolium lyophilisea with phosphate buffer
and sodium chloride. This was reconstituted by the
addition of 1 ml distilled water, with a resultant pH of
7.2 .
A commercially available preparation of low molecular
weight dextrans in sugar was employed. "Lomodex 70"
(Fisons Ltd., England) comprises 6% w/v dextrans in 5% w/v
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dextrose for injection. This was supplied in sterile
containers, but being slightly viscous was diluted 2:1
with buffered sterile saline, pH 7.2, before use.
In summary, the basic test was performed by
collecting 2.5 ml peripheral venous blood in EDTA-coated
plastic tubes, to which were added 2 ml saline-dextrose
solution (sds) and 1 ml NBT solution containing 1 mg NBT.
These were thoroughly mixed and the tube incubated at 45°
to the vertical under various conditions subsequently to
be described. Following incubation, 0.1 ml aliquots of
the supernatant fluid were placed in wells of the
cytocentrifuge as detailed in chapter 2, and glass slide
preparations made from which a semi-quantitative assay of
NBT reduction was made. Each test was performed in
duplicate and five counts of 100 neutrophils made per
slide (at x 500 magnification with oil immersion), so
that ten counts were made in total from which a mean was
calculated. The results were expressed as a percentage
of positive cells.
Based on the literature describing NBT test methods,
some aspects of the test conditions had to be determined,
while others were predetermined. The time of incubation,
the medium of incubation (air or water), the effect of
storing the blood samples, the most appropriate level at
which to remove cells for centrifugation after incubation
and, finally, testing the method in a "stimulated"
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system, all had to be investigated. From many published
methodologies already reviewed, it was clear that the
temperature of incubation should be 37°C for several
reasons. It is physiological and the reaction is more
likely to proceed at an acceptable rate than at room
temperature (generally around 19-23°C in a laboratory).
Also, using a laboratory incubator, the temperature can
be fully controlled, whereas this is not possible on a
laboratory bench. The final concentration of NBT in the
above described system was 1 mg in a total volume of 5.5
ml, i.e. 0.18 mg/ml. This was in accordance with other
methods (Segal, 1974; Ward, 1974) and was therefore
adopted as standard.
Time of incubation
It was clear from the literature that a standard
incubation time for this type of experiment is 30 min.
The test was conducted as described above with incubation
at 37°C in air for 20 min, 30 min and 40 min. Peripheral
venous blood was taken from three healthy adults and
tested within half an hour of venepuncture.
Incubation in air and water
Bjorksten (1974) suggested that a water bath is
preferable for incubation since the test sample
equilibrates to 37°C more quickly than in air. This was
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examined by performing the above test on two samples from
one healthy subject in the same incubator simultaneously.
One sample was placed in air, while the other was placed
in a 37°C water bath within the incubator.
The effect of storage on blood samples
For many routine haematological assays, blood
samples that cannot be processed immediately are stored
at 4°C. Bjorksten (1974) also found this to be the
optimum storage temperature for subsequent NBT testing of
cells.
PVB was taken from each of two healthy volunteers
and divided into seven 2.5 ml aliquots in EDTA tubes as
before. One sample was processed immediately as above
and the remaining six were divided into two groups.
Three tubes were left on the laboratory bench (23°C) and
three were placed at 4°C in a refrigerator. Tests were
subsequently conducted on these at 2, 4 and 8 hour
intervals.
Effect of sedimentation on NBT reduction
After 30 min incubation, despite the use of a
relatively low molecular weight dextran solution,
significant erythrocyte sedimentation always occurred,
thus facilitating the counting of neutrophils on the
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slide preparations. The two 0.1 ml aliquots taken
following incubation were routinely removed, one from
the upper and one from the lower level of the supernatant
region. No differences were apparent in the activity of
neutrophils from these two sites, but an experiment to
test this possibility was performed on samples from three
subjects. Figure 3.4 illustrates the four levels from
which 0.1 mi aliquots were removed, following 30 min
incubation at 37°C.
Application of stimulants to NBT tests
Finally, it was essential to establish that the
test now devised would function as required when a
stimulant was applied to the neutrophils. Several
bacterial species and a commercial endotoxin preparation
(Sigma Chemicals, USA) were tested against blood samples
from six healthy adult volunteers. The test was
modified by replacing 0.5 ml of the saline-dextrose
solution during the incubation with 0.5 ml suspension of
bacteria, at an original concentration of 1 x 10s
organisms per ml as estimated turbidometrically and
checked by viable counting. The final concentration of
bacteria was therefore approximately 9 x 10s per ml.
None of the organism samples was preopsonised for these
experiments. The endotoxin was reconstituted as
recommended by the manufacturer with distilled water, and










FIG. 3.4: Following incubation with NBT, neutrophils





Table 3.1 shows the mean values for each of the
three individuals tested for incubation for three time
periods. The results are expressed as percentage of
positive cells with the standard error of the mean shown.
TABLE 3.1: EFFECT OF INCUBATION TIME ON NBT REDUCTION
(PERCENTAGE POSITIVE CELLS ± sem) BY PVB NEUTROPHILS
Incubation Time (min)
Subject Sex Age 20 30 40
MJK M 28 1.3 ± 1.1 2.0 ± 1.0 1.7 ± 0.9
GHM M 35 4.0 ± 1.2 2.5 ± 0.9 3.2 ± 1.6
LB F 22 5.7 ± 1.7 4.010.8 2.911.4
From these few results, it was apparent that the test was
functioning as anticipated in that the percentage of
positive cells was low, with little variation between the
values for the three incubation periods. For the sake
of conformity, 30 min was chosen as the standard
incubation time.
Incubation in air and water
The mean percentage positive cells from the test
performed after 30 min incubation in air was 3.5% 1 sem
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0.5 and in water was 3.9% ± sem 0.6. Comparison of
these means by Student's 't" test revealed no significant
difference. However, in the light of Bjorksten's (1974)
observations, it was proposed to continue with water bath
incubation. The temperature would also be less likely to
fluctuate if, for example, the incubator door were to be
opened during the course of an experiment.
Effect of storage on blood samples
The effects of storing the blood samples prior to
testing are shown in Table 3.2. Although the percentage
of positive cells fluctuated with time, slightly more for
the blood stored at room temperature, this was not marked.
Storage at 4°C produced only slight variation, so that in
accordance with accepted principles, blood samples were
subsequently stored at 4°C, and the NBT incubation
sequence commenced within 4 hours of venepuncture.
TABLE 3.2: EFFECT OF STORAGE ON PVB NEUTROPHIL NBT
REDUCTION (Results expressed as percentage positive cells)
Time of
storage (h) 0 2 4 8
23°C 3.1 6.1 2.9 5.8
0 2 4 8
2.1 1.4 4.9 6.1
Temperature
of storage
4°C 3.1 4.6 2.9 3.4 2.1 1.9 3.2 4.2
GHM = 35 yr old male
MJK = 28 yr old male
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Effect of sedimentation on NBT reduction
Table 3.3 shows the mean percentage of positive
cells obtained from tests on three subjects. Cells were
sampled from levels Li - as shown in Fig. 3.4.
TABLE 3.3: PERIPHERAL VENOUS BLOOD NEUTROPHIL NITROBLUE
TETRAZOLIUM REDUCTION
Mean Percentage of Positive
Neutrophils at Four Levels
Subject Sex Age ll l2 l3 li+
mjk m 28 4.2 5.1 2.9 4.0
ghm m 35 5.4 4.9 3.6 4.6
pg f 21 2.1 1.8 2.6 3.1
No difference in reduction by neutrophils sampled from
different levels was detected. Subjectively there was
no difference in the numbers of neutrophils on the
preparations from each level. As a point of note,
eosinophilic granulocytes were prominent in levels Li
and L2.
Application of stimulants to NBT tests
From Table 3.4 it can be seen that in each case in
which a stimulated test was performed, the neutrophils
demonstrated an elevated response. Clearly the extent
of the increased NBT reduction was variable, but
application of Student's 't* test to the means of control
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and stimulated results in each case showed the increase
to be statistically significant (p < 0.001).
TABLE 3.4:
EFFECT OF MICROBIAL AND ENDOTOXIN STIMULANTS ON
NITROBLUE TETRAZOLIUM REDUCTION TEST
Percentage of Positive Cells ± sem
Stimulant Control Stimulated value
Endotoxin 3.3 + 1 .3 25.6 + 3.0
7.2 + 1 .6 59 .2 + 3.4
7.2 + 1 .6 37.3 + 2.8
0.2 + 0.3 21 .0 + 2.2
1 .5 + 1 .3 21 .3 + 2.4
1 .8 + 1 .5 60 .2 + 9.1
3.5 + 1 .6 24 .3 + 4 .1
Staphylococcus 4.2 + 1 .1 16.9 + 1 .6
aureus
6.0 + 1 .4 38 .0 + 3.2




6967 5.5 + 1 .5 23.0 + 1 .5
F62 8.0 + 0.7 30 . 1 + 0.9
M81 31 7.1 + 2.1 25 .7 + 4.2
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Conclusions
Before the present study was undertaken there was a
considerable amount of information available from the
literature, both with regard to different methods for
performing an NBT test, and some of the problems and
technical factors that must be considered.
Having tried, unsuccessfully, to develop a glass-
adherent assay which may have proved satisfactory given
more time and effort, the method adopted was simple and
easy to perform. The use of standard clinical equipment
was also an advantage in that future development of the
test for either clinical or purely laboratory research
purposes would be facilitated. The limited experiments
designed to verify published data on optimal test
conditions supported the view that, if storage of blood
is necessary, 4°C is preferable to room temperature but
ideally blood samples should be processed within a few
hours from collection. The functional capacity of
neutrophil granulocytes is known to be impaired by
freezing, but at least one group of workers has
demonstrated a significant level of NBT reduction in
neutrophils carefully reconstituted after freezing at
-196°C in liquid nitrogen (Hill et al., 1978). This
clearly has important implications for cell replacement
therapy.
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Sedimentation of neutrophils in this test system
appeared to occur uniformly, although no specific
quantitation was attempted. The development of
positivity in cells and thus the accumulation of formazan
did not appear to make the cells more dense for example
and, as the results showed, sampling at any level would
have been representative of overall activity.
The percentage of positive cells in the resting (or
unstimulated) tests performed was low, and always less
than 10%. The figures published from several groups
of workers are shown in Table 3.5 and it can be seen that
the results of the test described here were within the
published range.
TABLE 3.5:
PUBLISHED RESULTS OF PERCENTAGE OF NBT-POSITIVE
PERIPHERAL VENOUS BLOOD NEUTROPHILS
Authors Mean and/or Range
Park et al., 1968 8.5
Andersen, 1971 0-9
Freeman and King, 1971; 1972b 1-1 1
Freeman and King, 1975 6.8 (3-11)
Gordon et al., 1973 6.1
Bjorkstdn, 1974 0-13
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The final test of validity was to ensure the ability
of neutrophils in such a system to respond to a
stimulant. When each of the stimulants was tested,
invariably the response was increased as shown in Table
3.4. The degree of positivity was not, however, as high
as in some other assays described (for example, Preisig
and Hitzig, 1971).
Summary of the Peripheral Venous Blood Nitroblue
Tetrazolium Reduction Test Method
Into a standard sequestrene tube are collected
2.5 ml peripheral venous blood to the marked line, and
to this are added 2 ml saline-dextrose solution and 1 ml
NBT solution containing 1 mg of NBT. The tube is
incubated in a water bath at 37°C for 30 min, placed at
45° to the vertical. Following incubation, two 0.1 ml
aliquots are centrifuged at 400 rpm for 5 min in a
cytocentrifuge and the glass slide preparations stained
with routine Romanowsky stain (e.g. Leishman Giemsa or
Wright's). The positive cells exhibit the blue/black
formazan staining, and a mean percentage positive count
is made from five random field counts of 100 neutrophils
per slide.
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It was now possible to proceed to the development
of a suitable NBT test for gingival crevicular
neutrophils.
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NITROBLUE TETRAZOLIUM REDUCTION TEST FOR
GINGIVAL CREVICULAR NEUTROPHILS
Introduction
The principal objective was to apply an NBT test to
crevicular neutrophils in order to determine their
metabolic integrity. This had not been reported
previous to this study.
As for the blood test, a number of experiments were
undertaken to optimise conditions for NBT testing of
crevicular cells. Once the system was shown to be
satisfactory in the way described previously, it became
possible to adapt the method to the exudate cells. It
was soon apparent that some basic differences in the
methodology would be essential, and these are described
in the following section.
Materials and Methods
As for the blood samples, crevicular washings were
taken from healthy adult donors and collected in the 2 ml
plastic tubes as described in chapter 2. The crevicular
rinsing fluid used, however, was the saline-dextrose
solution (sds) and not phosphate buffered saline as
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before. A fixed volume of crevicular cell suspension
was then mixed with further sds and NBT solution,
incubated and cytocentrifuge preparations made. The sds
was clearly not required for sedimentation of
erythrocytes but used for consistency. All microscopic
counting and scoring of cells was performed as before at
x 500 magnification with oil immersion.
Concentration of NBT
The final NBT concentration for the blood test was
0.18 mg/ml. To obtain similar conditions 0.05 ml of
crevicular fluid suspension, 0.05 ml sds and 0.02 ml NBT
solution were placed in a 2 ml plastic tube. The final
concentration of NBT was therefore 0.17 mg/ml. The
tube was incubated in a water bath for 30 min,
cytocentrifuge preparations made, these stained with
Leishman's stain and the scoring of positive cells done
as before.
In view of the possible toxic effects of NBT on the
crevicular cells, the experiment was repeated at double
and half the concentration, i.e. a further 0.02 ml of
NBT was substituted for 0.02 ml sds and 0.01 ml NBT
solution was replaced by 0.01 ml sds respectively.
Incubation time
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The morphology of cells in the cytocentrifuged
preparations was less satisfactory than that for the
untreated cells described in chapter 2. This may have
been an unavoidable consequence of NBT toxicity but a
further experiment was performed to investigate this on
the basis that a shorter exposure to NBT might provide
sufficient evidence of cellular activity with less cell
disruption- Accordingly, the above experiment was
repeated using NBT at a concentration of 0.08 mg/ml and
0.34 mg/ml, but with incubation times of 20 min and 30
min.
Influence of EDTA
Although it was not possible to create identical
incubation conditions for both crevicular and blood
neutrophils, one remaining factor that had to be examined
was the absence of EDTA in the crevicular system. An
attempt was made to investigate this in the following
4 mnaol/1
way. The EDTA in a sequestrene tube^is dissolved into
2.5 ml of blood and the volume of crevicular washing
used in the above test was 0.05 ml. Thus, the crevicular
volume was 0.2% that of the blood. Into an EDTA blood
tube 2.5 ml sds were placed, shaken, and 0.02 ml used to
substitute for 0.02 ml sds in the crevicular NBT test.
The original NBT concentration was 0.17 mg/ml and
incubation was for 20 min.
The final molar concentration ofEDTA was therefore 0.67 mmol/1.
120
Effect of bacterial stimulation on crevicular
neutrophil NBT reduction
In order to determine the extent to which crevicular
cells may be stimulated further, the test was repeated in
which a 0.05 ml suspension of Staphylococcus aureus at
1 x 108 organisms per ml harvested in log phase growth
were substituted for the 0.05 ml sds normally incorporated.
Incubation was at 37°C for 20 min. A control experiment




Results of incubating cells with three concentrations
of NBT are given in Table 3.6. The cells were collected
from one healthy male subject aged 21 years.
TABLE 3.6: EFFECT OF NITROBLUE TETRAZOLIUM CONCENTRATION
ON CREVICULAR NEUTROPHIL REDUCTION
NBT Concentration Percentage Positive Neutrophils
(mg/ml) (± sem)
0 .085 20.7 ± 1.4
0 .17 24.2 ± 1.2
0.34 < 10*
*This result is approximate because the cellular morphology
was greatly disrupted so as to make scoring inaccurate.
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The lowest concentration of NBT (0.085 mg/ml) clearly
produced a reduction value close to that for the 0.17 mg/
ml test, in neither of which was the extent of
morphological disruption of the highest concentration
seen.
Incubation time
The effects on NBT reduction of varying the incubation
time with the three concentrations of NBT are shown in
Table 3.7. The increase in reduction with the 0.17 mg/ml
test was more marked, and the toxicity at 0.34 mg/ml
confirmed. The percentage of positive cells produced at
the two incubation periods was similar but subjective
assessment showed that the shorter incubation preserved a
much clearer morphology.
TABLE 3.7: EFFECT OF NITROBLUE TETRAZOLIUM CONCENTRATION
ON REDUCTION VALUES FOR CREVICULAR NEUTROPHILS
Mean Percentage Positive Cells




0.085 20.4 ± 1.4 18.2 ± 1.9
0.17 25.8 ± 1.8 26.6 ±2.3
0.34 ** **
•k k
At this concentration cell disruption was considerable
but more so in the cells incubated for 30 min.
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Influence of EDTA
When EDTA was incorporated into the reaction, the
percentage of positive cells was 27.1% ± 3.3% as compared
to 23.8% ± 2.6% without EDTA. In this system there was
therefore no evidence of a depression in the production
or scoring of formazan-containing cells.
Effect of bacterial stimulation on crevicular
neutrophil NBT reduction
In the control experiment NBT reduction by the
crevicular neutrophils was 36.6% ± 2.0%, and in that
incorporating Staph, aureus, 67.8% ± 4.2%. This
difference was statistically significant when a Student's
't' test was applied to the means (p < 0.001) .
Conclusions
As far as possible the crevicular NBT test was
devised to be similar to that for the blood. In all
these experiments the proportion of positive cells was
far in excess of that for the blood studies on unstimulated
cells. The implication is that the crevicular cells are
therefore stimulated. Further stimulation of the cells
demonstrated further NBT reduction, illustrating the
metabolic potential still present.
123
The variation in preservation of cellular morphology
of crevicular cells was noticeable. This had not been
seen to such an extent in the peripheral blood tests
although strongly staining blood neutrophils did show
marked alteration in morphology. To improve the
preservation of the crevicular cells, a standard
incubation time of 20 min was shown to be acceptable.
A concentration of 0.17 mg/ml for NBT seemed
appropriate, although it must be remembered that this is
a volume-related calculation and not related to final cell
number or concentration. To have achieved this for both
blood and crevice would have made the test considerably
more complicated.
Unlike the evidence regarding storage of blood prior
to testing, the data presented in chapter 2 suggested that
at 4°C satisfactory preservation of cells was obtained
only up to 30 min from collection. In the case of
crevicular cells 37°C was more suitable, but storage for
*
up to 4 hours as for blood was not recommended.
* In order to confirm that the crevicular cells were vital
throughout the incubation period, a simultaneous
incubation as control was performed with one NBT test in
which the NBT solution was replaced by sds. Samples
were removed at 0, 10 and 20 min and the cells examined
for viability by Trypan blue dye exclusion as detailed
in chapter 2. The mean percentage viable cells based
on five random counts at each time interval were
77.4% ± 2.9%, 78.7% ± 2.1%, and 81.7% ± 2.4% respectively.
Outwith the influence of the NBT test itself therefore,
the cell viability was unchanged during the 20 min
incubation period.
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Despite discussion in the literature on the relative
merits and problems associated with different
anticoagulants (Helium and Solberg, 1973; Ward, 1974),
incorporation of EDTA in the test system did not lower
the activity of the cells at least in terms of formazan
production. The reason for this is not clear except that
it must be emphasised that all the experiments in this
section were performed on cells from one subject. The
objective was simply to develop a viable test which would
subsequently be applied on a larger scale.
It was often observed that bacteria lying between
cells on the slide preparations had apparently stained
blue/black as with the formazan. It was assumed that
either the Leishman stain had been concentrated in the
bacterial cell walls or that the organisms had reduced the
NBT to formazan. This point will be discussed further
in a later section of this chapter.
125
Summary of the Crevicular Neutrophil Nitroblue
Tetrazolium Reduction Test Method
Gingival crevicular neutrophils are collected with
sds into a 2 ml plastic tube. A 0.05 ml aliquot is
placed into a fresh 2 ml plastic tube to which are added
0.05 ml sds and 0.02 ml NBT solution (1 mg/ml). The
tube is incubated in a water bath at 37°C for 20 min
after which 0.1 ml is removed and placed in a
cytocentrifuge well. Cytocentrifugation is at 400 rpm
for 5 min, after which standard Leishman-stained glass
slide preparations are made and the percentage of
formazan-containing neutrophils determined. Clearly
it is advisable to perform the experiment in duplicate.
Having now developed satisfactory assays for NBT
reduction by both peripheral blood and gingival
crevicular neutrophils, a study was undertaken to
investigate both in a group of volunteer subjects.
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NITROBLUE TETRAZOLIUM REDUCTION BY PERIPHERAL BLOOD
AND GINGIVAL CREVICULAR NEUTROPHILS IN
20 HEALTHY ADULT SUBJECTS
Introduction
In the development of an NBT test, it had been shown
that circulating neutrophils exhibited a very low degree,
and the exudate neutrophils a much higher degree of
activation. Based on these limited data, it may be
assumed that the former cells were giving a true resting
value while the latter were demonstrating their stimulated
nature, presumably in response to the bacteria in the
gingival crevice. The purpose of this part of the study
was to determine the extent of NBT reduction in blood and
crevicular neutrophils sampled simultaneously from a
group of systemically healthy subjects.
Materials and Methods
Ten male and ten female adult subjects were chosen
for this study. All were systemically healthy, taking
no drugs and had clinically healthy gingival tissues
(Gingival Index < 0.02; Loe and Silness, 1963). The
following routine was adopted for cell collection. From
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each subject 5 ml PVB were taken and divided into two
sequestrene tubes as previously described. From some
subjects additional blood was taken for an estimation of
total white cell count and differential, but this was not
routine. A 0.05 ml sample of the blood was used for
vitality testing by Trypan blue dye exclusion. Gingival
crevicular fluid was then immediately collected into a
2 ml plastic tube. A total of 0.3-0.4 ml were collected
in order to have sufficient cells for the subsequent
tests. The NBT test was then conducted as previously
described for blood and crevicular fluid, each in
duplicate.
Having removed a total of 0.1 ml of the crevicular
washings for the NBT test, two further 0.1 ml aliquots
were spun onto glass slides on the cytocentrifuge in
order to obtain a differential cell count. One was
subsequently stained with Leishman's stain and the other
for esterases as described in chapter 2. A final small
sample was used to determine the vitality of the cells by
Trypan blue dye exclusion. Much of this was accomplished
during the incubation of the NBT samples. After 20 min,
the crevicular cell incubation was terminated and the
resultant samples spun onto glass, soon after which the
procedure was repeated for the blood samples. This




All the leucocytes from the blood samples were vital
as assayed by Trypan dye exclusion. The mean value for
the crevicular cells for the 20 subjects was 78.04% ± sem
0.8% vital.
Differential cell counts of crevicular cells
Based on morphological criteria, for the Leishman
stained preparations the differential count was 95.8% ±
0.6% neutrophils, 2.4% ± 0.5% monocytes and 1.8% ± 0.3%
lymphocytes.
With the esterase method the values were 98.0% ± 0.5%
neutrophils, 1.6% ± 0.6% monocytes and 0.4% ± 0.2%
lymphocytes.
NBT reduction
Examples of NBT positive neutrophils are shown in
Fig. 3.5a for blood and Fig. 3.5b for crevicular cells.
The latter show weak staining but in Fig. 3.5c a much more
strongly stained crevicular cell is seen with considerable
disruption to structure.
The mean values for percentage positive neutrophils
in blood and crevicular fluid for each of the 20 subjects
FIG. 3.5:
Cytocentrifuge preparations
of NBT positive neutrophils
Wright's stain, x 1200.







are shown in Table 3.8. The means were calculated for
each subject on the basis of ten random counts of 100
cells from the two slides. Clearly, for each group of
cells there was a fairly wide range of mean values (0.8%
to 13.8% positive for blood and 16.0% to 68.8% positive
for crevicular cells). Comparison of the means for
blood and crevicular cells by Student's 't' test indicated
a significant difference (t = 10.91, p < 0.001). There
was no significant difference for mean values of either
blood or crevicular cells between the ten male and the
ten female subjects (p > 0.5, NS). A distribution of
the results for the blood and crevicular cell values was
plotted, with 20% increments for the axis designating NBT
positivity. Figure 3.6 shows this distribution to be
heavily grouped at the lower values for the blood,
whereas for the crevice the results are widely distributed
over the higher range.
Further analysis was performed by plotting a linear
regression of crevicular on blood values (Fig. 3.7), by
calculating the slope and the 'best fit' lines for the
male, female and total group data. The correlation
coefficient for each was also determined and the method
of analysis is outlined in Appendix 6.
The correlation coefficients, r, were as follows:
a) For the male group, r = 0.52. Degrees of freedom
= 9, therefore not significant at 5% level.
131
TABLE 3.8:
MEAN PERCENTAGE NBT-POSITIVE CELLS FROM BLOOD AND
CREVICULAR FLUID FROM 20 SUBJECTS
Age







35 1 .3 + 0.4 16.0 + 1.2
28 0.8 + 0.2 24.2 + 2.4
45 2.1 + 1 .0 29.1 + 1.3
25 1 .5 + 0.4 42.6 + 2.4
22 13.4 + 1 .7 58.9 + 2.3
21 11.9 + 0.7 54 .4 + 1 .0
21 2.6 + 0.5 48.6 + 3.5
21 3.1 + 0.6 61.4 + 2.8
24 4.8 + 1 .0 23.4 + 1.5
22 3.3 + 1 .2 57.9 + 2.3
26.4 4.5 + 1.4 41.7 + 5.4
22 3.1 + 0.5 27.6 + 1 .7
18 7.1 + 0.7 68.8 + 1 .4
21 11 .5 + 1 .0 46.0 + 2.0
21 4.8 + 0.5 47.8 + 2.4
28 12.5 + 1 .2 37.1 + 2.0
23 6.8 + 0.9 35.3 + 2.3
22 3.2 + 1 .0 44 .7 + 1 .0
27 5.1 + 0.7 32.4 + 2 .1
22 4.4 + 1 .0 43.7 + 2.6
21 9.3 + 1.8 59.9 + 2.5
22.5 6.8 + 1 .1 44 .3 + 4.0
Total mean
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b) For the female group, r = 0.23. Falls far short of
5% level of significance.
c) For the total group, r = 0.42. Degrees of freedom
= 18; therefore very close to significance at 5%
level (at 5% level, p = 0.05, r = 0.44).
Thus, for the total group there was some indication that
crevicular and blood neutrophil NBT reduction values were
positively correlated.
Conclusions
The results from these experiments demonstrate that
gingival crevicular neutrophils are stimulated cells in
comparison to neutrophils sampled simultaneously from the
peripheral blood. Even where no clinical inflammation
is present, the gingival crevice contains bacteria,
endotoxins and antigen-antibody complexes (Simon et al.,
1972; Wilton, 1977), which may result in membrane
activation. Furthermore, in chapter 2 data were presented
from subjects with tissues in a similar state of clinical
health to those in this study, in whom in vivo phagocytosis
could be demonstrated in approximately a quarter of the
crevicular neutrophils. By direct inference the data
also demonstrate the ability of these cells to respond to
the stimulus present in this."in vivo stimulated NBT
test".
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The small positive correlation between the
stimulation levels in blood and crevicular cells is of
interest and may indicate a potential for microbicidal
ability in a given individual. That is, using linear
regression to predict a value for crevicular activity
from a given blood value may have significance in
predicting the outcome of long term confrontation between
host and bacteria, and thus disease. At this stage such
a hypothesis is mere speculation. However, systemically
healthy individuals have only a small proportion of
circulating neutrophils which show a positive response
(Segal, 1974) , and the results presented suggest that the
gingival crevice may be one source of bacteria or
bacterial products giving rise to that stimulation. It
is well known that vigorous mastication or toothbrushing,
particularly when gingivitis is accompanied by marked
hyperaemia and oedema, will give rise to a transient
bacteraemia. The consequences of this in immunodeficient
patients are well known to haematologists. This may
provide one explanation. It has been pointed out from a
different perspective that, since neutrophils do not
recirculate from the tissues and it is circulating cells
which show an increased response in infection, somehow
the signal must be transmitted back and produce the
metabolic change (Harkness, 1981). In this paper it was
further emphasised that the inflammatory process rather
than the bacteria may be responsible.
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The results of the vitality estimations and the
differential leucocyte counts accord with those shown in
chapter 2.
In summary, it has been shown that in terms of
ability to reduce NBT to formazan and thus demonstrate an
intact metabolic burst, the crevicular cells must be
considered a functional population of phagocytes. One
final technical point must be made here. All cells,
whether vital or not, were included in the microscopic
analysis when counting NBT positive cells, since
presumably non-vital cells also take up the counterstain.
Thus, corrected for a mean viability of 78%, the group
mean NBT positivity would have been approximately 55% of
potentially functional cells.
Footnote to this study:
Having established the clear difference in NBT reduction
levels between neutrophils of blood and crevicular origin,
a small investigation was performed to determine the
values in age matched subjects with gingivitis. Four
male and two female systemically healthy subjects were
chosen. Each had a clinically evident gingivitis
(G.I. > 1.5; Loe and Silness, 1963). The NBT tests were
performed precisely as in the main study. For blood
neutrophils the group mean was 9.6% ± 1.6% positive cells,
and for crevicular neutrophils 44.2% ± 3.9%.
Although these limited results do not permit statistical
comparison with the main study, the indication is that
both blood and crevicular cells are in a similar metabolic
state whether there is clinically obvious inflammation or
not. Clearly, a larger study would be required to
properly verify this point.
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NITROBLUE TETRAZOLIUM REDUCTION BY
WHOLE HUMAN SALIVA
Introduction
During the course of the previously described
experiments on crevicular neutrophils, a chance
observation revealed that at room temperature whole
human saliva reduced NBT to its formazan over a
comparable time period to that for the cell suspension.
That is, a clearly visible blue colouration developed
within 20-40 min of mixing the reagents.
Whole saliva is in fact a mixture of the secretions
of the three main paired salivary glands, the minor
mucosal salivary glands and the gingival crevicular
fluid, and so contains many neutrophil leucocytes, most
of which migrate from the gingival crevice and may be
degenerating (Raeste, 1972c). Thus, one possible source
of NBT reduction in saliva may be these cells. Saliva
is a very complex fluid and varies in composition, and
its reducing capacity although well known, has never been
properly identified or localised. In a text book chapter
of 75 pages on saliva, Jenkins (1978: 318) has discussed
the oxidation-reduction activity in two very small
paragraphs. He points out that the net reduction has
been erroneously attributed to glucose.
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Apart from the leucocytes, there are of course many
agents in saliva which may influence the reducing
capacity, e.g. glutathione, inorganic ions, ascorbic
acid and other free enzymes (Tenovuo and Valtakoski,
1976). The involvement of bacteria in this context has
been inconclusively discussed (Pincus, 1940; Eisenbrandt,
1943), but a significant correlation has been shown
between the quantity of sediment and the oxidation-
reduction potential, Eh (Nikiforuk, 1954). The sediment
of whole saliva comprises approximately 86% epithelial
cells, 13% leucocytes and 1% bacteria by volume
(Klinkhamer, 1968b) which would suggest that any one of
these could be the main source of NBT reductase activity.
This study was designed to identify if possible the
agent or group of agents responsible for the marked
reducing properties of human whole saliva. All
experiments were performed on saliva collected without
stimulation since the original observation had been made
on such a sample. Saliva collected after stimulation




The approach adopted was one of identification by
elimination; that is various components of whole saliva
were investigated independently after the removal of
other components or their activity. All tests were
conducted in triplicate on 2 ml samples (unless otherwise
stated) of whole saliva freshly collected without
stimulation (by spitting into plastic test tubes) from
systemically healthy adult volunteers exhibiting no
clinical signs of active oral disease.
In each NBT test the 2 ml saliva sample was incubated
in a plastic test tube with 0.3 ml NBT solution (Sigma
standard NBT solution 1 mg/ml as previously described) in
a water bath at 37°C for 10 min. This relatively short
incubation period was always sufficient to allow for
reduction of the NBT in a 'positive' experiment. When
no colour change was visualised, the incubation was
always allowed to continue for 30 min in the event of
there being a slower reaction.
In studying the involvement of bacteria, following
each particular isolation procedure and prior to NBT
testing, single standard loopful samples of treated saliva
were inoculated onto blood agar plates and cultured
aerobically overnight at 37°C. Subsequent bacterial
growth was assessed subjectively as positive (heavy or
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light growth) or negative. The assessment of NBT
reduction was also as positive (strong or weak) or
negative.
Physical methods of assessment
The objective was to distinguish activity between
the sediment and supernatant fraction of whole saliva.
a) Centrifugation and isolation of the salivary pellet
Saliva samples (2 ml) were centrifuged at 2,500 g
for 30 min after which the pellet was resuspended in 2 ml
phosphate buffered saline (PBS). The resuspended pellet
and the original supernatant fluid were each tested for
NBT reducing activity.
The three main constituents of the pellet i.e.
epithelial cells, leucocytes and bacteria, were then
examined individually. From the buccal mucosa,scrapings
were made to obtain epithelial cells, which were suspended
in PBS. These cells were then washed twice by
centrifugation and resuspension in PBS, after which the
test was performed along with the standard bacteriological
plating. The leucocyte fraction was studied indirectly
by shaking saliva samples in an excess of distilled water
in order to lyse the leucocytes. The samples were then
centrifuged and the pellet resuspended in PBS and tested
as before.
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The contribution of the salivary bacteria will be
discussed more fully below.
b) Filtration,dialysis and freezing
Samples of saliva were filtered through a millipore
filter (Millipore UK, Ltd., Harrow, Middlesex), size
0.25 urn, and the filtrate tested for NBT reducing capacity
and bacterial contamination. Dialysis of whole saliva
against normal sodium chloride was performed for 24 hours
at 4°C and the dialysate tested. Finally, samples were
frozen for three weeks at -40°C, rapidly thawed and tested
without further manipulation.
Bacteriological methods of assessment
The contribution of bacteria was examined by treating
saliva samples in three ways:
a) Pasteurisation
b) Incubation with aqueous chlorhexidine gluconate
c) Incubation with antimicrobial drugs
a) Pasteurisation: Samples of saliva were collected and
divided into two. One sample was allowed to stand at
room temperature as control and the other was pasteurised
by incubation for 45 min at 60°C. NBT testing and
bacteriological plating were undertaken as before.
b) Incubation with aqueous chlorhexidine gluconate: As
for pasteurisation, 2 ml samples of whole saliva were
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incubated for 1 hour with 1 ml of 2% w/v aqueous
chlorhexidine gluconate and tested.
c) Incubation with antimicrobial drugs: Samples of
saliva were incubated for 3 hours at 37°C with benzyl
penicillin at a final concentration of 100 mg/ml and
nalidixic acid at a final concentration of 15 j-ig/ml.
NBT testing and assessment of bacterial growth were
conducted as before.
Further investigation of the effect of penicillin was
undertaken by incubating with saliva at final concentrations
of 0, 1, 10, 50, 100 and 250 mg/ml prior to testing.
Following incubation with NBT, a quantitative reduction
assay was then performed and the optical density of each
sample determined. In order to do this, a calibration
curve had to be drawn to determine the optimum wavelength
at which to monitor the reactions. A Pye Unicam SP600
Series 2 spectrophotometer was used (Pye Instruments,
Cambridge, UK) and, as a blank with which to perform the
calibration, 3 ml NBT solution (1 mg/ml) in the glass
phial. The calibration of optical density against
wavelength is shown in Fig. 3.8. The optimum wavelength
so determined was 540 nm.
The experiment was conducted as follows. Saliva
samples were incubated with increasing concentrations of
benzyl penicillin up to 250 mg/ml as stated above for
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FIG. 3.8:
Absorption spectrum: for the spectrophotometry assay
of formazan produced from NBT reduction by saliva
samples.
It was assumed that there was a linear relationship betweei
absorption at 540 nm and the volume of saliva.
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2 ml removed and reincubated with 0.3 ml NBT solution for
30 min at 37°C. As before, samples were plated on
blood agar after incubation with penicillin to determine
the extent of residual bacterial growth. After
incubation with NBT the optical density of each sample
was assayed. It was soon apparent that, even where the
higher concentrations of penicillin had been used, the
intensity of the blue colouration was too great to permit
readings to be taken. By experimentation it was found
that a standard dilution of the sample six times with PBS
permitted readings to be made at all concentrations of
penicillin.
NBT reduction by salivary bacteria
From the large number of saliva samples incubated on
blood agar, it became possible to identify morphologically
those bacterial species which were quantitatively prominent
or distinctive. These were subcultured and identified by
their appearance on blood agar and by Gram staining. They
were then grown on blood agar aerobically, and from
overnight cultures, harvested and suspended in PBS at a
concentration of 1 x 109 bacteria per ml. These
suspensions were then incubated for 30 min at 37°C with
NBT solution. As before, 0.3 ml NBT and 2 ml of bacterial
suspension were the volumes used. Subsequent NBT




Pure parotid saliva was collected using a Carlsen-
Crittenden cannula which comprises two circular concentric
chambers to each of which is attached plastic tubing and
a disposable syringe. The inner chamber was placed over
the opening of the parotid duct and suction applied to the
outer chamber, so forming a seal with the mucosa of the
cheek. The syringe attached to the inner chamber was
then used to withdraw the parotid secretion from the duct.
Parotid saliva was thus collected and, being lesser in
volume than whole saliva, 0.2 ml samples were incubated
with 0.03 ml NBT solution.
The relevance of salivary glucose was determined by
incubating whole saliva samples of 1 ml with 0.1 ml
glucose oxidase, thus removing the glucose before
incubation with NBT.
Results
In cases where the NBT reduction was positive, the
intense blue colouration was always produced within 10
min incubation period. In no case was a slower reaction
seen. The concentration of NBT used (0.3 mg in a total
of 2.3 ml = 0.13 mg/ml) thus gave a very clear positive
result. Examples of positive and negative reactions are
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shown in Fig. 3.9.
All the results and the effects of physical treatment
are summarised in Table 3.9.
The results clearly showed that the NBT reducing
activity of the whole saliva samples was entirely located
in the sediment fraction. The epithelial cells and
leucocytes in the saliva were insignificant in that the
former produced no reduction and elimination of the
leucocytes produced no diminution in the intensity of the
reaction.
The process of elimination showed that all significant
reducing activity was located in the bacterial fraction,
and this was subsequently borne out both by direct
experimental evidence and indirectly from the bacterial
cultures.
Pasteurisation and incubation with 2% chlorhexidine
gluconate totally abolished subsequent NBT reduction, and
incubation with benzyl penicillin at a concentration of
100 mg/ml subsequently produced a mild positive reaction.
This, and the fact that nalidixic acid did not affect the
reaction, led to the more detailed experiment with a range
of penicillin concentrations. The result clearly
demonstrated that increasing the concentration of penicillin
led to a decrease in subsequent NBT reduction, and these
data are presented graphically in Fig. 3.10. The
intensity of the positive reaction was again emphasised by
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FIG. 3.9:
NBT reduction by human saliva. The strongly
positive reaction is clearly seen in the tube
on the right, while that on the left is negative.
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TABLE 3.9:
EFFECT OF VARIOUS PHYSICAL AND BACTERIOLOGICAL PROCEDURES
ON THE NITROBLUE TETRAZOLIUM REDUCING CAPABILITY OF HUMAN
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Spectrophotometric assay of forraazan produced from
NBT reduction by saliva samples pre-incubated with
benzyl penicillin. Inhibition of reduction increases
with increased concentration of penicillin.
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the necessity to dilute the samples six times in order to
permit transmission of light. The evidence for bacterial
involvement was reinforced by the concomitant decrease in
subsequent bacterial growth with increasing antibiotic
concentrations, and examples of the growth plates are
shown in Fig. 3.11.
As shown in Table 3.9, parotid saliva had no
reducing activity, and the removal of glucose did not
diminish the reaction intensity.
The above results strongly suggest that salivary
bacteria were responsible for the very intense and rapid
reduction of NBT to formazan. The species identified as
being most prominent numerically were viridans
streptococci, Branhamella catarrhalis and members of the
genus Micrococcacea. Only the latter gave a convincing
positive result with NBT and the reaction was extremely
rapid and the colour intense.
Conclusions
This investigation into an area which had previously
been little examined and largely abandoned, stemmed from
a chance observation. It seemed logical to pursue the
identification of the reducing activity in whole saliva
for two reasons. Firstly, it extended experience of
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FIG. 3.11:
Indication of the reduction in salivary bacterial
flora as a result of pre-incubation of saliva
samples with benzyl penicillin. Blood agar plates
incubated aerobically overnight at 37°C. From
upper left to lower right, the penicillin
concentrations were 0, 1, 10, 50, 100 and 250 mg/ml.
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using nitroblue tetrazolium experimentally and led to its
use in a quantitative spectrophotometry assay.
Secondly, and more importantly, saliva contains neutrophil
leucocytes at a concentration of approximately 200 to 400
cells per ml (Calonius, 1958) and it was supposed that
these might contribute significantly to the observed
reduction of NBT, so indicating their metabolic viability.
This latter assumption was not upheld, but in the process
of tracing the activity to bacteria, some experience was
gained in basic laboratory microbiological techniques. In
all cases where bacteria were reduced in number or
eliminated, the subsequent NBT reduction showed a parallel
decline. One considerable advantage was the very clear
result given by the experimental conditions employed.
The initial results, using antimicrobial methods, i.e.
pasteurisation and the antiseptic chlorhexidine gluconate,
were conclusive except that it was possible for the
physical conditions of the former and the very powerful
cationic character of the latter to have produced
denaturing of some active reducing agent in the whole
saliva. Thus, the study was extended and the results
reinforced by the use of more specific antimicrobial drugs.
Nalidixic acid is bactericidal to Gram negative anaerobic
organisms at the concentration used (Deitz et al., 1963).
The experimental approach could not otherwise eliminate
the involvement of these species, but the lack of
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inhibition in reduction to a visible extent suggested
that the aerobic or facultatively aerobic Gram positive
bacteria were responsible. This was strongly supported
by the convincing dose response seen with penicillin
which had a wide spectrum of activity against the species
grown on the overnight cultures. Presumptive
identification of the principal bacteria as Micrococcacea
was based on the colony appearance, colour (yellow shiny
colonies) and Gram positive nature. This genus
certainly possesses NADH and metabolises glucose via the
HMPS (Buchanan and Gibbons, 1974), so that the potential
for electron transfer to NBT exists. It must be
emphasised that the bacteriological methods employed were
in some ways imprecise. For example, in plating the
bacteria on blood agar, a single loopful of saliva was
used in each case. Although the same loop was used
throughout, it is unlikely that the original inoculum
size was identical in each case. More precise
identification of bacterial species was not attempted.
This was felt to be beyond the scope of the principle
upon which this particular study had been undertaken.
The component of whole saliva responsible for the reducing
activity as shown by NBT reduction had been isolated and
more detailed bacteriological identification would have
necessitated the use of chemical techniques and
considerable expertise.
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The experimental approach did not totally eliminate
a contribution by glucose or the leucocytes, but simply
demonstrated that neither was responsible in a major
capacity. Having developed a spectrophotometric assay
for NBT reduction, careful manipulation may have enabled
any effects of these two agents to have been revealed.
Finally, there may be an obvious explanation for the
inconclusive studies undertaken 30 to 40 years ago, which
attempted to define the reducing activity in saliva
(Pincus, 1940; Eisenbrandt, 1943; Nikiforuk, 1954).
The means of separating the active constituents of the
sedimented pellet were largely unavailable, and although
some early antibiotic drugs would have been in clinical
use, it is possible that their application as laboratory
tools had yet to emerge. The identification of reducing
activity in saliva as shown in this study was made more
convincing by the use of benzyl penicillin.
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DISCUSSION
The ingestion of bacteria and their subsequent
destruction is regarded as the principal function of
neutrophil phagocytes and the mechanisms by which these
processes occur have received close attention, particularly
over the past 20 years. The reduction of oxygen to active
species is thought to play a key role in bactericidal
events, and the generation of these species, so closely
linked with the supply of pyridine nucleotides and
glycolysis has received particular attention.
Considerable progress has been made through a fuller
understanding of membrane biology (Elsbach, 1977; Henson,
1980). The nature of the stimulus, not surprisingly, may
have a crucial role in determining the type of radicals,
the relative proportion of these radicals and perhaps most
importantly for how long they are produced (Dahinden et
al. , 1983). The nature of the NADPH oxidase has been the
focus of collaborative studies worldwide, and has largely
been elucidated.
When the functional pathways in host defence
mechanisms are identified, they can be clinically
investigated in patients. The NBT test was seen 10 to
15 years ago as a simple method by which to determine the
integrity of the neutrophil metabolic burst, and possibly
to establish the presence of bacterial infection. With
156
regard to the former, a well performed NBT test remains
part of the diagnostic panel of tests crucial to the
diagnosis of chronic granulomatous disease, in which the
respiratory burst is absent (Baehner and Nathan, 1967).
Unfortunately, however, due to the many reports of false
positive and, more importantly in this context, false
negative results being obtained, its use in the diagnosis
of infection has never gained widespread support. It
remains for individual clinical laboratories to use their
own tests in which confidence is gained by experience.
The reduction of NBT by phagocytes has retained
respectability in the field of applied research. It is
often used in conjunction with other measurements of
metabolic stimulation in neutrophils and, for example, has
been shown to correlate with oxygen uptake more than with
phagocytosis (Torres et al., 1979). Stavridis et al.
(1981) have used a cross-sectional study to show that,
throughout life, there is a parallel fluctuation in
neutrophil NBT activity and alkaline phosphatase, and
suggested from their data that both are under some degree
of hormonal control.
The mechanism of reduction remains an issue of
discussion but is either by electron transfer from the
superoxide anion or from direct reduction by NADPH, or
perhaps both. Baehner et al. (1975) have argued that,
while solubilised fractions of neutrophils, including
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those from patients with CGD, will allow NBT reduction by
NADPH, in whole cells the generation of the superoxide
anion is essential. In whole cells, no reduction occurs
under anaerobic conditions. In principle, either
mechanism relates to the metabolic burst and the superoxide
involvement also implicates bactericidal pathways, thus
supporting the relevance of NBT reduction to assays of
neutrophil function.
The semi-quantitative histochemical tests, originally
devised by Park et al. (1968) and Gifford and Malawista
(1970) have received many modifications over the years and
are easily performed. The quantitative methods based on
Baehner and Nathan (1968) are probably more precise, but
are technically more involved and obscure one interesting
feature of NBT reduction by resting or stimulated
neutrophils. That is, neutrophils that have been
incubated with NBT show a proportion of cells on a
histochemical preparation that have reduced the dye and a
proportion that for some reason have not. Moreover, of
these positive cells (which are grouped together when
recording a test result), some are weakly positive and
some so strongly positive that the cell is totally
disrupted (see Fig. 3.5). It may be important to take
account of this.
Further technical points must be considered. Balogh
and Cohen (1961) observed fine granules of formazan on or
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in erythrocytes and this was occasionally seen in the
blood preparations made in the studies described in this
chapter. This in no way interfered with the clarity of
reading the test, but might be of relevance to a
quantitative assay. At the outset, in developing the
blood NBT test an advantage was seen in using standard
clinical equipment and this proved to be satisfactory.
However, it may be argued that the method is extravagant
with the use of blood, in that far more cells are
collected from the patient than are actually required.
A proportional reduction in the volumes of all reagents
could be employed, for example by using paediatric-sized
collecting tubes.
The studies described have concerned the development
of a peripheral blood NBT test and subsequently a test
for gingival crevicular cells. The results of the former
test were consistent with those of other workers, both for
resting cells and cells stimulated with a range of agents.
This test method is therefore considered suitable for
application in the areas described above. The crevicular
neutrophils were shown to be metabolically stimulated,
presumably by the bacterial and/or inflammatory components
of the gingival crevice. This was an important finding
because previously only limited studies of phagocytosis
and killing of Candida albicans had been conducted on
these cells (Wilton et al., 1977a). Subsequently, one
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other group of workers has confirmed that crevicular
neutrophils are able to reduce NBT and are highly-
stimulated cells (Charon et al., 1982). These authors,
however, were unable to make statistical deductions about
the relationship between blood and crevicular neutrophils
which was just possible in the present study by linear
regression analysis. The small positive correlation
demonstrated between the NBT reduction levels in the two
cell groups was intriguing both from the point of view of
a stimulus feeding back to the circulation and also by
opening the question of whether a predictive test of
crevicular cell function is possible from analysis of
PVB activity. In a recently published study of human
exudate (skin window) neutrophil NBT reduction, the resting
rate of activity was significantly higher than that from
blood neutrophils. There was no difference when both
cell types were phagocytosing paraffin oil emulsion
(Wandall, 1982). No comparable experiment to the latter
was performed in this study but it would be of interest to
compare stimulated as well as unstimulated blood neutrophil
values to those for crevicular cells and to determine the
maximum potential activity for the crevicular cells.
The limited data presented for patients with gingivitis
suggested that both blood and crevicular neutrophils are in
a similar state of activity as when oral tissues are
healthy. Further studies would be required to confirm
this but the similarity is in contrast to a study published
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by Kusunoki (1977). He showed that peripheral blood
neutrophils from patients with periodontitis had
depressed levels of NBT reduction which returned to normal
following clinical treatment. However, these values were
12.5% positive cells as opposed to over 25% for normal
subjects which are very high for an unstimulated test.
There was no phagocytic defect but the decrease in
reduction by periodontitis neutrophils was attributed to
some serum blocking factor. This again would be an
interesting finding to pursue. He did not test crevicular
cell function. In their series of patients with bacterial
infection, Park e_t al. (1 968) demonstrated slightly raised
peripheral blood neutrophil NBT reduction including a
patient with an acute gingival abscess.
Beyond any intrinsic merit in the study of salivary
reduction of NBT, there was the possibility that the
results could have a bearing on an understanding of host
defences in the oral cavity. Thus, although it has
been demonstrated that salivary neutrophils have a
reduced phagocytic capacity as compared to crevicular
cells (Scully, 1982), they may be sufficiently intact to
reduce NBT. The experimental evidence did not uphold
this supposition. However, one important point has
emerged. The dye reduction by bacteria was extremely
powerful so that if bacteria are used in a 'stimulated
test', and they are themselves capable of reducing NBT,
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then with an untrained eye, a false positive result may
be reported. A similar result was reported for
neotetrazolium chloride reduction by rat peritoneal
exudate cells phagocytosing brucella 30 years ago
(Shaffer et al., 1953) .
Two final points must be made about the results for
the crevicular neutrophil study. A practical advantage
would be gained from being able to study aspects of cell
function in a reliable manner from a small number of cells
collected atraumatically by a non-invasive technique.
Secondly, having established indirectly the integrity of
the metabolic burst in a significant proportion of
crevicular cells, the next step was to examine more







The previous chapter considered the respiratory
burst which, following activation, produces a number of
oxygen radicals and ionic species. These are thought to
be central to the oxygen-dependent microbicidal systems
of neutrophils. Of particular interest are the
oxidation reactions of hydrogen peroxide (H202), catalysed
by the neutrophil peroxidase now known as myeloperoxidase
(MPO) (Hydrogen peroxide = halide = oxidoreductase/ E.C.1.11.1.7) .
Historical Aspects - Lactoperoxidase and Myeloperoxidase
A peroxidase enzyme is not in itself bactericidal but
is so indirectly by virtue of its catalytic properties in
converting a substrate from a weak to a strong anti¬
microbial agent (Klebanoff and Clark, 1978: 410).
Peroxidases are generally haem proteins containing
variable amounts of iron and are extremely widespread in
both animal and plant tissues. Over 50 years ago
enhancement by peroxidase of the germicidal properties of
phenol and cresols was noted (Kojima, 1931). The first
studies of the mammalian enzyme were conducted on milk and
saliva, i.e. secretions, even earlier. In 1924, Hanssen
suggested that the antimicrobial properties of bovine
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milk may be related to the content of "oxydases" or
"peroxydases". In fact, the majority of studies which
followed were conducted on milk or saliva and indeed many
workers continue to investigate the bactericidal
properties of these secretions. Through the 1950s and
1960s several studies were published establishing the
antibacterial properties of the milk peroxidase termed
lactoperoxidase (LPO) (Jago and Morrison, 1962). It was
also shown that a secretory non-enzymatic co-factor was
required, later to be identified as the thiocyanate ion
(Reiter et al. , 1964). Since catalase strongly inhibited
the oxidation reaction, hydrogen peroxide was suggested
as a component (Jago and Morrison, 1962). It was not
incorporated as a reactant in the early experiments, but
fortuitously many of the test organisms used were hydrogen
peroxide producers, such as streptococci or lactobacilli.
Similarly, human salivary peroxidase was isolated
(Klebanoff and Luebke, 1965), and shown to be almost
identical to the enzyme from bovine milk (Morrison et a_l.,
1965). This enzyme is also inhibited by catalase as
shown with lactobacilli, which are hydrogen peroxide
producing (Klebanoff and Luebke, 1965). Provided a
source of hydrogen peroxide is included (which may be
appropriate microorganisms), non-hydrogen peroxide
generating organisms are also inhibited (Klebanoff et al.,
1966). The salivary and milk antibacterial systems were
thus seen as comprising peroxidase and thiocyanate
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contributed by glandular secretion, and hydrogen peroxide
contributed primarily by organisms. In human milk,
however, the peroxidase has recently been shown to be
derived from the leucocytes and is thus myeloperoxidase,
with distinctly different separation characteristics
(Moldoveanu et al., 1982). Lactoperoxidase is a single
unit polypeptide chain with a molecular weight of
approximately 78,000 daltons (Rombauts et al., 1967),
whereas human peripheral blood neutrophil MPO comprises
two sub-units and has a molecular weight of 120-140,000
daltons (Matheson et al., 1981). In whole human saliva
analysis has shown the peroxidase (LPO) to be
heterogeneous, with a mean molecular weight of 80-100,000
daltons (Slowey et al., 1968), but as stated above is
very similar to bovine LPO in antigenic cross-reactivity.
Saliva contains peroxidases with separate origins, i.e.
bacteria, leucocytes and a glandular secretion, which are
chromatographically distinct (Makinen and Tenovuo, 1976).
In inflammatory exudates, including gingival crevicular
fluid, the peroxidases at least in part are likely to be
derived from cellular disintegration (Tenovuo at al.,
1978) .
Both LPO and MPO are able to catalyse thiocyanate-
mediated reactions, but only MPO will catalyse the
chloride ion oxidations (Morrison and Schonbaum, 1976).
The oxidation of the thiocyanate ion (SON ) by hydrogen
peroxide produces the hypothiocyanite ion (OSCN ) at
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neutral pH (Hoogendoorn et al., 1977) or hypothiocyanous
acid (HOSCN) at a lower pH (Thomas, 19 81) :




The concentration of hypothiocyanite ion in human saliva
varies with stimulation, being higher in resting saliva
(Tenovuo, Pruitt et al., 1982), but hypothiocyanous acid
may be the more bactericidal of the products, having a
greater ability to penetrate bacterial cell membranes
(Thomas, 1981). The bacterial damage is affected by
the subsequent oxidation of protein sulfhydryl groups
(Thomas and Aune, 1978a).
The salivary and milk peroxidase-mediated
antimicrobial systems have been widely investigated for
their ability to control a range of microorganisms. Of
particular interest are potential pathogens. For
example, efficacy has been demonstrated against Salmonella
typhimurium (Purdy et al., 1983), Pseudomonas species
(Bjorck et al., 1975) , Escherichia coli (Thomas and Aune,
1978b; Stephens et al., 1979), and of particular
interest in dental caries, against Streptococcus mutans
(Tenovuo, Moldoveanu et al., 1982; Thomas et al., 1983).
Tenovuo, Moldoveanu et al. (1982) have suggested that
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secretory IgA in saliva may enhance the bactericidal
properties of LPO. A positive correlation has been
demonstrated between the state of health in the oral
cavity (with respect to dental caries) and the
concentration of hypothiocyanite in salivary sediment
(Tenovuo and Anttonen, 1980). There is also accumulated
evidence, both in animal models (Stephens et al., 1979)
and humans (Cockle and Harkness, 1978; 1983), for one
of the control mechanisms for peroxidase secretion being
hormonal, specifically oestrogenic.
MPO is also able to catalyse the thiocyanate
reaction (Klebanoff and Luebke, 1965) but in 1967 it was
shown .that the halide ions (iodide, bromide and chloride)
could be successfully substituted for thiocyanate in the
MPO-mediated system (Klebanoff, 1967). Many subsequent
studies have confirmed the efficacy of this system
against a range of microorganisms and viruses (Klebanoff
and Clark, 1978: 412-413). It was simultaneously
reported that the peroxidase-hydrogen peroxide bactericidal
system of leucocytes (guinea pigs) could be isolated from
a granule fraction of the cells (McRipley and Sbarra,
1967b).
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Myeloperoxidase - Development and Properties
Agner (1941) first described neutrophil peroxidase
as verdoperoxidase because the purified enzyme was green,
but since this also applied to lactoperoxidase, the name
myeloperoxidase was later adopted. Other leucocytes,
particularly eosinophilic granulocytes and monocytes,
also contain peroxidases. That of the monocytes closely
resembles neutrophil peroxidase and the term
myeloperoxidase is currently applicable to the neutrophil
and monocyte enzyme (Klebanoff and Clark, 1978: 44).
Mature neutrophils contain very large amounts of
MPO, exclusively in the azurophil or primary granules
(Bainton et al. , 1971; Spitznagel et al., 1974), which
are formed at the promyelocyte stage of development in
the bone marrow (Bainton et al., 1971). Agner (1941)
estimated a content of 1-2% of the dry cell weight, while
Schultz and Kaminker (1962) suggested a figure of more
than 5%. Venge et al. (1978) found that normal
peripheral blood neutrophils contained approximately
40 jig MPO per 107 cells. There is a considerable
variation in the presence and activity of the enzyme
between animal species. For example human, squirrel
monkey and dog neutrophils contain large amounts, whereas
goat, cat and guinea pig cells have very little, and
chicken neutrophils have none (Rausch and Moore, 1975;
Klebanoff and Clark, 1978: 45). Enzyme activity
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comparisons may not always equate with actual protein
(enzyme) quantities. The enzyme activity may be altered
appreciably by the extraction procedure, and evidence is
conflicting as to the effects of phagocytosis (Klebanoff
and Clark, 1978: 45-46). The human enzyme has a
molecular weight of 120-144,000 and molecular weights for
other species are similar (Klebanoff and Clark, 1978: 46).
Myeloperoxidase is a basic protein, the main amino acid
being arginine, with two iron atoms constituting up to
0.1% of the molecular weight. Electrophoretic analysis
has revealed that the molecule can be divided into
separate component parts and speculation as to the
existence of distinct isoenzymes has existed for some
time (Klebanoff and Clark, 1978: 47). Recently,
distinct forms of MPO have been isolated from human
neutrophils both by cytochemical (Lippi and Cappelletti,
1982) and chromatographic (Pember et al., 1982)
techniques. Although technical artefacts may be
responsible for some misinterpretation (Klebanoff and
Clark, 1978: 47), Pember, Shapira et al. (1983) have also
suggested that the different forms of MPO may exist in
separate granule fractions. In human saliva the
existence of three distinct peroxidases (not MPO),
presumably lactoperoxidases, have been identified
(Iwamoto et al., 1972) , and recently it has been suggested
that two of these may aggregate under the influence of
oestrogenic stimulation (Cockle and Harkness, 1983).
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Components of the MPO-Dependent Microbicidal System
Satisfactory function of this microbicidal system
depends on the presence of MPO, hydrogen peroxide and
halide ions. In the original scheme, fusion of the
MPO-containing granules with the phagocytic vacuole
permits intracellular combination of these agents with
bacteria, although by secretory processes or leakage the
system may react extracellularly with target organisms
(Klebanoff, 1975; Sips and Hamers, 1981). Hydrogen
peroxide is produced either by bacterial or leucocyte
metabolism.
Bacteria may be classified as either 'producers' or
'non-producers' of hydrogen peroxide. Producers lack the
haem enzyme catalase which catalyses the conversion of
hydrogen peroxide to water. They therefore tend to
utilise flavoproteins for terminal oxidation processes,
being devoid of cytochromes (Klebanoff and Clark, 1978:
414). Examples of catalase-negative, and therefore
hydrogen peroxide producing microorganisms, are
pneumococci, streptococci, lactobacilli and mycoplasma,
but there are considerable inter-strain differences in
production within a species (Klebanoff and Clark, 1978:
414-415). The hydrogen peroxide formed may contribute
to auto-inhibition for that organism, or antagonism
towards another species. To the advantage of host
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defence, the potential toxicity of the hydrogen peroxide
is increased markedly by the addition of MPO and halide
ions, which means that the organisms contribute to their
own demise (Klebanoff, 1968). Bacterial production of
hydrogen peroxide is sufficient for killing by the MPO
pathway. This has been shown to occur in classical
chronic granulomatous disease (Klebanoff and White,
1969). Hydrogen peroxide is also produced in
leucocytes as a consequence of the respiratory burst,
as described in chapter 3, and may be summarised as:
NADPH NADP+ + H+
These two pathways account for the generation of nearly
all the hydrogen peroxide (Root and Metcalf, 1977).
Production of superoxide and hydrogen peroxide is centred
in the plasma membrane and phagocytic vacuole fractions
(Briggs et al., 1975; Dewald et al., 1979; Badwey et
al., 1980; Butterick et al., 1983). Also, a recent
study has demonstrated considerable hydrogen peroxide
production in cytoplasts of human neutrophils, which
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contain no nuclear or granular components (Roos, Voetman
et al., 1983). Most of the hydrogen peroxide produced
is utilised in peroxidatic and catalytic reactions
(Romeo et a]../ 1979) . Thus, as was stated in chapter 3,
hydrogen peroxide is a significant physiological product
of activated neutrophils, and recent evidence suggests
that it may be more relevant in vivo than superoxide
anion per se (Roos et al., 1982; Curnutte and Tauber,
1983; Roos, Hamers et al., 1983).
The third component of this antibacterial system
is halide (Klebanoff, 1967; 1968), the most extensively
studied being iodide. In the original experiments
iodide was shown to be the most effective co-factor,
with a total bactericidal effect observed at a
concentration of 5 x 10 (Klebanoff, 1968). The
iodination reaction (peroxidation of iodide by MPO with
hydrogen peroxide as substrate) was considered to be the
most likely basis of the microbicidal mechanism for some
years, but reservations have been expressed (Klebanoff
and Hamon, 1972; Segal, Garcia et al., 1983) . The
possible roles of bromide and thiocyanate within
neutrophils are as yet unknown (Klebanoff and Clark,
1978: 418-420), but evidence has been accumulating to
support the involvement of chloride as the chief co-factor
in vivo. Klebanoff (1968) demonstrated the total
bactericidal capacity of the MPO-mediated system with
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chloride as a co-factor at a concentration of 5 x 10 M.
The concentration of chloride available within human
neutrophils is more than sufficient to permit
physiological involvement in the system (Baron and
Ahmed, 1969; Morrison and Schonbaum, 1976).
The microbicidal mechanisms are complex and
incompletely understood but include halogenation
reactions, i.e. the formation of covalent bonds between
the halogen and appropriate grouping (e.g. tyrosine) on
the organism, or oxidations in which halides are
oxidised by the MPO-hydrogen peroxide complex to a
variety of microbicidal compounds (Klebanoff and Clark,
1978: 421). Halogenation also seems a probable
mechanism for bacterial protein denaturation, although
Segal, Garcia et al. (1983) have cautioned that many
conclusions are based on extrapolations of theoretical
biochemical models. The physiological product of
chloride oxidation is thought to be hypochlorous acid
(HOC1) (Stelmaszynska and Zgliczynski, 1974;
Zgliczynski and Stelmaszynska, 1975; Wever et al., 1981),
and this is formed over a broad range of pH values
(Zgliczynski et al., 1977) . The mechanism may be
governed by two independently operative chloride binding
sites on the MPO molecule (Andrews and Krinsky, 1982a).
The efficacy of an hypochlorous acid generating system
in neutrophil killing of E. coli has been demonstrated
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(Sips and Hamers, 1981) and was found to be effective
both extracellularly and intracellularly. Chlorination
reactions catalysed by MPO have been demonstrated
(Harrison and Schultz, 1976). Recently it was shown
that approximately 30% of the oxygen consumed on
neutrophil stimulation is utilised in chlorinating
reactions (Foote et al., 1983).
Klebanoff and Clark (1978: 425) have summarised a
possible reaction for the production of hypochlorous
acid:
MPO + CI + H202 + H+-Fe *
MPO~!!e*JJ°OH ^ MPO~!]e + H20 + HOC1-F .Cl -Fe z
(Hypochlorous acid is used commercially as a germicidal
agent, for example in swimming pools.)
Apart from hypochlorous acid production, chloramines
may be formed by oxidation of nitrogenous compounds by
the MPO-hydrogen peroxide-chloride system (Zgliczynski
et al., 1971; Thomas, 1979). These could be bactericidal
in a number of ways, principally by the ultimate release
of activated chloride (Klebanoff and Clark, 1978: 426).
Soluble aldehydes and singlet oxygen species may also be
generated with bactericidal consequences but much of the
evidence is theoretical (Klebanoff and Clark, 1978: 426-
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428). Recent evidence also suggests that glutathione
may be oxidised by the MPO system with microbicidal
results (Turkall and Tsan, 1982).
A number of schemes have been proposed for killing
of microorganisms by the MPO system but have not been
completely elucidated. As for the LPO-dependent system,
oxidation of sulfhydryl groups is probable (Thomas and
Aune, 1978a). Decarboxylation reactions, lipid
peroxidation and the toxicity of hypochlorous acid for
bacterial nucleic acids have also been demonstrated
(reviewed by Klebanoff and Clark, 1978: 429).
Hypochlorous acid contributes to increasing the
permeability of cell walls in E. coli (Sips and Hamers,
19 81) and this is supported by the work of Thomas (19 79) .
Finally, Albrich et al. (1981) have proposed that the
toxicity of hypochlorous acid is directed towards bacterial
adenine nucleotides with the subsequent destruction of the
electron transport chain.
In summary, the components of the myeloperoxidase-
hydrogen peroxide-halide system exist in normal human
neutrophils, and sufficient data are available to suggest
that it is operative. The relative importance of this
microbicidal mechanism with respect to other oxygen-
dependent and the oxygen-independent pathways in vivo,
however, remains open to argument. Some insight may be
gained by a brief consideration of microbicidal activity
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in circumstances of deficiency in hydrogen peroxide
generation or myeloperoxidase.
Deficiencies in the Myeloperoxidase-Hydrogen
Peroxide-Halide System
The literature discussing this system as a host
defence mechanism is extensive and the investigation of
deficiency states should provide complementary evidence.
In experimental circumstances, reduced hydrogen peroxide
production is accompanied by decreased microbicidal
efficiency, but in a brief review of this subject
Klebanoff and Clark (1978: 431-432) emphasised that, as
in a genetically-based deficiency state such as chronic
granulomatous disease, the killing defect may equally
result from inadequacy in other components.
Inhibition of MPO may be produced experimentally by
a number of agents, with variable effects on killing.
Azide, for example, inhibits MPO and bacterial killing
(Klebanoff, 1970). The antithyroid drug propylthiouracil
inhibits iodination and killing of staphylococci by human
neutrophils (Klebanoff and Hamon, 1972), so illustrating
an effect on the halide component of this system.
Naturally occurring (hereditary) human MPO deficiency
has received most attention recently. This was first
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described 20 years ago by Grignaschi et al. (1963) and a
further 13 cases were reported over the following 15 years,
suggesting a rare condition. The most quoted of these
case reports has been that of Lehrer and Cline (1969) ,
who described a reduced ability of their patient's
neutrophils to kill Candida albicans. Many papers and
reviews have since quoted this one study as conclusive
evidence for the importance of MPO in Candida killing.
Recent larger studies also support this claim (Parry et
al., 1981). It is often overlooked that Lehrer and
Cline's patient was also diabetic, as have been others
(Cech et al., 1979) . This deficiency of MPO,
susceptibility to Candida infection and endocrine
disturbance, has appeared in other conditions such as
pregnancy (El Maallem and Fletcher, 1980) .
In their review of MPO deficiency to date, Klebanoff
and Clark (1978: 711-733) observed that interest in this
area was increasing, and so predicted the reporting of
more cases. This point was reiterated by Segal (1981)
by which time more sophisticated analytical equipment had
become available for screening. Parry et al. (1981)
found 28 patients deficient in MPO by screening 60,000
individuals, and Cramer et al^. (1982) found 45 from
approximately 100,000. These figures suggest a total
population prevalence of approaching 0.05%, and led
Parry's .group '1981) to suggest that MPO deficiency may
be the commonest functional disorder of human neutrophils.
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Several studies have been able to investigate the
families involved and uniformly agree on an autosomal
recessive pattern of inheritance (Lehrer and Cline, 1969;
Cramer et al., 1982; Larrocha et al. , 1982).
Many of the studies, whether large or small, report
both complete and partial deficiency and a recent
investigation has revealed that in partial deficiency the
MPO is present in approximately half the normal amount,
but is structurally, biochemically and immunologically
normal (Nauseef, Root et al., 1983). Perhaps the most
striking feature of these studies is the inconsistency
between deficiency and susceptibility to infection, and
an enormous variation in the severity of infection when
present. For example, in the 28 cases identified by
Parry et al. (1981) only four were considered to be
severely compromised. In some cases killing occurred
normally but over a protracted time period (Cramer et al.,
1982).
The conclusion to be drawn at this stage is that the
MPO-dependent bactericidal and fungicidal pathways are
complex and interrelated to other systems of killing.
This point was emphasised strongly by Lehrer and Cline
(1969) who showed that in four sons of their MPO-deficient
proband, the MPO activities were 22 to 38% of the control
value and yet all were healthy. Other compensating
systems must therefore exist, and it should be remembered
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that neutrophils contain very large amounts of this
enzyme, which means that a deficiency of 90% may be
tolerable before clinical manifestations occur (Harkness,
1981). Finally, careful interpretation of data is
necessary since discrepancies may arise between the
histochemical identification of an enzyme and activity
measurements as determined, for example,
spectrophotometrically (Harkness, 1981).
Other Functions of Myeloperoxidase
In addition to the directly bactericidal action of
the MPO system, several other functions have been
described and these can be classified into two groups.
One concerns microbicidal functions, but in which MPO
acts by modifying other processes. The other is the
role of MPO-mediated reactions in cytotoxicity.
a) The regulatory role of myeloperoxidase
A succession of studies has demonstrated the
involvement of MPO in modifying chemotactic factors by
neutrophils (Clark and Klebanoff, 1979; Clark and Szot,
1982; Lane and Lamkin, 1983). These studies also showed
that the mechanism involves oxidation of sulphur in the
methionine residues of chemotactic peptides. A recent
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report has further shown that MPO-mediated oxidation of
the Fc and C3b receptors on the neutrophil membrane may
occur, so affecting particle binding and phagocytosis
(H&kansson and Venge, 1983).
Myeloperoxidase may modify the respiratory burst
(Segal et al., 1980), and in MPO-deficient neutrophils
(Rosen and Klebanoff, 1976; Cech et al., 1979) and
monocytes (Locksley et al., 1983) there is increased
activity. The prime function of MPO here may thus be
to terminate the burst and the production of reactive
radicals (Nauseef, Metcalf et al., 1983).
Myeloperoxidase may influence inflammation further
in two other ways. Firstly, MPO may inactivate protease
inhibitors by a similar oxidative mechanism that operates
against bacteria (Matheson et al., 1979; Clark et al.,
1981). This could have serious consequences in the
pathogenesis of many chronic inflammatory diseases.
Secondly, MPO may modify inflammatory and hypersensitivity
reactions by the oxidation and iodination of arachidonic
acid, thereby affecting subsequent prostaglandin and
leukotriene function (Turk et al., 1983).
It may be therefore that MPO has several roles to
play in addition to the classical one of direct bacterial
killing. Clearly, some of these activities may be
protective and others potentially destructive to the host.
Recent data have shown that neutrophil MPO may enhance
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the release of histamine from mast cells (Stendahl et cil.,
1983) and the same group had previously implicated MPO in
the pathogenesis of dermatitis herpetiformis (Stendahl et
al., 1978).
b) Myeloperoxidase and cytotoxicity
The second major field of influence for MPO-mediated
oxidations is in cytotoxicity towards mammalian cells
(Klebanoff and Clark, 1978: 255-258). A number of cell
types have been studied. For example, spermatozoa, in
which LPO, MPO or uterine peroxidase with iodide or
thiocyanate as co-factor may induce loss of mobility.
The hydrogen peroxide may be generated from the neutrophil
or by spermatozoal metabolism. Toxicity towards human
erythrocytes, platelets and leucocytes has also been
demonstrated in a similar fashion, but of particular
interest have been the studies of tumour cell sensitivity
to MPO-mediated damage. This aspect is included in the
above review and reinforced by more recent studies.
Clark and Klebanoff (1975) demonstrated tumour cell
killing by the MPO system from intact neutrophils, and
more recently a similar observation was made with mast
cell peroxidase (Henderson et al., 1981). The efficacy
of this tumoricidal function is probably related to the
extracellular activity of MPO (Clark and Szot, 1981). In
fact, the extracellular release of MPO from stimulated
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cells was described by Baehner et al. in 1969, and
subsequently it was shown that particle ingestion led to
a 50-fold increase in the extracellular release of
hydrogen peroxide (Root et a_l., 1975) . The efficacy of
this system against E. coli has been demonstrated (Sips
and Hamers, 1981) and this applies to both prokaryote and
eukaryote cell toxicity.
These aspects of neutrophil peroxidase function will
undoubtedly receive more attention, but in conjunction
with the recent interest in multiple forms of MPO, it has
been hypothesised that there may be a link. It is
possible that a heterogeneous group of enzymes with
similar, overlapping activities are individually able to
selectively catalyse oxidations against a broad group of
target cells (Kinkade et ajL. , 1983).
Clearly, MPO plays a key role in neutrophil
activities and the diverse nature of these (within the
context of a single enzyme) may provide part of an
explanation as to the apparent over-endowment of each
cell. Such an important and widely studied enzyme also
lends itself to investigation from another and equally
important viewpoint with respect to host defence. That
is, the influence of agents including antimicrobial drugs
on both the enzyme per se and the enzyme as a marker of
neutrophil function.
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The Influence of Various Agents on Neutrophil
Function and Myeloperoxidase
In purely experimental situations, the most commonly
employed inhibitor of MPO is sodium azide (NaN3), which
inactivates the enzyme directly by forming a complex
(Klebanoff and Clark, 1978: 432). It has been shown
that azide inhibits bacterial killing and this inhibition
is absent when MPO-deficient neutrophils are used
(Klebanoff, 1970).
More relevant to clinical therapeutics are the
possible effects on host defence of agents employed in
the treatment of disease. Adverse effects may be so
severe as to warrant discontinuation of a drug or so
apparently mild as to go unnoticed. Yet in the long run
clinically significant problems may be insidiously
produced. By contrast, it is possible that a drug may
achieve its designated therapeutic effect and
simultaneously stimulate some component of the immune
system to the benefit of the host. This field has been
extensively researched in recent years, and with the
continuing development of chemotherapeutic regimes in all
areas of clinical practice, will continue to be so.
The effects of many drugs on neutrophils have been
documented but this introductory review will be limited
to those considered most relevant. The influence of
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antimitotic chemotherapy will be mentioned in chapter 5.
As examples of differing agents, tobacco smoke has been
shown to inhibit neutrophil chemotaxis and metabolism
(Bridges et al., 1977; Corberand et al. , 1980) and to
stimulate the release of lysosomal elastase (Blue and
Janoff, 1978). Povidone-iodine compounds, widely used
as disinfectants, are toxic to human neutrophils and
monocytes in vitro, at concentrations used clinically
(van den Broek et al., 1982). The influence of hormones
on phagocytic cell function both physiologically and
pharmacologically has been studied. Some neutrophil
enzymes including MPO may be under oestrogenic control
(Cockle and Harkness, 1978; Harkness et al., 1979) and,
during pregnancy, neutrophil oxygen consumption may
increase (Kvarstein and Gj^nnaess, 1981). Steroid drug
administration, particularly glucocorticoids, may markedly
influence neutrophil function in a manner which is drug
and dose dependent (Watson et al., 1979). It is
generally agreed that hydrocortisone inhibits particle
binding to the C3b receptor (Boxer et al., 1978) and the
Fc receptor (Klempner and Gallin, 1978a) of the neutrophil,
and that reduced metabolism is secondary to these effects
(Forslid and Hed, 1982).
Of particular relevance, however, are the possible
harmful or beneficial effects of antimicrobial drugs
which are administered as an adjunct to host defences and
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are rarely successful in their total absence. A number
of reviews have recently appeared, so underlining the
importance of this aspect of antimicrobial chemotherapy
(Finch, 1980; Mandell, 1982; Raeburn, 1982). Moreover,
in 1981 the first international workshop was convened to
discuss the effects of antibiotics on host defence
mechanisms (Eickenberg et al., 19 82) . Many studies have
employed drugs at concentrations far in excess of those
used in practice and others have been performed on animal
neutrophils, so that results must be interpreted with
caution (Mandell, 19 82) . The vast majority of studies
have been conducted in vitro which provides technical
advantages but may not be entirely relevant to in vivo
conditions. Among the first reports of an adverse
effect on human neutrophils by an antimicrobial drug was
that of Lehrer (1971) who demonstrated a reduced
fungicidal and bactericidal activity induced by
sulphonamides. He presented indirect evidence that the
inhibition was directed at MPO, although this finding was
not reproduced in vitro. It has been suggested that the
sulphonamide inhibition may be irreversible but slow in
reacting with its binding site (Harkness, 1972). Many
results are difficult to compare and are equivocal. For
example, at different concentrations tetracyclines may
have no effect on neutrophil functions (Hoeprich and
Martin, 1970; Midtvedt et al., 1982) or inhibit
phagocytosis (Forsgren et al., 1974) and bacterial killing
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(Welch et al., 1981). Both moxalactam and to a greater
extent gentamicin inhibit neutrophil chemotaxis but have
no effect on phagocytosis or microbicidal function
(Burgaleta et al., 1982). Ampicillin in vivo was shown
to depress subsequent neutrophil killing of staphylococci
in vitro (Raeburn et al., 1976) . A newly introduced
cephalosporin, AC-1370, enhances neutrophil phagocytosis
in vitro (Ohnishi et al., 1983).
Neutrophil chemiluminescence provides an indirect
measurement of oxygen radical production and thus killing
potential (Allen, 1979) and is being increasingly used to
monitor drug effects. Unless standardised, however, it
cannot be equated with either phagocytosis or killing but
it is an extremely convenient and sensitive assay. The
chemiluminescence response is depressed by rifampicin
and a combination of trimethoprim and sulphamethoxazole
(Siegel and Remington, 1982) but enhanced by the anti¬
fungal agent amphotericin B (Supapidhayakul et al., 1981).
A further problem in interpretation beyond those
already mentioned, is the extent to which the agent
penetrates the cell and this has also been an area of
controversy (Brown and Percival, 1978; Raeburn, 1982).
Once again methodologies, concentrations and cell types
have varied so that benzyl penicillin, for example, was
shown not to penetrate the phagolysosomes of human
neutrophils (Mandell, 1973) or penetrate only slowly
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(Prokesh and Lee Hand, 1982). In the latter study,
three cephalosporins (cephalexin, cefamandole and
cefazolin) also gained only limited access to the interior
of the cell. By contrast tetracycline (Park and Dow,
1970), rifampicin and gentamicin (Easmon, 1979) were all
readily taken up by neutrophils.
A clinically important consideration stems from a
corollary to the above discussion. Bacteria that are
phagocytosed and remain viable within neutrophilic or
monocytic phagocytes for a considerable time, are
protected from the extracellular antibiotic, and
especially so if that drug fails to enter the phago¬
lysosome in sufficient concentration (Solberg and Helium,
1978; Lam and Mathison, 1983). The interaction between
phagocyte, bacterium and antibacterial drug is complex.
Some experimental work has been directed specifically
at drug effects on MPO (e.g. Lehrer, 1971). In 1972
Renz et al. reported a 40% reduction in the activity of
horseradish peroxidase by ampicillin and 15% by benzyl
penicillin, an inhibition that was irreversible. These
authors qualified their conclusions by stating that
accessibility of the drug to the appropriate site in vivo
was unknown, but later demonstrated an in vivo reduction
of MPO activity by ampicillin to approximately 70% of the
normal value (Harkness and Grant, 1977). A larger study
confirmed the earlier observations and further demonstrated
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that the reduction in MPO activity by ampicillin was
paralleled by a reduction in phagocytosis of staphylococci
(Grant et al., 1983). Intracellular killing was not
affected. The same study also demonstrated an
enhancement of MPO activity and phagocytosis by cefaclor.
The antifungal agent, clotrimazole, was investigated
similarly and shown to significantly enhance MPO activity
in infants suffering from candidiasis (Renz et al.,1974).
An interesting point was that the clotrimazole was clinic¬
ally effective despite attaining serum levels that were
not fungistatic in vitro. The absence of an in vitro
effect of clotrimazole may indicate a stimulation of
synthesis of MPO, and a hormonal control (which has
been mentioned previously) was suggested by the in vivo
elevation of MPO activity in male subjects given the
anti-oestrogenic drug clomiphene (Harkness et al., 1979).
In a recent study benzyl penicillin did not affect
the MPO-mediated iodination of staphylococci, and
increased killing was the result of non-oxidative
pathway stimulation (Root et al., 1981). Other agents
that have been shown to affect MPO include dapsone, an
anti-inflammatory and antileprotic drug which caused a
depression in activity (Stendahl et al., 1978; Anderson
et al., 1981). A large number of anti-arthritic drugs
inhibit MPO (Matheson, 19 82) , and several non-steroidal
anti-inflammatory drugs inhibit MPO-generated (cell free)
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chemiluminescence (Pekoe et al., 1982). Fluoride
(Gabler and Leong, 1979) and ascorbate (Anderson, 1981)
have also been shown to inhibit the activity of MPO-
mediated reactions.
Myeloperoxidase therefore seems to be amenable to
study with respect to drug effects as a model of enzyme
function in neutrophils. Considering the possible
complexities of control of this and inter-related
antimicrobial pathways, in vivo studies should prove
fruitful.
Assays of Myeloperoxidase
Myeloperoxidase may be assayed for its presence in
whole cells by cytochemical methods or for its activity
in extracts of whole cells spectrophotometrically.
Until recently, when it was shown that benzidine has
carcinogenic properties, the cytochemical method of
Kaplow (1965) was widely used in haematological
identification of MPO, particularly in the diagnosis of
leukaemias. In 1964, Hayhoe et ad. described a scoring
system for cells on blood films to establish the overall
intensity of a cytochemical reaction, so making the
assay semi-quantitative. This has been applied to
neutrophils stained with benzidine, for example recently
in both normal and leukaemic cells (Bendix-Hansen and
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Kaspersen Nielsen, 1983a). The leukaemic states will
be considered in chapter 5. Graham and Karnovsky (1966)
described a similar method using 3,3'-diaminobenzidine
(non-carcinogenic) to localise MPO in the azurophilic
granules. A recent comparison of the two reagents
demonstrated that both were satisfactory with a slightly
greater sensitivity being noted for benzidine (Sheibani
et al., 1981). Another substrate, p-phenylenediamine and
pyrocatechol was also found to be suitable. The Kaplow
(1965) method has been used successfully with the
diaminobenzidine reagent (Cramer et a^L. , 1982). In
1975, Kaplow introduced a further reagent, chemically
unrelated to benzidine, 3-amino-9-ethylcarbazole.
The identification of an enzyme, however, does not
provide a measure of its activity and the spectrophoto-
metric assays available provide this information. In
principle, addition of the enzyme to a coloured substrate
in the presence of hydrogen peroxide allows a continuous
assay of the initial reaction, measured as absorbance at
an appropriate wavelength. Thus the rate of oxidation
is proportional to the enzyme concentration (Babior and
Cohen, 1981). Orthodianisidine (Klebanoff, 1965) is a
commonly used substrate, and variations on the original
method have been described (for example, Cramer et al.,
1982). Another benzidine derivative, tetramethylbenzidine,
has recently been used for peroxidase quantitation
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(Andrews and Krinsky, 1982b) and increasingly used is
2,21-Azino-di(3-ethylbenzthiazoline-6-sulfonic acid), or
ABTS (Shindler et al., 1976). Once again, modifications
have been described in an attempt to improve sensitivity
(Makinen and Tenovuo, 1982).
Lehrer and Cline (1969) used the orthodianisidine
method of Klebanoff (1965) in their study of MPO
deficiency and their normal values were reproduced in
the UK by Renz et al. (1974), and in a later study by
the same group (Harkness et al., 1979). Within a
laboratory consistency in methodology is essential because
there may be small differences between pathways for the
various substrates (Childs and Bardsley, 1975).
Neutrophils can now be differentiated from other
leucocytes on the basis of their uniquely high peroxidase
content (Mansberg et al., 1974), and this system facili¬
tates the identification of MPO deficiency in very large
numbers of blood samples (Parry et al., 1981; Cramer et
al., 1982). Finally, chemiluminescence assays
mentioned previously are being increasingly used in whole
cell and cell free systems. Isolated peroxidase, including
MPO, can generate light in an experimental system (Puget
et al., 1977; Pekoe et al., 1982) and intact neutrophil
luminescence depends at least in part on MPO activity
(Klebanoff and Clark, 1978: 300-308; De Chatelet et al.,
1982; Dahlgren and Stendahl, 1983).
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The Present Study
The purpose of this study was primarily twofold.
Firstly, to determine the presence and activity of MPO
in gingival crevicular neutrophils, and to compare this
to known data on peripheral blood neutrophils. Secondly,
to investigate the sensitivity of MPO in blood and
crevicular cells to antibiotics.
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MATERIALS AND METHODS
Determination of Myeloperoxidase in Peripheral Venous
Blood and Gingival Crevicular Neutrophils
1. Cytochemical methods
Cytochemical determination of MPO was first
conducted on PVB neutrophils from routinely prepared
blood films fixed in 10% formalin/90% ethanol, as
described by Kaplow (1965). The staining method is
described in Appendix 3. The method has been widely
used and is simple to perform, so that cytocentrifuge
preparations were made of crevicular washings in PBS and
treated in a similar fashion.
This pilot experiment was designed to establish the
reliability and accuracy of the technique and determine
the presence of MPO in crevicular cells in six healthy
adults. The preparations were counterstained with
Leishman stain or May Griinwald/Giemsa, and the percentage
of positively staining neutrophils counted. A semi¬
quantitative determination of MPO was made using the
criteria of Cline (19 81) , which are based on those of
Hayhoe et al. (1964).
For one subject it was possible to repeat the
measurements on several occasions including once during
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a severe upper respiratory tract infection.
In addition to the above method, several crevicular
samples were also stained with the 3-amino-9-
ethylcarbazole reagent (Kaplow, 1975). The method is
described in Appendix 4. The objective was simply to
confirm the presence of MPO as determined by the
benzidine method and no counts were performed as above.
2. Spectrophotometric assay
For several years the laboratory in which the MPO
activity measurements were made had been using the
method of Klebanoff (1965), which is based on the
oxidation of orthodianisidine. Having a method so well
established for blood neutrophils provided a singular
advantage in that a normal range of MPO activity values
was available, and those for a new test group would be
directly comparable. This method should also be
appropriate for the estimation of MPO in crevicular
cells.
To determine MPO activity in gingival crevicular
and PVB neutrophils simultaneously, blood and crevicular
fluid were collected from 30 systemically healthy adult
volunteers, 15 male and 15 female. The age range was
17-48 years with a mean of 27.1 years. At this stage
the clinical state of the gingival tissues was not
specifically recorded.
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Preparation of neutrophils: The method was based
on that described by Renz et ad. (1974) . Neutrophils
were separated from 6-7 ml venous blood collected into a
lithium heparin coated plastic tube to which were added
1.5 ml 6% w/v dextran (molecular weight 200,000, Sigma
Chemicals, USA) in PBS, pH 7.2. After thorough mixing,
the tube was incubated for 45 min at 4°C and the
leucocyte-rich supernatant fluid removed into conical
glass tubes. These were centrifuged for 10 min at
1,500 rpm (approx. 500 g) to pellet the cells and the
supernatant fluid was discarded. The cell button was
resuspended in approximately 10 ml 0.87% ammonium
chloride to remove erythrocytes by differential hypotonic
lysis. The tube was allowed to stand for 10 min at
room temperature and then centrifuged for 10 min at 1,500
rpm (500 g) as above. When necessary this step was
repeated to ensure complete removal of erythrocytes, as
judged visually. The cells (approximately 90%
granulocytes) were washed in PBS and resuspended in 0.2
ml acetate buffer 0.01 M, pH 4.0. This was then stored
at -20°C or -40°C until required for assay.
Gingival crevicular neutrophils were collected in
sds, pH 7.2, as previously described. Epithelial cells
were removed and gross bacterial contamination reduced by
the addition of further saline dextrose and sedimentation
at room temperature for 5 min. The 'supernatant' fluid
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contained the neutrophil leucocytes which were concentrated
into a pellet by centrifugation at 500 g, resuspended in
0.1 ml acetate buffer and stored as for the PVB cells.
For convenience, some cell samples were stored at
-40°C and others at -20°C, which was shown by
experimentation not to affect the subsequent assay. In
practice, the enzyme assays were performed within a few
weeks of cell collection.
Myeloperoxidase assay: The cell preparation was
thawed before assay, made up to 0.5 ml with acetate
buffer, and subjected to two further freezing and thaw
cycles to rupture the cell membranes. Cellular debris
was removed by centrifugation at 6,000 rpm and free
enzyme activity was assayed from the supernatant fraction.
Details of the spectrophotometric assay are given in
Appendix 5, and the protein was determined by the Miller
(1959) modification of the method of Lowry et al. (1951).
All measurements were made with a Pye Unicam SP-8-100
spectrophotometer (Pye Instruments, Cambridge, England).
The results were reported as units of activity per \xg
protein, for blood and crevicular cells from each of the
30 subjects based on a mean of duplicated tests.
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Gingival Crevicular Neutrophil Myeloperoxidase
Activity and Gingival Inflammation
To investigate the gingival crevicular neutrophil
MPO activity further, particularly in the light of
finding six samples in which no enzyme activity was
detectable in the first experiment, a study group of 30
subjects (15 male, 15 female) was sampled. They had no
clinical evidence of gingivitis (G.I. = 0), including the
six with no MPO activity. Twenty subjects (10 male, 10
female) with measurable gingivitis (G.I. > 0.5) were also
examined. All were systemically healthy. For the
non-inflamed group, the mean age was 25.7 years (male
27.7, female 23.6 years) and for the gingivitis group,
26.9 years (male 25.5, female 28.5 years).
A 50 |il sample of the crevicular washings from each
subject was diluted with 50 jj.1 PBS in a cytocentrifuge
well and a glass slide preparation made for cytochemical
staining of MPO (Kaplow, 1965).
Effect of Ampicillin and Cefaclor on Peripheral Blood
and Gingival Crevicular Neutrophil Myeloperoxidase Activity
Nine systemically healthy adult volunteers, 5 male
and 4 female, with no clinical evidence of gingivitis,
but all of whom had demonstrated crevicular neutrophil MPO
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activity, were used in this study. None was taking any
form of medication. The age range was 23-39 years.
A single 500 mg oral dose of ampicillin or cefaclor
was administered between 8 and 9 a.m. on a random double
blind basis. Venous blood and crevicular fluid samples
were collected immediately prior to drug administration
and at specific time points thereafter for 4 hours.
Preparation of neutrophils and the spectrophotometric
assay of MPO were carried out as described in the previous
section.
From the whole blood samples taken, serum was
separated and assayed for the level of antibiotic by a
standard plate diffusion method at pH 7.4, using Sarcina
lutea as test organism. Since cefaclor is inactivated
in serum, clotting of the sample was accelerated by the
addition of thrombin and stabilised by the method of
Broughall et al. (1979). Test samples and antibiotic
standards were set up in quadruplicate. The test method
was sensitive to 0.1 jag/ml.
Since it was likely that a drug effect on the enzyme
activity could be partly masked by normal fluctuations,
the crevicular neutrophil MPO levels were monitored 14




Determination of Myeloperoxidase in Peripheral Venous
Blood and Gingival Crevicular Neutrophils
1. Cytochemical methods
The percentage of cells staining positively for MPO
and the scores for each of the six healthy subjects are
shown in Table 4.1.
TABLE 4.1:
CYTOCHEMICAL DEMONSTRATION OF MPO IN SIX SUBJECTS
Percentage
Positive Cells Score
Age Sex Blood Crevice Blood Crevice
39 M 78 95 198 299
24 F 89 65 316 126
22 F 91 85 202 160
24 M 86 61 256 82
22 M 95 92 359 264
29 M 75 84 157 131
80 59 135 90
83 81 206 164
- 95 - 299
99* 00 00 * 369* 179*
Estimations of MPO during systemic infection.
For one subject several sets of data were available
including one determined during an untreated respiratory
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*
infection . Figure 4.1a shows a peripheral blood
neutrophil staining positively for MPO while an adjacent
lymphocyte is clearly negative. Figure 4.1b shows a
typical appearance of crevicular neutrophils similarly
stained from the same subject and Fig. 4.1c illustrates
crevicular cells treated with 3-amino-9-ethylcarbazole
reagent. All preparations treated with the latter
reagent stained positively as illustrated. Thus, overall,
a majority of crevicular neutrophis were shown to contain
MPO. For the positive cells it was possible to examine
the distribution of scores and an example of this is
shown in Fig. 4.2 for the subject for whom data were
available during health and a systemic infection.
2. Spectrophotometric assay
The normal activity measurements for blood neutrophil
MPO expressed as units per p.g protein from this laboratory
are given in Table 4.2.
TABLE 4.2:
ESTABLISHED BLOOD NEUTROPHIL MPO ACTIVITY VALUES
(units/(ig protein)
Source of Neutrophils Range Mean + sem n
Cord blood 0.7 - 18.5 5 . 8 + 1.2 19
Healthy neonates 0 - 42 .0 7.0 + 1.4 80
Healthy children 0.3 - 8.7 4.7 + 0 . 8 32
(3-13 years)
Healthy adults 2.0 - 7.5 4.5 + 0 . 8 44
( Male 3.9 + 0.9) 26



















Giemsa stain, x 1200.
b) MPO positive crevicular
neutrophils. Kaplow's
(1965) benzidine method.
Giemsa stain, x 1200.



















CREVICE SCORE = 179
%. ve = 8 8.
0 12 3 4
SCORE.
BLOOD SCORE = 369.
°A>♦ ve = 9 9
0 12 3
SCORE.
FIG. 4.2: Distribution of scores for cytochemical
MPO assay in one adult male subject (age 29 yrs).
The test was performed during an upper respiratory
tract infection.
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The results of MPO investigations from both blood and
crevicular cells from the 30 healthy adults are shown in
Table 4.3.
TABLE 4.3:
MPO ACTIVITY (units/ng protein) IN PERIPHERAL BLOOD AND





































































Note: Values are means of duplicated tests.
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In general, the blood values were higher than those
for crevicular cells. Five of the blood values fell
below and four above the stated normal adult range,
although these could not be considered abnormal,
particularly without repetition. Six subjects whose
crevicular samples had no activity were re-examined and
it was found that all had clinically healthy gingivae.
For all 30 subjects, the mean blood neutrophil activity
was 4.14 and the crevicular cell value was 1.46 units/jig
protein. The respective mean values for male subjects
were 3.8 (blood) and 1.46 (crevice), and for female
subjects 4.47 (blood) and 1.45 (crevice). The total
group value accords with the established laboratory
figure, and with Student's 't' test, the means for blood
MPO between male and female subjects were not significantly
different (t = 1.71, p = 0.1). However, the slightly
higher value for female subjects accorded with the
existing laboratory data (see Table 4.2). Crevicular
neutrophil MPO values for both female and male subjects
were virtually identical. To determine any relationship
between the crevicular and blood neutrophil values, a
linear regression was plotted and the correlation
coefficient, r, determined. The r value was 0.034, as
determined by the formula given in Appendix 6, and thus
no relationship between the values was demonstrated.
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Gingival Crevicular Neutrophil Myeloperoxidase
Activity and Gingival Inflammation
The crevicular neutrophil MPO activity levels for
each of the 50 subjects are shown in Fig. 4.3. The
values for all those with inflamed gingivae were scattered
within or around the established range for peripheral
blood neutrophils. All the samples had measurable
activity.
By contrast, the samples from non-inflamed tissues
could be divided into two groups. In one, comprising
14 of the 30, the values fell closely in and around the
normal range for blood, while in the second group
comprising 16 of the 30 subjects, no activity was
detectable. This latter group represented just over
half the total subjects with no inflammation, and since
10 of the 16 were female, this constituted two-thirds of
the female and two-fifths of the male subjects studied.
In all 50 cases, positive staining for MPO was
seen on the cytocentrifuge preparations.
The individual MPO measurements of all 50 subjects
were plotted against the Gingival Index for each subject
and this is shown in Fig. 4.4. The correlation
coefficient r for the total group was 0.48, which was
statistically significant (p < 0.01). When the r value


































MPO activity values for 50 subjects with both
clinically healthy and inflamed gingival tissues.
MPO
The normal range for blood neutrophil^ activity is
shown by the vertical bar.
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FIG. 4.4:
Relationship between MPO activity in crevicular




the result was also 0.48 (p < 0.05). Thus, increasing
inflammation as determined clinically, was accompanied
by increasing MPO activity in neutrophils from those
tissues.
To investigate any relationship between the results
obtained from the group with gingival inflammation and
those with perfect health, a non-parametric statistical
test was used. The Mann Witney U test is a powerful
test for comparing two independent samples, and depends
upon initially ranking the values to be compared for both
groups. Details of this test are given in Appendix 7.
In this case, there were 30 subjects with no gingivitis
and 20 subjects with gingivitis.
The value for U = 126.5, and z = 3.436, therefore
p £ 0 .0003. Thus the difference between the two groups
was highly significant.
Effect of Ampicillin and Cefaclor on Peripheral Blood
and Gingival Crevicular Neutrophil Myeloperoxidase Activity
Complete data were available for 7 subjects with
cefaclor and 10 (two subjects repeated all experiments
and for one data were incomplete) with ampicillin. The
MPO values in gingival crevicular cells, monitored in
one subject over a 22 hour period are shown graphically
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in Fig. 4.5. It can be seen that there was some
fluctuation, but this was not marked. Figure 4.6 shows
the MPO activity in blood and crevicular neutrophils in
one subject as an example, after the administration of
ampicillin and cefaclor on separate occasions. As for
Fig. 4.5, the values were plotted as log units of
enzyme activity. Although in this case there was a
marked rise in activity of the crevicular cells with
cefaclor, the effect of ampicillin, particularly on the
blood neutrophil enzyme, was less easily interpreted.
This feature was common to many of the results and for
this reason, and because enzyme activities may follow a
log-normal distribution, the following analysis was
considered appropriate to determine the overall effect of
the antibiotics.
The pre-drug level of MPO activity (i.e. at zero
time) was taken as the base level. The maximum and
minimum levels reached during the course of the experiment
were recorded. To determine the overall net change in
enzyme activity, the calculation was : -
(log max - log base) - (log base - log min) = x
For each population of cells a mean value was obtained
for each drug, and the final value was obtained by taking






Gingival crevicular MPO activity measured 14 times
over 22 hours in one healthy male subject (age 31 yrs) .
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TIME AFTER DRUG ADMINISTRATION (HR)
FIG. 4.6:
Effect of 500 mg ampicillin (AMP.) and cefaclor (CEF.)
on peripheral blood and crevicular neutrophil MPO
activity in one healthy male subject (age 40 yrs).
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The negative value for the effect of ampicillin on blood
neutrophil MPO demonstrated an overall depression, whilst
all other values were positive, implying elevation of
activity. This was small, with the single exception of
crevicular neutrophil MPO as stimulated by cefaclor.
Comparison of the means for elevation with cefaclor for
blood and crevicular neutrophils by a paired 't' test
revealed a significant difference (p < 0.01). No other
comparisons produced significant differences.
There was a considerable variation between individuals
as to the response seen, and this is illustrated for the
total experimental data in Fig. 4.7. The results are
plotted as percentage changes in the MPO levels, taking
100% as the base line value. The MPO stimulating effect
of cefaclor can be clearly seen and for the total group
was at a maximum for the blood neutrophils at 4 hours
(subsequent effects were unknown), but for the crevicular
cells had clearly reached a peak at 3 hours.
The serum drug assays showed that ampicillin levels
reached a maximum in 1-3 hours following ingestion with
a mean of 1.5 hours, at a level of 1.45 ± sem 0.27 jig/ml.
The cefaclor levels reached a maximum in 1-2 hours, mean
1.5 hours at a level of 9.14 ± sem 1.1 )j.g/ml. Figure 4.8
shows an example of one experiment in which the peak
serum cefaclor level was followed by an increase in the
MPO activity, particularly for crevicular cells.
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TIME AFTER ADMINISTRATION OF DRUG (HR)
FIG. 4.7: Effect of ampicillin and cefaclor on
peripheral blood and crevicular neutrophil MPO
activity. The results are expressed as the percentage
variation after administration of a single, 500 mg oral
dose of drug. Vertical standard error bars are shown.








FIG. 4.8: The effect of cefaclor on peripheral blood
and crevicular neutrophil MPO activity (shown as
percentage of baseline value). The peak serum drug
level is followed by an increase in blood neutrophil
and then crevicular neutrophil MPO activity.
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DISCUSSION
The very extensive literature on all aspects of
myeloperoxidase shows the significance granted to this
enzyme. In their extensive review of neutrophil function,
the largest ever published, Klebanoff and Clark (1978)
devoted 60 pages to MPO. Recent studies have suggested
that the functions of MPO extend far beyond the classical
oxygen-dependent microbicidal activity, and that it is an
important regulator of surface receptor activity
(Hakansson and Venge, 1983) and the respiratory burst
(Segal et al. , 1980). The microbicidal efficiency of
MPO-mediated oxidations by hydrogen peroxide is also
equally effective extracellularly, at least against
E. coli (Sips and Hamers, 1981). As if to support these
impressive requirements, human neutrophils are heavily
endowed with the enzyme (Evans and Rechcigl, 1967; Venge
et al., 1978), and yet surprisingly even total deficiency
does not appear to lead, in most cases, to increased
susceptibility to infection. Indeed, chickens seem to
survive well despite being totally MPO deficient (Rausch
and Moore, 1975). In man and other species there must
be overlapping and compensatory bactericidal systems.
Lehrer and Cline (1969) showed that individuals with only
20-30% of the normal MPO complement were healthy, and
later showed that neutrophils possessed equally powerful
fungicidal cationic proteins (Lehrer et al.. , 1975) . Thus,
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deficiency may have to be severe before becoming
"potentially" clinically significant (Klebanoff and
Clark, 1978: 466-467; Harkness, 1981). The total
absence of any granule proteins did not prevent the
killing of Staph, aureus in an in vitro system (Roos,
Voetman et al. , 1983), but in vivo, physical and chemical
circumstances differ, and may make more demands on the
host.
Myeloperoxidase in Gingival Crevicular Neutrophils
The initial experiments with the cytochemical
assay showed that gingival crevicular neutrophils
contained large quantities of the enzyme, with a minority
of cells giving a negative stain. Although the Kaplow
(1965) method of staining is simple to perform, there may
have been underscoring, particularly with weak reactions.
Harkness (1981) has also pointed out that in some
instances MPO activity is detectable spectrophotometrically,
even when apparently absent by cytochemical estimation.
In the later part of this study, the crevicular neutrophil
preparations demonstrated in excess of 80% positive cells
for every subject. The small group on whom the
cytochemical method was initially tested were not however
as homogeneous or constant (one subject) as those of
Bendix-Hansen and Kaspersen Nielsen (1983a). The MPO
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scores were in the same order of magnitude, but showed
more interpersonal variation. As with these authors,
staining with the 3-amino-9-ethylcarbazole reagent was
quite satisfactory, but required more time and gave
preparations on which it was more difficult to distinguish
between the less intense degrees of staining.
Since the objective was simply to adopt a technique
that might be ultimately applicable to a variety of
clinical situations, the benzidine reagent was preferred.
From the distribution of scores calculated for one subject
(Fig. 4.2), it appeared that in the systemically healthy
state there were slightly fewer strongly MPO positive
cells in the gingival crevice, although the proportion of
positive cells was slightly higher than in blood. With
the onset of infection, the blood neutrophil picture
altered dramatically, so that 81% of the cells were
ascribed a score of 4. By marked contrast, only 2% of
the crevicular cells stained so intensely. Since 88% of
the latter cells were positive, the most likely explanation
is that the majority of cells had partly degranulated in
the bacteria-containing inflammatory exudate. An
alternative explanation is that by some selective mechanism
almost none of the score 4 cells from the blood gained
access to the gingival crevice.
While the quantity of an enzyme may be important,
especially when below a critical threshold level, the
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activity of that enzyme is probably biologically and
perhaps clinically, more important. A spectrophotometric
assay was employed to measure MPO activity and this
method had been well established. The final measurement
depends on overall activity; that is, 20% or less of the
cells could be very active or 95% weakly active to produce
the same result. Nevertheless, this type of biochemical
investigation has been widely used, and was employed to
study the MPO activity in PVB and gingival crevicular
neutrophils from 30 healthy adults. The first
encouraging observation was that the blood MPO values
were similar to the established mean figures for the
laboratory, including the levels for female subjects
being higher than those for males. In general, blood
values were higher than those for crevicular cells. Two
interesting features emerged. The crevicular MPO values
for male and female subjects were virtually identical, and
six of the samples had no measurable activity. Moreover,
no correlation was found for MPO activity between blood
and crevice, implying that they are under the influence
of independent factors. In the crevice, local factors
may influence the enzyme or the gingival cells may belong
to a population of neutrophils unrepresentative of those
circulating in peripheral blood.
The expanded study gave a clear grouping of crevicular
neutrophil results into three categories. The MPO values
for all subjects with gingivitis were similar to the normal
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range for blood. The values for 14/30 subjects without
gingivitis also fell within this normal range. In the
third group, comprising 16/30 subjects with no gingivitis,
no enzyme activity was detected. This group included
those with no activity from the first experiment. Ten
out of 15 female and six out of 15 male subjects had no
activity. For the inflamed group, the mean activity
for the female subjects was 4.17 units and for the males
5.6 3 units/)j.g protein. The non-parametric statistical
test, the Mann Whitney U test, indicated that the values
for the inflamed and non-inflamed groups were quite
independent (p < 0.0003). This may be explained by some
component of the exudate, in the presence of overt
inflammation, increasing MPO activity. The lack of
correlation between the crevice and blood values seen
previously would support that conclusion, as would the
subsequent correlation shown between the Gingival Index
and MPO activity (r = 0.48, p < 0.01). It is not
possible to deduce from this data whether the MPO activity
by enhanced catalysis of oxidation processes might
contribute to the inflammatory response or whether the MPO
was being influenced by the inflammatory response.
Klinkhamer and Mitchell (1979), in the only other
experiment of this type, demonstrated a positive correla¬
tion (r = 0.876, n = 77) between salivary leucocyte
peroxidase and the rate of cell migration. Cell
migration, however, is too variable as a correlate of
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clinical inflammation (Hase and Reade, 1979) . Several
possible explanations exist for finding such a large
proportion of negative results in the group with no
gingivitis.
1) The Gingival Index is insufficiently sensitive to
distinguish two groups of apparently inflamed gingivae.
That is, the lack of enzyme activity in one group is a
true reflection of non-inflamed tissue, but in the other,
activity which is similar to that for the "obviously
inflamed" group, indicates subclinical inflammation.
2) The lack of enzyme activity was caused by one or
more technical factors. For example, the method was too
insensitive, or some natural inhibitor of the enzyme may
have been present, although this has not been previously
reported. Neither does this explain why the other 14
cases did not behave similarly. Another possibility is
that the enzyme from cells in inflamed tissue may be
more easily extracted. This seems quite possible since
degranulation would be occurring anyway, but does not
account for the distinction between the two "healthy"
groups, unless a factor as in point 1 is operating.
3) There was no enzyme in the inactive group, perhaps
due to total degranulation and extracellular discharge.
This is unlikely in very healthy tissues with limited
bacterial challenge. In addition, all cytochemical tests
were positive, indicating the presence of enzyme at the
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stage of cell collection. The cells were not undergoing
gross degeneration but the majority were morphologically
intact.
4) It is possible that these differences reflect the
migration of distinct subsets of neutrophils. Recently
it has been demonstrated that neutrophil groups (murine)
with different density characteristics contained MPO with
differing activity, sensitivity to stimulation and
quantity (Pember and Kinkade, 1983). Distinct forms of
human MPO may be contained within distinct granule
populations in a single cell (Kinkade et al., 1983).
The concept of neutrophil subsets or subpopulations has
been receiving close scrutiny in recent years, and these
have been proposed from several types of investigation.
Klempner and Gallin (1978b) and Silvani et al. (1983)
identified human neutrophil subsets on the basis of cell
surface markers. Two groups of workers have separated
cells immunologically on the basis of surface antigen
differences with monoclonal antibodies (Ball et al., 1982;
Clement et al., 1983). Membrane potential differences
(Seligmann et al., 1981) and surface charge density
(Brown, 1983) have revealed two sets of human cells
(proportionally 83% and 17% in the latter study), and on
the basis of chemotactic activity, human neutrophils have
also been categorised into two groups (Harvath and Leonard,
19 82) . Murine peritoneal exudate neutrophils" and human
blood neutrophils were separated by density gradient
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fractionation (Pember, Barnes et al., 1983) . Two
recent papers are of particular relevance to studies on
gingival crevicular cells. On the basis of membrane
properties and esterase staining, Edwards et al.. (19 82)
suggested that synovial cells represent a subpopulation
of monocytes, and a population of human blood monocytes
has been separated on the basis of unusually low
peroxidase activity (Akiyama et al., 1983). By electron
microscopic examination, the low activity cells were
found to contain less enzyme.
The principle of phagocytic cell subsets seems viable
and could be applied to the results of this study. Three
groups of neutrophil migration patterns, involving two
sets of neutrophils, may be hypothesised. In the first
group, in non-inflamed tissue, one set of peroxidase-
inactive neutrophils is marginating to phagocytose but
not kill bacteria or kill by other mechanisms. The
second group involves migration of peroxidase-active
cells into non-inflamed or subclinically inflamed tissue,
and the third includes the same peroxidase-active cells,
now migrating into clinically inflamed gingivae.
Following analysis of the results, it was possible
to re-check the PVB neutrophil MPO activity in 11 of the
16 subjects who had no activity in the crevicular cells,
and all were normal. If MPO deficiency is now considered
the most common disorder of neutrophils (Parry et al., 1981),
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it would still require the screening of approximately
2,000 people based on published figures (Parry et al.,
1981; Cramer et al., 1982) to reveal a true case of MPO
deficiency. It is therefore unlikely that one out of
the 50 healthy adults studied would have proved to be
MPO deficient. These results are subject to several
explanations and raise some questions, some of which are
open to further investigation.
Effect of Antibiotics on Myeloperoxidase
Just as adverse effects of antibiotics may not be
readily distinguishable clinically from the infection
itself, so beneficial effects in the normal host may be
disguised. The drug's effect on the host is likely to
be transient, although any lasting influence particularly
adverse is likely to be attributed to the wrong choice of
antibiotic in relation to the infecting organism (Raeburn,
1982). It may be that an adverse or beneficial
manipulation of defence mechanisms could be relevant to
the patient with an evident or subclinically compromised
immune response. Thus, if for genetic or other reasons,
a defence component is operating at a "borderline"
efficiency following infection with a particular organism,
treatment with a potentially immuno-modulating drug may
push the defences into compromised inefficiency or
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conversely into enhanced efficiency.
Ampicillin has been shown to depress human blood
neutrophil killing (Raeburn et al. , 1976), and MPO
activity in vitro (Harkness and Grant, 1977) and in vivo
(Grant et al., 1983). In the latter study the effect
was associated with reduced phagocytosis, although once
internalised the bacteria were killed normally.
Staphylococcus aureus was the test organism and it may be
that MPO is necessary for killing this bacterium (Roos,
Voetman et al., 1983). That is, killing may have been
significantly impaired for an organism requiring MPO-
mediated oxidations.
Enhanced MPO function has been shown in neonates
treated with clotrimazole for oral candidiasis at
concentrations of the drug not considered fungicidal in
vitro (Renz et al., 1974) . Recently, several parameters
of neutrophil function (chemotaxis, migration, NET
reduction and microbial killing) were improved in vitro
by an experimental cephalosporin (Ohnishi et al., 1983).
The results of this study reflected those above
relating to ampicillin effects on blood neutrophil MPO in
that the overall effect was depression. For the
crevicular cells, the ampicillin effect was variable but
overall there was elevation of MPO activity. By contrast,
the data from the cefaclor studies were more convincing,
and showed an elevation of MPO, both in blood and crevice,
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being particularly marked for the crevicular cells. The
changes were greater than any normal fluctuation as
demonstrated in Fig. 4.5. Several points should be
noted. Although the drug dose was identical for each
antibiotic, it was evident that the peak serum levels
varied, being considerably higher for cefaclor than
ampicillin. The reason is unclear but the most likely
explanation is a difference in absorption. This is one
problem of in vivo experimentation, even though it is more
relevant to clinical therapeutics. The kinetics of drug
effect were observable and are exemplified in Fig. 4.8. A
sequential latency between the peak serum drug level,
blood neutrophil MPO response and crevicular neutrophil
MPO response was seen. A further aspect of this pattern
was seen in the early stages following drug administration
with cefaclor. As shown in Fig. 4.7 the blood neutrophil
MPO activity produced a small peak, followed by a small
depression at half an hour. For the crevicular cells,
this occurred at one hour. In both cell groups a marked
increase was seen and the true maximum may not have been
reached at 4 hours for blood, as shown. Quite clearly
the crevicular enzyme activity reached the maximum at 3
hours, proportionally greatly in excess of that for blood.
This may be supportive evidence for the hypothesis of
selective cellular migration as discussed previously. At
the least, antibiotic manipulation of cellular components
in this manner may provide a useful tool for studying
neutrophil migration and function.
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The mechanism by which the MPO activity was altered
is unknown and may have been direct or indirect.
Ampicillin, as other antibiotics, may affect haem enzymes
(Harkness et al. , 1979). Cefaclor is a chlorinated
cephalosporin so that part of the effect may be due to a
direct interaction with the MPO-hydrogen peroxide-halide
system. The ability of cefaclor to penetrate neutrophils
is unknown but in vivo such an interaction could operate
powerfully in the extracellular environment.
During infection, neutrophils migrate to the areas
of bacterial challenge. If tissue penetration of the
antibiotic is satisfactory, then the cells will be
exposed to the drug for a protracted period. This in
itself could further influence the interaction between
host and parasite. Many methods have been employed to
study tissue penetration of antibiotics (reviewed by
Raeburn, 1978) and several antibiotics including
ampicillin (Simon et al., 1978) and cephalexin (Raeburn,
1976) have been shown to enter artificially induced
exudates. Moreover, both ampicillin and cephalexin enter
gingival crevicular fluid (but not saliva) at concentrations
approaching those in serum (Stephen et al., 1980). It is
therefore possible that in vivo crevicular neutrophils
are exposed to antibiotic effects for longer than the cells
sampled from peripheral blood. This could, of course,
prove most beneficial in the treatment of oral infections,
if the activity of host defence cells can be boosted.
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Summary
Gingival crevicular neutrophils have been shown
to contain MPO and this is variably active. Several
reasons for the inactivity of the enzyme in a proportion
of subjects studied who had no clinical evidence of
gingivitis have been proposed. Further work is needed
to exclude the possibility that this was a technical
artefact, but this is unlikely. It is possible that
the findings support the hypothesis of selective neutrophil
migration, and therefore the published evidence for
subpopulations of neutrophils has been reviewed. A positive
correlation was shown between the degree of clinically
measurable inflammation and MPO activity. Which parameter
was the primary influence is open to conjecture.
In view of the widespread use of antimicrobial drugs
and the possible effects these may have on host defence
mechanisms, two such drugs were studied. Ampicillin
increased MPO activity in gingival neutrophils, but
depressed activity in blood neutrophils. Such studies
may have relevance to clinical therapeutics and to the
further understanding of cellular defence mechanisms.
Having determined the functional integrity of
gingival crevicular neutrophils in several respects, it
was now possible to apply these tests to cells from
patients with specific neutrophil abnormalities.
CHAPTER 5
GINGIVAL CREVICULAR NEUTROPHILS IN PATIENTS WITH
NEUTROPENIA, LEUKAEMIA AND CHRONIC
GRANULOMATOUS DISEASE
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THE RELEVANCE OF STUDIES ON NEUTROPHIL DISORDERS
The studies so far have demonstrated a degree of
functional integrity in gingival neutrophils which, in
combination with evidence of their phagocytic ability
(Wilton et ad., 1977a; Murray and Patters, 1980; Scully,
1982), must be regarded as valuable constituents of host
defence at the mucosal surface. It should be possible to
test such a hypothesis by considering the gingival changes
in patients who have primary neutrophil disorders or
dysfunction secondary to another related disease.
Moreover, if neutrophils are important or even critical in
the maintenance of health, then measurements of their
function either systemically or locally should be relevant
for monitoring disease processes.
Many disorders of neutrophils have been identified
and described, some in great detail. Congenital
neutropenias predispose to chronic and recurrent
debilitating infection, while some leukaemic states and
their treatment produce life-threatening neutropenia.
Neutropenias represent a quantitative host defence defect,
but highly specific functional abnormalities have also
been reported. MPO deficiency has already been described:
a condition until recently thought to be rare, but now
considered possibly the commonest disorder of neutrophils
(Parry et al., 1981). Nevertheless, MPO deficiency may
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go unnoticed clinically. A rare, highly investigated
disorder which causes significant clinical infection is
chronic granulomatous disease (CGD). Such conditions
provide models for the scientific study of normal
neutrophil function. With increasing experience and
technological sophistication, many other phagocytic cell
disorders and variants will be described.
Because these conditions are rare, it was not
possible to study large groups of patients. Even
leukaemia patients, both in their disease and response to
treatment, present individual problems. Rather, the
present study explores gingival crevicular cells in
neutrophil disorders and the sequential changes therein.
The possibilities of monitoring disease and treatment
were investigated.
Congenital neutropenia and leukaemias with and
without neutropenia were studied and it was also possible
to monitor gingival cell changes during granulocyte
transfusion. No patients with MPO deficiency were
available for investigation but it was possible to study





The term neutropenia defines a state of relative
neutrophil depletion in peripheral blood counts. Several
hereditary forms have been catalogued by McKusick (1983).
In classical cyclical neutropenia, a rare disease which
has been recognised clinically for many years (Leale,
1910), neutrophils are produced in, and released from the
bone marrow for approximately 21 days, followed by five
to seven days of variably depressed production and
release (Page and Good, 1957; Guerry et al. , 1973).
Neutropenias are, however, a heterogeneous group of
disorders with differences in aetiology. The cause may
be a hypoplastic lesion of the marrow, maturation arrest,
i.e. a release failure in which the marrow contains
mature cells as well as myelocytes, or loss of mature
cells (Kauder and Mauer, 1966; Dancey and Brubaker,
1982). In benign familial (or hereditary) neutropenia,
there is no periodicity in production, and patients are
often clinically healthy (Cutting and Lang, 1964).
Studies have revealed that this condition may also be
characterised by a defect in cell release from the marrow
(Shoenfeld et al., 1982). The accumulating data that
implicate mononuclear cells as prime controllers of
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granulopoeisis (discussed in chapter 1) has led to a more
detailed classification of neutropenias based on monocyte
activity and dysfunction (Chilcote et al., 1983). Other
neutropenias may be caused by the presence of anti-
neutrophil antibodies, so leading to post-maturation
destruction (Boxer and Stossel, 1974; Verheugt et al.,
1 978; van Leeuwen et al. , 1983). In cyclical
neutropenia a population of suppressor lymphocytes may be
responsible for interfering with granulopoeisis, by
inhibiting mononuclear cell production of colony
stimulating factor (Verma et ad., 1982).
The diagnosis of congenital neutropenia will only be
fully elucidated by taking a comprehensive history,
clinical examination, sequential peripheral blood
estimations, cytological studies in the family and marrow
investigations. In some cases other cellular and
humoral immune components are altered. For example,
there may be a relative or absolute lymphocytosis and
monocytosis (Cutting and Lang, 1964). The monocytosis
may be quite marked (Page and Good, 1957; Krill and
Mauer, 1966), but rarely, monocytopenia accompanies
neutropenia (Chilcote et al., 1983). It has been
proposed that monocytes may compensate in part for the
missing neutrophils (Kay et al., 1976). Other variants
include neutropenia with altered immunoglobulin and
eosinophil levels (Bjorksten and Lundmark, 1976).
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The in vitro function of neutrophils in neutropenic
states has been reported as either normal (Kay et al.,
1976) or reduced (Bjorksten and Lundmark, 1976). Other
conflicting reports have been reviewed by Klebanoff and
Clark (1978: 612). This lack of consistency indicates
the heterogeneous nature of the neutropenias and the
limited number of thorough studies that have been
conducted. In each patient there must be a threshold
level of neutropenia, possibly indefinable, which may be
affected by many factors including the nature of the
challenging organism. Quie (1976) has suggested that
the development of infection increases with the degree
of neutropenia, and that a general threshold level is a
count of 1.5 x 109 cells/L in peripheral blood.
The severity of infection in affected individuals
varies considerably (Cutting and Lang, 1964; Bjorksten
and Lundmark, 1976; Kay et. al. , 1976; Chilcote et al. ,
1983). In cyclical neutropenia, the patient classically
becomes unwell when the neutrophil count drops.
Infections may be caused by commensal organisms or
opportunists such as Staph, aureus or Pseudomonas species,
and are typically associated with mucosal surfaces and
skin. Some patients thus grow through childhood and
adolescence with intermittent hospitalisation and many
courses of antibiotics. Oral infections are very common,
and ulceration wnich in some individuals may mark the
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periods of neutropenia (Cohen and Morris, 1961; Wade
and Stafford, 1963), and in some may be the only clinical
manifestation of the disease (Baikie et al. , 1967) .
Gingivitis and periodontitis are often marked, especially
in that the deciduous as well as the permanent dentition
may be affected (Page and Good, 1957; Cohen and Morris,
1961; Wade and Stafford, 1963; Cutting and Lang, 1964;
Davies, 1980; Scully et al., 1982).
Established neutropenias were frequently fatal
before the development and widespread use of antibiotics.
Treatment is now aimed at controlling infection. It has
been suggested that, at least in some cases, the severity
and frequency of infections may decrease with age (Kauder
and Mauer, 1966). Recently some success has been
achieved in stimulating marrow release of cells with
systemic corticosteroids (Wright et al., 1978).
In summary, the clinical evidence suggests that,
where neutropenia is severe, infection will supervene.
The oral cavity is particularly susceptible, perhaps due
to the very high number of bacteria normally present.
Crevicular neutrophil function was therefore studied in
patients with diagnosed neutropenias. These will be
discussed as individual case reports.
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Case I: Hereditary Cyclical Neutropenia
The first case studied was an 8 year old boy (IS)
who had suffered from repeated infections since the age
of 8 months. Most of these had been associated with the
skin, upper respiratory tract and gums. He was first
referred for specialist advice when 3 years old, at
which time gingival inflammation and oral ulceration were
the primary clinical symptoms. A family study revealed
that his father had also been troubled with recurrent
infections, particularly oral problems, which had
necessitated the loss of all teeth by the age of 21 years.
The pedigree is shown in Fig. 5.1. By the age of 7§
years serial studies had shown that the neutropenia in
this young boy was cyclical, occurring for approximately
one week in three. His paternal grandfather had died
from carcinoma of the pancreas but otherwise the family
history was not relevant. With the clear history
obtained of his father's illness, his mother being healthy,
a diagnosis of hereditary cyclical neutropenia (autosomal
dominant) was made. A brother (GS), four years his
junior, had a history of an above-average frequency of
chest infections, and neutropenia has been provisionally
diagnosed.
Gingival crevicular and PVB neutrophil studies were
performed at the age of 8 and again at 10 years. At the
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FIG. 5.1: Pedigree of Case I, an 8 yr old boy with
hereditary cyclical neutropenia.
235
second examination studies were also performed on the
younger brother (GS), now aged 6 years, and the father
(JS) for whom blood values were obtainable.
The results of the first study on IS alone (aged 8
years) are shown in Table 5.1.
TABLE 5.1:
NEUTROPHIL DATA FOR IS, AGED 8 YEARS
Neutrophil Differential NBT Reduction NBT Reduction
No. x 109/L % % +ve Cells Stimulated
Blood 1.3* 27* 5.3 65.0
Crevice 0.0021* 59.5* 46.9
:k
Values abnormally low.
The cell counts were low in both cell groups but NBT
reduction values were normal. Slightly more extensive
data were available for the three subjects tested two
years later and these are shown in Table 5.2.
It was interesting to note at this second
examination that the gingival condition of IS was
extremely severe for a child of 10 years, in that not
only was there widespread inflammation but also evidence
of periodontitis with alveolar bone loss. By contrast,
the oral condition of GS was healthy and at this stage
the nature of his deficiency was under review, since he
consistently presented with a singular problem of an
TABLE5.2: NEUTROPHILDATAFORIS,aged10years,GS,aged6years,nJ(f ther),ag d36y ars Neutrophil No.Differential Subjectour ex109/L% * ISBlood0.923 10yrsCrevice0. 3787 GSBlood3.947 6yrsCreviceO.Oll100 ■kk JSBlood0.710
NBTMPOActivity




asthmatic type of complaint, and there was eosinophilia
in the peripheral blood. All these male members of the
family had consistently shown high levels of serum
immunoglobulin, particularly IgG.
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Case II: Cyclical Neutropenia
A young boy (DC) aged 2 years had been referred for
advice concerning repeated infections and, by the age of
3 years, had been diagnosed as having cyclical neutropenia.
In vitro tests for neutrophil function demonstrated
normal phagocytosis but bacterial killing was reduced. In
this case there was no suggestion of a genetic background,
at least of a dominant trait, both parents being healthy
and the family history negative. Between the ages of
4 and 5 years, he was clinically well, but by this time a
younger brother (GC) had been suffering from repeated
infections of the ears and gastro-intestinal tract and from
allergic phenomena since infancy. As in the previous
family, intensive investigation was difficult, but all four
members of the family were seen simultaneously on one
occasion and both blood and gingival crevicular neutrophil
studies performed. The results are shown in Table 5.3.
Apart from slightly low activity levels of blood
neutrophil MPO for DC and his father, all other parameters
measured were normal. Both parents had most of their
natural teeth with healthy soft tissues, and both boys
had extremely healthy mouths, with no gingivitis and
below average caries. In the light of the data presented
in chapter 4, and the crevicular MPO value of zero for
subject GS in the case I report, the absence of detectable
activity in the crevicular cells must be construed as




5yrsCrevice0.00833.2 GC Blood3.4 2yrs ICBlood (father) 31yrsCrevice3.0 0.0225.0 GCBlood (mother) 29yrsCrevice3.0 0.01326.8
NBT Reduction
%+veCells
NBT ReductionMPOAct vity Stimulated(units/ygprot in)
0.7 41.4 14.0 15.0 39.2 9.8 39.2
20.2 41.3 35.1 28.6
1.99 0 6.61 1.12 0.34 3.42 0.62
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being normal. Crevicular studies on the younger brother
(GC) in this family were not possible owing to a lack of
cooperation.
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Case III: Chronic Benign Neutropenia
The third patient was another boy (LO) who had
initially presented at the age of 3 years with a severe
upper respiratory tract infection which subsequently
caused recurrent problems. Haematological monitoring
showed that the absolute neutrophil count in peripheral
blood was always low, generally fluctuating between
0.2 and 0.8 x 109 neutrophils/L. No cyclical pattern
was seen but the consistent depression in neutrophils
with a corresponding increase in the percentage of
eosinophils, monocytes and particularly lymphocytes,
provided a diagnosis of chronic benign neutropenia.
Both parents were healthy. In vitro neutrophil function
tests had demonstrated normal phagocytosis with reduced
intracellular bacterial killing. Immunoglobulin
(particularly IgG) levels were normal but at the upper
limit.
Crevicular and blood neutrophil studies were first
performed when LO was 8 years old at which time he was
well. There was a moderate degree of gingivitis but
oral hygiene was poor and dental plaque levels high to
account for this. It was possible to repeat the studies




AgeNeutrophilNBTReductionReduct on (yrs)SourceNo.x109/L%+veCellsStimu ated PVB2.210.4 8 Crevice0.01637. PVB0.62* 1.016.3 Crevice0.01731.8 PVB0.78* 7.934.5 Crevice0.00841.010 * Valuesabnormallylow
InvivoMPO
DifferentialPhagocyto-A vity %sis(un t /yg
protein)
40 9836.30 6 23-1.4 9833.10* 28
1.77
lOO54
MPO% (Kaplow, 1965) 86 92 90 94
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The circulating neutrophil count was low on two
occasions, with concomitantly slightly reduced values
for MPO activity. On the third occasion, the crevicular
neutrophil count was approximately half that on the
previous two occasions, and this was unusual in that an
active gingivitis was also present. This may be a
reflection of the neutropenia. Crevicular NBT reduction
and in vivo phagocytosis were highest on this third
occasion and yet MPO activity was undetectable. Of
interest also in this respect was the normal staining of
both blood and crevicular cells for peroxidase.
Conclusions
Although the data for these three case studies are
limited, several points merit comment. For all three a
diagnosis of the neutropenic condition had been made
several years prior to the initial crevicular cell
investigations. The first of the two boys (IS) with
cyclical neutropenia had a more severe deficiency as
evidenced both by the sequential neutrophil counts since
diagnosis and the clinical history of infections.
At the first examination of this study both cell
groups were reduced in number and a low differential
count was seen for neutrophils in the gingival crevice.
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This was unprecedented and has not been seen subsequently
in this or other neutropenic patients. It is possible
that microscopic haemorrhage had permitted efflux of
cells from the gingival vessels but there was no evidence
of erythrocytes on the cytocentrifuge preparation.
Throughout all investigations in the affected
members of these three families, crevicular NBT reduction
values were normal, suggesting that whatever the cell
number the metabolic activity of the neutrophils was
intact. Except for IS on the second occasion, this also
applied to the blood neutrophils. It must be remembered
that the crevicular neutrophil counts quoted are made from
the crevicular washings, and thus do not represent the
absolute cell number in native crevicular fluid. The
dilution factor is probably of the order of 30 times
(Scully and Challacombe, 1979).
The crevicular neutrophil MPO activity values would
require further study against a background of age matched
control children to understand the relevance to clinical
monitoring and management. In the two boys in whom
there was no MPO activity, oral health was excellent, but
in the third case studied (LO), activity was absent on
two occasions, and yet plaque-induced gingivitis was
evident. Confirmation of these data is necessary, but
they do suggest some inhibition of the enzyme or low
levels "ab initio" also seen in part for the peripheral
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blood cells. From the three sets of data available for
patient LO, it can be seen that the crevicular neutrophil
NBT values were paralleled by in vivo phagocytosis
estimations. However, there is no obvious link between
these two measurements and MPO activity, which supports
the conclusions drawn from the studies described in
chapters 3 and 4.
In summary, these limited studies show that the
quantitative and functional studies of crevicular
neutrophils are applicable to patients with neutropenia.
More extensive work is required to determine if, for
example, a strong correlation exists between cell numbers
in blood and the exudate, and if differences in the





The term leukaemia denotes a neoplasia of leucocyte
precursors. The clinical sub-divisions of leukaemia are
based on the acute or chronic nature of the disease, and
whether the myeloid or lymphocytic series of cells are
primarily affected. Diagnosis according to this basic
classification determines the subsequent treatment
regime. The general features and principles of treatment
of the leukaemias will only be discussed briefly.
General Features and Treatment
1) Acute leukaemias
The patient with an acute leukaemia is usually
severely ill and symptoms will only have been present for
a short time. Malaise, anaemia, fever, bruising and
possibly bleeding are the commonest presenting features.
Most of these are the result of the bone marrow being
dominated by the leukaemic infiltrate at the expense of
the normal haemopoietic elements. Gingival bleeding
may occur and oral ulceration may be severe, particularly
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when there is neutropenia. The peripheral blood white
cell count may be normal, low or raised, but the essential
feature is the presence of immature forms of either the
myeloid or lymphocyte series, particularly blast cells.
Distinction between acute myeloid leukaemia (AML) and
acute lymphoblastic leukaemic (ALL) is made on the basis
of cellular morphology and cytochemical reactions.
According to the cell line which predominates, AML can be
further characterised as granulocytic, monocytic or
myelomonocytic. In AML mature segmented neutrophils may
be absent. Thrombocytopenia and erythrocyte deficiency
will also be revealed in the blood screen. Bone marrow
biopsy confirms the predominance of either myeloblasts or
lymphoblasts and a reduction of red cell precursors and
megakaryocytes.
Treatment is aimed at inducing a remission of the
disease by reducing the output of blast cells, thus
hopefully permitting normal stem cell proliferation.
Over several years many chemotherapeutic agents have been
tested. These include folic acid antagonists, steroids,
purine antagonists and alkylating agents which are
generally used in combination. The most successful
results have been achieved for ALL in children. Acute
myeloid leukaemia, particularly in young patients,
continues to hold a poor prognosis. Chemotherapy for
AML generally requires to be more aggressive than in ALL
so that there is an increased risk of serious haemorrhage
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and infection. The problem of infection will be
discussed subsequently.
In 1970, an interesting adjunct to chemotherapy was
introduced in a series of UK clinical trials, based on
immunisation of the patients against their leukaemic
cells with irradiated autogenous or allogeneic cells,
boosted with BCG. Regrettably, long term survival of
the patients was not increased and further trials of this
type have produced variable results (Alexander and
Powles, 1978) .
The prognosis of acute leukaemia, particularly the
myeloid type, remains poor. Apart from attempting to
induce remission, therapy aims at providing as comfortable
and as normal an existence for the patient as possible.
2) Chronic leukaemias
Unlike the acute forms of the disease, chronic
leukaemias present with milder and more protracted
symptoms such as weight loss, tiredness and excessive
sweating. As the disease progresses, often over several
years, symptoms may become more severe and, for example,
chronic myeloid leukaemia (CML) often terminates in an
acute phase. Oral symptoms and signs are not usual in
the chronic leukaemias. The disease usually presents in
patients aged 40 to 60 years, with chronic lymphocytic
leukaemia (CLL) being more common than CML.
249
The peripheral blood picture also differs markedly
from that in the acute disease, with the predominant cell
being the mature lymphocyte or segmented neutrophil.
Immature stages are seen, but are in a minority. Most
striking is the highly elevated leucocyte count which
frequently exceeds 100 x 109 cells/L and splenomegaly
is thus very common. A classical cytochemical feature
of CML is a low neutrophil alkaline phosphatase score.
Bone marrow biopsy reveals a large number of myelocytes
(CML) or lymphocytes (CLL), but as in the acute
leukaemias, anaemia and thrombocytopenia may be produced
by a diminution in the proportion of erythrocyte and
platelet-forming components. A classical feature of
the vast majority of patients with CML is the loss of a
segment of chromosome 22, the so-called Philadelphia
chromosome. This segment may be translocated to
chromosome 9.
The lifestyle of patients with chronic leukaemia may
be virtually normal for long periods. The alkylating
agent chlorambucil and/or steroids can be used to treat
CLL but, in the absence of symptoms, no treatment may be
required for long periods of time. Chemotherapeutic
reduction of the leucocyte count in CML allows for
recovery of the platelets and haemoglobin concentration,
and the alkylating drug, busulphan, has been employed for
many years with considerable success. Once the cell
count in peripheral blood is within normal limits,
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carefully administered intermittent doses can maintain
the condition. Because treatment may be continued for
several years, side effects of busulphan, for example,
may be seen. Many physical and psychological
disturbances have been documented but a form of pulmonary
fibrosis develops in a small proportion of patients,
which may become extremely disabling, much more so than
the disease itself. Ultimately, CML may undergo acute
transformation or there may be a sudden "blast" crisis.
Death is usually from internal haemorrhage, rupture of a
splenic infarct or infection.
Infection in Acute Leukaemia and Granulocyte Transfusions
With progressive development of techniques for the
efficient collection and replacement of blood components,
the problems of haemorrhage in the patient with acute
leukaemia can be largely prevented and treated with
transfusions of whole blood, packed red cells or
platelets. Infection has therefore replaced haemorrhage
as the major cause of death (Levine et al. , 1972; Chang
et al. , 1976). The frequency of infections is
proportional to the degree of granulocytopenia (Bodey et
al. , 1966), which is either a result of the overwhelming
leukaemic infiltration of bone marrow or the subsequent
cytotoxic chemotherapy. Infections are often caused by
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endogenous organisms, or by colonisation with Gram
negative species such as Pseudomonas aeruginosa or
Klebsiella pneumoniae. It is ironical that many of the
infections acquired are from contamination by hospital
staff, food or equipment (Pizzo, 1983). Non absorbable
antimicrobial drugs, laminar flow environments and
encouraging "colonisation resistance" by the normal
aerobic flora (Young, 1983) have all been used.
Unfortunately the antibiotic regimes so widely used may
further increase the patient's susceptibility to hospital-
acquired pathogenic organisms (Klastersky, 1983; Young,
1983). The combination of trimethoprim and
sulfamethoxazole has been used successfully to treat Gram
negative bacillary infection (Riben et al., 1983).
Approximately 30% of neutropenic patients receiving
empirical antibiotic therapy will not respond (Klastersky,
1983) and this underlines the principle that these drugs
only function predictably well when the host defences are
intact (Glynn, 1983).
In an attempt to supplement the host's defences and
provide additional, healthy phagocytic assistance, the
other development in recent years has been that of
granulocyte transfusion. To achieve successful control
of infection, it is necessary to transfuse at least 1 x
1010 granulocytes, and since difficulties were initially
encountered in collecting sufficient cells,-the best
donors were patients with chronic myeloid leukaemia (Bodey
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et a_l. , 1 966; Lister and Yankee, 1978). Subsequently,
several methods were developed for the collection of
concentrated cells from healthy donors so that relatives
of the patient who were HLA compatible might be called
upon (reviewed by Lister and Yankee, 1978). Cell
collection is not without risk to the donor who must be
given anticoagulants, and possibly also corticosteroids
(to mobilise as many neutrophils from the bone marrow as
possible). Granulocyte transfusion has been partially
successful, more so when the neutropenia is severe and
the transfusions given in multiple units (Lister and
Yankee, 1978).
In a critical review of granulocyte transfusion
therapy, Strauss (1978) expressed strong reservations as
to its indiscriminate use, on economic as well as clinical
grounds. He stressed the paucity of well conducted and
controlled studies to date, emphasising that the ultimate
success of treatment is bone marrow recovery, which was
little influenced by the transfusion of phagocytes.
Subsequently other trials were conducted, including one
by Strauss' group which concluded from a study of 102
patients, in whom half were transfused prophylactically
during chemotherapy, that the risks of transfusion
outweighed any benefits gained (Strauss et al., 1981).
This conclusion was endorsed by Young (1982) who cited
tne increasing evidence for cytomegalovirus infections in
transfused patients, at least in the United States, and
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suggested that the single indication for granulocyte
transfusion in acute leukaemia should be as a treatment
for infection, once antimicrobial drugs had proved
unsuccessful. McCullough (1983) outlined a regime of
treatment, including broad spectrum antibiotic
administration, intensive hygiene and rigorous
identification of the infecting agent, transfusing
granulocytes only as a last resort.
It is naturally a prerequisite of granulocyte
transfusion that the cells collected are functional, and
several studies have produced conflicting results. The
general conclusion has been that either continuous or
discontinuous flow centrifugation and filtration
leukapheresis provide functional cells, with the latter
method being slightly superior, and this has been verified
by a recent British study (Martin et al., 1983).
Finally, two recent editorial reviews from either
side of the Atlantic Ocean have reiterated the
regrettable conclusion that granulocyte transfusion, with
or without antibiotic therapy, has not been shown to
significantly prolong life in patients with acute
leukaemia, surely the ultimate goal (Klastersky, 1983;
Young, 1983).
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Neutrophil Function in Leukaemia
Neutrophil production will be affected either
directly or indirectly by the leukaemic state, and
function may also be altered by any one of four influences.
Already discussed in chapter 4 is the possible influence
of the antimicrobial drugs administered. This may well
be particularly relevant in acute leukaemia, since the
patient is essentially immunocompromised. In this
susceptible state, infecting micro-organisms may interfere
with host defence mechanisms (O'Grady and Smith, 1981;
Mims, 1982). Of obvious relevance is the disease process
itself as well as the cytotoxic chemotherapy which will
almost certainly affect neutrophil function adversely.
Klebanoff and Clark (1978: 601-609) have reviewed in
detail the literature on neutrophil function in
leukaemia, citing many conflicting and concurring reports.
They concluded that clinical infection problems are
undoubtedly related to quantitative neutrophil deficiency,
but that it is not so easy to generalise when discussing
the functional problems, since methods, diagnosis,
treatment and stage of the disease all vary, and have not
been standardised in the published reports. The
relatively inefficient phagocytosis by immature myeloid
cells as compared to segmented neutrophils would seem to
be an obvious factor predisposing to infection. Metabolic
responses are more variable. Neutrophil NBT reduction is
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impaired in CML (Whittaker et al., 1974; Pinkerton and
Robinson, 1976) , AML (Wantzin and Wantzin, 1975) and ALL
(Humbert et al., 1976) . Patients with AML may have
normal, reduced or elevated quantities of MPO (Odeberg
et al. , 1975; 1 976). The deficiency of this enzyme in
leukaemia has been specifically reviewed by Klebanoff
and Clark (1978: 727-728). In the study of Hayhoe et
al. (1964), 10% of patients with AML were MPO deficient,
while the proportion was over 40% in a subsequent report
by Catovsky et al. (1972). In the latter study the
proportion of negative neutrophils in each affected
patient was 8 - 70%. Other more recent studies have
provided similar conclusions (Cech et al., 1982;
Bendix-Hansen and Kaspersen-Nielsen, 1983a). By contrast,
in one recently reported case study, AML occurred in a
neutrophil population which had highly elevated peroxidase
activity (Patterson et al., 1982) .
Recent reviews have concluded that most of the
anti-cancer agents impair phagocytosis (Mandell, 1982;
Pruzanski et al., 1983). For example, reduced
granulocyte chemiluminescence, following antimitotic
chemotherapy, is thought to indicate drug-induced
impairment of microbicidal pathways (Matamoros et al.,
1983). In contrast, however, was the finding in the
study of Whittaker et al. (1974) that busulphan treatment
of CML invariably restored NBT reduction values to normal.
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The difficulty in comparing studies has been mentioned,
and the altered function seen in vitro may be caused by
one or more of the factors operating. Ultimately this
is important in two key areas. One is the obvious and
critical predisposition to infection, so that
increasingly it is becoming possible to carefully balance
the types and doses of anti-cancer drugs in relation to
disease and influence on host defences. The other is
the possible usefulness of monitoring host defence
function as a prognostic guide to the leukaemia, as
treatment progresses.
Crevicular neutrophil investigations and peripheral
blood counts were performed in five patients with
diagnosed leukaemia using the techniques previously
described.
Case I: Chronic Myeloid Leukaemia
A 57 year old married woman (MRy) attended her
general medical practitioner complaining of tiredness,
shivering and aching limbs. A routine blood screen
revealed an abnormally raised total white blood cell
(WBC) count and she was referred for a haematological
opinion. On presentation, the WBC count was 187 x 109/L,
comprising 46% neutrophils, 2% lymphocytes, 2%
eosinophils, 7% basophils, 29% myelocytes, 8%
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promyelocytes and 6% blast forms. The neutrophil
alkaline phosphatase (NAP) score was 30 (low and high
controls 65 and 154 respectively). A diagnosis of CML
was made. Treatment was instigated with allopurinol,
busulphan and 6-thioguanine, with the result that within
seven weeks, the peripheral blood picture was near
normal: WBC 4.8 x 10 /L, comprising 59% neutrophils,
28% lymphocytes, 2% eosinophils, 1% basophils and 10%
myelocytes. The NAP score was 80 (control 48).
The situation was static for two months, when
carcinoma of a breast was diagnosed, and surgical
treatment was undertaken. The patient became
septicaemic in the post-operative phase but this was
controlled by antibiotic therapy. Control of the CML
was difficult at this time and thereafter 5-8% blast
cells were seen in the peripheral blood, despite the
chemotherapy maintaining the total WBC and neutrophil
counts within normal limits. Mrs Ry died following
extensive intracranial bleeding approximately nine months
after diagnosis.
Gingival crevicular neutrophil studies were
performed sporadically on this patient, the first being
an NBT test (result = 38.8% positive cells) performed at
the time that the peripheral blood count was initially
restored to normal. The gingival tissues were
consistently mildly inflamed, and crevicular cells were
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readily collected. Crevicular neutrophil MPO activity
was assayed on eight occasions and the results are
presented graphically in Fig. 5.2. No investigations
were possible during the period of surgical care but
after this the MPO activity was within normal limits on
three occasions. No crevicular assays were performed
in the weeks prior to death. At the first examination
after Mrs Ry returned to the haematology clinic from the
surgical ward, the crevicular neutrophil count was
39,200/ml, cytochemical MPO (Kaplow, 1965) demonstrated
82.1% positive cells, with an MPO activity of 3.1 units/
p.g protein, i.e. totally normal values.
Clearly, however, there was a problem of incomplete
sampling and thus data collection.
Case II: Chronic Myeloid Leukaemia
The second patient (DN) was a 53 year old married
man who complained of weight loss and limb pains. The
presenting blood picture revealed a leucocyte count of
97.9 x 109/L, i.e. approximately half that of the first
patient, and apart from 64% of the cells being segmented
neutrophils, the remaining cells were all immature forms.
Again, NAP was low and cytology of a bone marrow biopsy
showed that 100% of the dividing cells were positive for
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FIG. 5.2: Peripheral venous blood neutrophil count ( )
and crevicular neutrophil MPO activity ( ) in a patient
with CML (Case I). Ca Op refers to the period during
which the patient was undergoing treatment for carcinoma
of the breast. Normal values are represented by the
vertical bars.
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the Philadelphia chromosome. Thus, a positive diagnosis
of CML was made. The commencement of treatment with
busulphan and 6-thioguanine was delayed pending a report
by a respiratory physician, since the patient had a
history of chronic obstructive airways disease, and as
mentioned previously, busulphan is known to induce
serious pulmonary fibrosis in some patients. However,
complete drug therapy was started 24 days after diagnosis
and the effect on maintaining the PVB neutrophil count
over four years until his death is shown in Fig. 5.3.
The history throughout was complex but several points
should be noted.
In addition to the antimitotic chemotherapy, DN was
taking ampicillin or other broad spectrum antibiotics
virtually continuously, due to the presence of chronic
respiratory infections. These became progressively
debilitating but he continued to smoke. Approximately
two years after diagnosis, the PVB platelet count
started to rise dramatically and control was attempted,
unfortunately with little success, by steroid drugs and
plateletpheresis. The serum alkaline phosphatase rose
steadily and reached 3,210 units/L on the day of his
death (normal level 30-140 units/L). The CML thus
terminated in acute blast crisis. Post mortem in
addition revealed a perforated duodenal ulcer and
peritonitis. Splenomegaly and right ventricular
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FIG. 5.3: Circulating neutrophil count and MPO activity
in peripheral blood and crevicular neutrophils in a
patient with CML (Case II), over 4 years. Vertical
bars represent normal values.
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hypertrophy (associated with the respiratory disorder)
were marked.
It was possible to monitor the crevicular cells
throughout the course of this patient's disease, from
two weeks before treatment commenced until several weeks
before his death. The results of 36 crevicular
neutrophil MPO activity measurements are shown with the
PVB neutrophil counts in Fig. 5.3. While enzyme
activity was detectable for most of the four year period,
the values were generally below the normal range for
blood neutrophils. There were three occasions on which
the values were high. The first increase was associated
with a reduction of PVB cell counts to normal by
treatment. The second peak did not coincide with other
obvious changes. The third coincided with the beginning
of erratic marrow production of neutrophils, and
thrombocytosis. During 19 months, 13 measurements of
PVB neutrophil MPO activity were made. These are also
depicted in Fig. 5.3 and show an extremely variable
pattern.
A number of other crevicular neutrophil functions
were measured. The NBT reduction value after the
commencement of treatment was 42.7% positive cells. The
differential cell count performed on three occasions was
also normal, with 98%, 96% and 99% neutrophils. The
total neutrophil counts varied between 8,330 and 25,100
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cells/ml of washings but were not made prior to treatment
or in the terminal stages when the peripheral blood
values were so high. At the time of starting
treatment, the crevicular NAP was determined and the
results for the percentage positive cells and distribution
of scores are shown in Fig. 5.4. The values for a
healthy male subject measured on the same day are shown
adjacent to those for DN. The peripheral blood NAP
score of the patient was 22 (controls 100 and 140) as
determined by the routine haematological screen. Thus,
the crevicular neutrophils demonstrated a marked reduction
in NAP, which is in accordance with the typical findings
in CML. The results of cytochemical determinations of
crevicular MPO on three occasions are shown in Table 5.5.
Before treatment started (day 10), the value was low and
then increased to normal as the peripheral blood picture
improved.
TABLE 5.5:
CYTOCHEMICAL (QUALITATIVE) MYELOPEROXIDASE IN GINGIVAL
CREVICULAR NEUTROPHILS FROM A PATIENT WITH CHRONIC
MYELOID LEUKAEMIA (Case II)


































FIG. 5.4: Distribution of crevicular NAP scores in
a patient with CML (Case II) and a healthy adult
control subject.
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Case III: Acute Myeloid Leukaemia
A 25 year old married woman (FO) was referred with
symptoms of weight loss, appetite loss, tiredness and a
diagnosis of anaemia which had not responded to treatment.
The presenting blood picture showed a total WBC count of
16.8 x 109/L, with a differential count of 10% neutrophils,
14% lymphocytes, 6% monocytes, 9% metamyelocytes, 16%
myelocytes, 21% promyelocytes and 24% blast cells. The
serum lysozyme level was also high. Following cranio¬
spinal irradiation, courses of chemotherapy were used to
control marrow activity. In fact, within two months the
blood picture was essentially normal, with a total WBC
count of approximately 3 x 109/L and no blast cells
present. The treatment used was the so-called TRAMPCOL
regime consisting of thioguanine, daunorubicin, cytosine
arabinoside, methotrexate, prednisolone, cyclophosphamide,
vincristine and L-asparaginase. Unfortunately she
suffered an acute phase relapse one year after diagnosis,
and died several weeks later after a massive intra¬
abdominal haemorrhage.
It was during this latter phase, while undergoing a
course of chemotherapy, that she was first seen for
crevicular neutrophil studies. At that time, the
gingival tissues were cyanotic but otherwise little
inflamed. The crevicular MPO activity was determined
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FIG. 5.5: Peripheral venous blood neutrophil count and
crevicular neutrophil MPO activity in a 26 year old
female patient with AML (Case III). The bars marked
T represent periods of chemotherapy.
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against the PVB absolute neutrophil count. Two points
are clear from these limited data. Firstly, Mrs 0
was neutropenic throughout the observation period but
neutrophils were present in the gingival crevice.
Secondly, there was an indication that the chemotherapy
(marked with bars on the graph as T) was influencing
the crevicular MPO activity. On three occasions MPO
was assessed cytochemically, and the results are shown
together with the appropriate MPO activity in Table 5.6.
TABLE 5.6:
CREVICULAR NEUTROPHIL MYELOPEROXIDASE IN ACUTE MYELOID
LEUKAEMIA (Case III)
Cytochemical Activity
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Crevicular neutrophil NBT test - 7.5% positive cells.
Despite low activity level on one occasion and no
activity previously, the neutrophils stained very
strongly for the enzyme indicating that neither the
disease nor the chemotherapy were preventing its synthesis.
At the time of the last assay the crevicular neutrophils
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demonstrated diminished NBT reduction.
At no time were blast cells seen in the crevicular
washings, although present in peripheral blood (for
example, 38% leucocytes were blasts when the crevicular
neutrophil MPO activity was 6.55 units/jag protein).
This crevicular cell observation was confirmed by a
haematologist.
Case IV: Acute Monocytic Leukaemia
(monitoring Granulocyte Transfusion)
Acute monocytic leukaemia (AM0L) was diagnosed in a
15 year old girl (MR) who had been complaining of a sore
throat and rash, with fever. There was generalised
lymphadenopathy, and her blood screen showed severely
reduced haemoglobin with neutropenia. A course of
radiotherapy was followed by cytotoxic chemotherapy in a
similar manner to the previous patient, with intermittent
combined antimicrobial therapy as necessary. For three
months she was able to live at home for most of the time,
but then suffered a relapse and was admitted to hospital
with a WBC count of 12.9 x 109/L, comprising a differential
of 41% lymphocytes and 56% blast cells. No segmented
neutrophils were seen. The day of admission was taken
as time 0 for the purpose of monitoring subsequent
progress. Five days of chemotherapy (in a laminar flow
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unit) produced a WBC count of 0.8 x 109/L mostly
lymphocytes with 2% neutrophils and no blast cells.
After ten days, during which no neutrophils appeared in
the circulation, a further course of chemotherapy was
given. One week later the WBC count was 0.3 x 109/L
and consisted entirely of lymphocytes. She became
febrile and extremely ill. Two days of aggressive
combined antimicrobial therapy did not reduce the fever
(T = 39.8°C) and a viridans streptococcus was cultured
from the blood. Two successive granulocyte transfusions,
using the most suitable HLA matched donor, her 17 year
old brother, were then given. Granulocytes were
collected using a continuous flow cell separator, 2 units
of cells (1.9 x 1010 cells/unit)being transfused with a
17 hour interval between. This treatment successfully
overcame the infection and the patient's own marrow
subsequently showed signs of recovery (see Fig. 5.6).
Between days 45 and 60, however, the neutrophil count
started to fall and the reappearance of blast cells was
confirmed. A "maintenance" regime of chemotherapy was
introduced, but the patient became acutely ill and,
despite the reintroduction of more aggressive therapy,
died from an intracranial haemorrhage. At this time the
serum lysozyme level was 280 ji.g/ml (normal range 3-12 \ig/
ml), so indicating a massive breakdown of cells.
The principal investigations of '.crevicular neutrophils
in this young girl were quantitative. The cell count was
270
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FIG. 5.6: Absolute PVB neutrophil count in a 15 year
old female patient with AM0L. Bars marked T indicate
periods of chemotherapy. G.T. = transfusion of two
units of granulocytes. M.C. = period of 'low dosage'
chemotherapy. The vertical bar indicates the normal
circulating neutrophil count.
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monitored just before, during and after the granulocyte
transfusions, and the results are shown in Fig. 5.7.
The time scale has been adjusted so as to demonstrate
the change in neutrophil counts, shown logarithmically.
The PVB neutrophil count is also shown, and none of the
transfused cells was seen in the circulation. The most
likely explanation is that the cells, on transfusion,
were immediately sequestered into the areas of bacterial
challenge, primarily the lungs, but to some extent into
the crevicular domain. Other cell preparations were
stained for MPO with the Kaplow benzidine reagent and an
estimate of in vivo phagocytosis was also made from the
cytocentrifuge slides. The results of these two
measurements are given in Fig. 5.8, and show a close
parallel with the cell counts.
A sample of cells was taken from the empty bag
following the second transfusion. They were assayed
for MPO cytochemically and shown to be 83.2% positive.
This test was performed approximately eight hours after
the cells had been harvested from the donor and
irradiated. Not surprisingly, the blood film made from
the donor cells showed a marked 'left shift' in the
neutrophils.
Prior to the transfusions, sufficient crevicular
cells were obtained to assay MPO activity on two
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FIG. 5.7: Peripheral venous blood and crevicular
neutrophil counts in a 15 year old female patient with
AM0L in response to two granulocyte transfusions (Case
IV). Normal values are represented by vertical bars.
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FIG. 5.8: Crevicular neutrophil MPO (cytochemical
staining with benzidine) and in vivo phagocytosis in
response to granulocyte transfusion (Case IV). Normal
values are represented by the vertical bars.
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until just before the patient died. The results are
shown in the upper part of Fig. 5.9. The values were
somewhat erratic but the activity fell sharply to zero
on day 57 and did not recover. This was close to the
time at which the PVB neutrophil count started to fall
(Fig. 5.6). An NBT test performed on the crevicular
cells 132 hours after the start of transfusion, by
which time the cell count was high, possibly with donor
and host cells, showed 43.1% of the neutrophils to be
positive, i.e. a normal value. On day 61, early in the
subsequent decline, the NBT response was 11.6% positive
cells.
Case V: Acute Myelomonocytic Leukaemia
An acutely ill, 25 year old married woman (JMcC)
was admitted, having been tired and generally unwell for
approximately one month. She reported bruising easily
and had "lumps" in her neck. General haematological
investigation led to a diagnosis of acute myelomonocytic
leukaemia (AMM0L) in which the bone marrow was
infiltrated by equal numbers of each blast type. Unlike
the previous two cases of acute leukaemia, the peripheral
blood picture on presentation was a WBC count of 150.7 x
109 cells/L, with a differential count of 4% neutrophils,
1% lymphocytes and 95% blast cells. The absolute mature
275








J.McC. Q 25yrs. A.M.M.^L
30 40 50 60
TIME (Days)
90 100
Fig. 5.9: Crevicular neutrophil MPO activity in two
female patients with acute leukaemia (Cases IV dnd V).
Bars marked T indicate pulses of chemotherapy.
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neutrophil count was 6.02, i.e. within the normal range.
A crevicular neutrophil NBT test demonstrated 28.6%
positive cells. Unfortunately, six courses of combined
chemotherapy were unable to successfully control the
marrow proliferation, so that blast cells were never
cleared from the peripheral blood, and the
thrombocytopenia and anaemia produced significant
clinical problems. She died from a cerebral haemorrhage
three months after diagnosis.
Figure 5.10 shows the crevicular neutrophil counts
monitored throughout, compared with the peripheral
blood neutrophil counts. In general, the crevicular
counts paralleled those of the blood. The simultaneously
performed functional assays of in vivo phagocytosis and
cytochemical MPO are shown in Fig. 5.11. Phagocytosis
started to decline noticeably before the cell counts in
Fig. 5.10. Although there were similar trends between
the two functional measurements, they were less closely
matched than those in the previous patient during
transfusion.
The crevicular neutrophil MPO activity was
determined on 17 occasions, and the values are shown with
those from the previous girl in the lower part of Fig.
5.9. Twelve of the 17 values were zero and once again
it is not possible to distinguish the effects of the
disease from those of the chemotherapy.
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FIG. 5.10: Peripheral venous blood ( )
and crevicular ( ) neutrophil counts in
a 25 year old female patient with AMM0L
(Case V). The bars marked T represent




FIG. 5.11: In. vivo phagocytosis and cytochemical MPO
determination in crevicular neutrophils of a 25 year
old female patient with AMM0L (Case V). Periods of
chemotherapy are marked as T. Normal values are
represented by vertical bars.
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Conclusions
It would not be appropriate to generalise as to the
nature and function of crevicular cells in leukaemia
from the study of five cases, but several points have
emerged. The individuality of disease in each patient
became increasingly apparent. The first and most
obvious observation was that, as for the neutropenic
patients, it was easily possible to collect and study
crevicular cells in patients with leukaemia. Perhaps
the most important practical point was that the method
of cell collection is non-invasive and therefore
atraumatic. This may be a critical consideration in
terms of research being conducted on extremely ill
patients. Even so, it was considered inappropriate to
disturb some patients and this produced some incomplete
studies. Problems in interpretation were created by
the difficulty in determining which factors were
responsible for the observed changes. At any one time
the patients were leukaemic, immunocompromised, or
infected and were taking a combination of cytotoxic and
antimicrobial drugs. This aspect will require to be
studied further.
Results from both CML and the acute leukaemia
patients studied suggested that crevicular cell functions,
particularly MPO activity, were sensitive to the disease
and/or cytotoxic therapy. It is tempting to suggest
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that crevicular studies indicate the seriousness of a
patient's condition (cf. MPO in DN and MR, and in vivo
phagocytosis in patient JMcC).
The results for crevicular cell studies showed
well established patterns when compared with blood.
For example, the low blood NAP values typical of CML
were shown in the crevicular cells of patient DN.
Also, in the same patient, initially low cytochemical
MPO measurements became normal as marrow function
improved.
Another important feature was the indication that
the circulating cells migrate rapidly to sites of
bacterial challenge such as the gingival crevice. In
patient FO there was a persistent neutropenia, and yet
sufficient cells were always present in the gingival
crevices to permit an estimation of MPO activity.
These cells were also endowed normally with MPO even if
activity was absent. This phenomenon was still more
pronounced with the granulocyte transfusion studies.
Although the donor cells were not labelled, it seemed
that they migrated immediately in the neutropenic
'vacuum' that had been created. Thus cells were not
evident in peripheral blood until 60 hours after the
start of the first transfusion, which was 48 hours after
the first significant increase in crevicular neutrophil
numbers.
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A possible relationship between cell numbers in
blood and in the crevice was raised with respect to
neutropenia. The studies on MR and JMcC suggested that
there may be such a correlation in leukaemic individuals
during therapy, especially when the peripheral blood
circulation contains normal numbers of neutrophils (seen
to some extent in JMcC). The relationship may not
hold when the equilibrium between the marginating and
mainstream circulating populations in the vessels alters.
Preference may be given to the marginating cells
(including those destined for the gingival crevice), with
the result that none appear when blood is taken by
venepuncture. Passage to the tissues is, of course,
potentially the predetermined fate of all functional
neutrophils. Radio-labelling of donor cells would be
the best way to calculate the proportion of these cells
that migrate to a given site such as the gingival
crevice.
A normal NBT response was not seen in crevicular
cells from the three patients with acute leukaemia
except at the end of the transfusion period in MR. In
the chronic leukaemias, normally segmented neutrophils
were always present so that the same abnormality did not
occur. Nitroblue tetrazolium reduction was normal in
both CML patients but these isolated NBT tests were
performed at different stages of different diseases under
different treatment regimes.
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A final point was the notable absence of leukaemic
blast cells in the crevicular washings. This is
perhaps logically explained in that presumably only
fully functional cells are able to respond to a
chemotactic stimulus and to migrate through blood vessels
and connective tissue onto the mucosal surface. By the
same argument the transfused cells were functional since
they all apparently marginated and migrated immediately





Chronic granulomatous disease (CGD) is a rare
functional disorder of phagocytic cells, which has been
extensively investigated both for the insight into
normal neutrophil physiology and because of the link
between the disease and a molecular abnormality. In
1977, Johnston and Newman stated that 162 cases of CGD
had been reported over the previous ten years and one
year later Klebanoff and Clark (1978: 644-645) reviewed
evidence from 226 cases described in the literature.
Such has been the interest in this rare disease that
several extensive and comprehensive reviews have been
published (Klebanoff and Clark, 1978: 641-709; Gallin
and Fauci, 1983; Hitzig and Seger, 1983).
The disease was first clearly described by a group
of workers in Minneapolis (Berendes et al., 1957;
Bridges et al., 1959). Severe recurrent infections in
males were associated with generalised granulomatous
lesions. Frequently these infections proved fatal,
during childhood. Hypergammaglobulinaemia and normal
phagocytosis were recorded and the four patients in the
initial study died in childhood. Holmes et al. (1966)
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proceeded to show that bacteria survived for prolonged
periods within neutrophil phagolysosomes and that the
essential defect was in oxidative metabolism (Holmes et
al., 1967). This latter study demonstrated that
phagocytosis was associated with an increased oxygen
uptake of only 36% in CGD neutrophils as compared to
520% in normal cells. There was a concomitant
reduction in HMPS activity and hydrogen peroxide
formation. Subsequently many workers have investigated
in detail neutrophils from patients with CGD. In
general, the production, morphology, phagocytosis and
chemotactic response of neutrophils have been reported
as normal (reviewed by Klebanoff and Clark, 1978: 656-
663). All studies have confirmed the Minnesota
reports that the defect is in microbicidal activity and
related to a deficient metabolic burst. Thus oxygen
consumption, hydrogen peroxide production, superoxide
anion formation, chemiluminescence, NBT reduction, HMPS
activity and iodination are all impaired (Klebanoff and
Clark, 1978: 659-663).
The failure of CGD neutrophils to reduce NBT was
first described by Baehner and Nathan in 1967. A
negative result from a stimulated test has now become a
definitive diagnostic test. Such has been the
confidence in this test that it is used for prenatal
diagnosis of CGD (Newburger et al., 1979; Borregaard
et ad., 1982). However, there is one report of positive
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NBT reduction in a boy with the classical X-linked form
of CGD (Borregaard, Cross et al. , 1983). An absence of
NBT positivity would be expected if superoxide anion
formation is deficient. Lack of superoxide production
in CGD neutrophils has indeed been demonstrated by
several authors (Curnutte et al., 1974; Weening et al.,
1975; Rosen and Klebanoff, 1976).
Over the past few years the focus of interest has
been the membrane oxidase (discussed in chapter 3) and
in at least some forms of CGD this enzyme is either
totally absent, or present but inactive (reviewed by
Babior, 1983). Moreover, Segal (1983) has reviewed
the evidence for involvement of the b_245 cytochrome in
this system and has emphasised that the different
genetic variants of the disease are associated with
different oxidase defects. For example, Segal and
Jones (1979) suggested that in classical X-linked CGD
the cytochrome is missing, and subsequently confirmed
this in a large multicentre study (Segal, Cross et al.,
1983). In one of the recent reviews, Hitzig and Seger
(1983) have detailed the six molecular defects associated
with the X-linked form of CGD and a further three
associated with the autosomal recessive form.
The clinical manifestation of the molecular lesion
is a variably increased susceptibility to infection.
However, it has been recognised for some years that the
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organisms involved generally fall into one category,
that is they do not produce hydrogen peroxide or destroy
any formed with endogenous catalase (Klebanoff and
Clark, 1978: 670). The most frequently encountered
pathogens are Staph, aureus, Gram negative bacilli,
Candida albicans and Aspergillus species (Klebanoff and
Clark, 1978: 654-655; Regelmann et al., 1983; Weening
et al., 1983). These organisms are phagocytosed and
may remain viable for protracted periods within the
cell. Klebanoff and White (1969) suggested that
bacteria which do manufacture large quantities of
hydrogen peroxide, e.g. streptococci and lactobacilli,
can replace that missing from the neutrophils. Their
work was confirmed by others (Mandell and Hook, 1969).
The MPO-mediated oxidative killing system can then
operate normally utilising hydrogen peroxide derived
from the bacteria (Stossel et al., 1972). However,
there is one interesting study which reported normal
killing of Staph, aureus by CGD neutrophils in vitro
in which it was assumed that much of the bactericidal
capacity was due to non-oxidative pathways (Segal et_ al.,
1982) .
Monocyte function is also decreased in most
patients with CGD (Klebanoff and Clark, 1978: 667) to an
extent which depends upon the basic defect (Donowitz and
Mandell, 19b3) .
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Two principal modes of inheritance have been
recognised. The more usual X-linked form which only
affects males, and an autosomal recessive form in which
female cases also occur (Klebanoff and Clark, 1978: 642).
The inheritance patterns have recently been reviewed
(Mills and Quie, 1983), but the predominance of the
X-linked disease is illustrated by the review published
by Klebanoff and Clark (1978: 644-645) in which 202 were
male and 24 female. In the female carriers there are
two populations of neutrophils resulting from the
inactivation of one of the X chromosomes of each cell
so-called Lyonization. No abnormalities are detected
in the fathers or unaffected male siblings (Hitzig and
Seger, 1983). According to the Lyon hypothesis (Lyon,
1972) carriers show no intermediate stages of activity
between the two cell populations, i.e. one group is
entirely normal and the other entirely abnormal. By
chance the relative proportions of the two cell types
within one individual may vary depending on the
inactivation of the normal or the defective X chromosome
(Mills and Quie, 1983). Neutrophil activity overall
should be intermediate in the female carriers of CGD and
this was again shown by the Minnesota group (Windhorst
et al. , 1968) using an NBT test and subsequently confirmed
by others (Ochs and Igo, 1973; Hitzig and Seger, 1983).
Microbicidal activity (Suzuki et al., 1971) and
chemiluminescence (Rosen and Klebanoff, 1976) measurements
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have also been intermediate between control values and
CGD patients. The studies of Segal's group mentioned
above have demonstrated an absence of cytochrome b_245
in CGD neutrophils and it was further shown that this
deficiency was also partial in the carriers (Segal, Cross
et al., 1983).
Over the past 20 years the mainstay of management in
CGD has been antibiotic therapy to control and treat
infection. Since one of the principal problems in CGD
patients is the survival of organisms within phagocytes,
recently increased success in treatment has been
attributable to the use of antibiotics which gain access
to the interior of the cell, for example, rifampicin.
This subject has been well reviewed (Klebanoff and Clark,
1978: 688-689; Johnston, 1983). The combination of
sulfamethoxazole and trimethoprim has also been used to
good effect (Gmiinder and Seger, 1981; Seger et al. , 1981;
Weening et al., 1983) , due probably to the high drug
concentrations obtained within the neutrophils. Seger
et al. (1981) showed that the cells concentrate
sulfamethoxazole three-fold and trimethoprim fourteen-fold.
Granulocyte transfusions have been given to CGD patients
during severe infection but with variable results
(reviewed by Johnston, 1983). Buescher and Gallin (1982)
have proposed that monocyte transfusion would be more
appropriate, since these cells persist longer in the
infected tissues.
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The prognosis for patients with CGD has been improved
by the more judicious use of antimicrobial drugs, coupled
with an increased understanding of the cellular lesion.
There is, however, no room for complacency since the
disease can still prove fatal particularly if highly
pathogenic organisms are involved (Seger et al. , 1982).
Crevicular neutrophil studies were conducted in one
boy with diagnosed CGD, and as part of an investigation
into carrier status in the female members of another
family, in which two boys with X-linked CGD had died.
Case I: Chronic Granulomatous Disease
A young boy (MS) first presented with severe
infection problems at the age of 6 months. Total
leucocyte and absolute neutrophil counts were normal and
no immunological abnormalities were revealed. At one
year of age, a neutrophil NBT test gave a low result, at
the time of an acute admission with an abdominal abscess.
Cytochemical MPO and in vitro Candida killing were normal.
The NBT test results for MS and his immediate family are
shown in Table 5.7. These tests were performed by a
service microbiology laboratory. Not only did these
data illustrate the patient's defect but suggested carrier
status in the mother.
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MS has continued to suffer from repeated ear and
upper respiratory tract infections which have been
successfully controlled with cotrimoxazole. His mother
has been confirmed as a carrier. A young brother
suffers from an excess of infections but a diagnosis of
CGD has not yet been confirmed.
At the age of 6 years, crevicular and PVB neutrophil
studies were performed and the results are presented in
Table 5.8. The state of the teeth and oral soft tissues
was extremely good. Twenty deciduous teeth were present
with no caries and no restorations. Cell counts in
both crevice and blood were normal as was in vivo
phagocytosis in the crevicular neutrophils. Reduction
of NBT was totally absent in blood neutrophils but seen
in 8 out of 1,000 crevicular cells scored. The only
other point of note was that the blood cells possessed
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Case II: Carrier Status in X-Linked Chronic
Granulomatous Disease
In a family in which there were six children, two
girls and four boys, two of the boys had died at aged 10
months and 7 years respectively, following histories of
severe, recurrent infections. Neither parent had
suffered significantly from infections, nor had any of
the other four children. Neutrophil function tests
performed on the 7 year old boy led to a diagnosis of
classical X-linked CGD.
At the age of 22 years the elder daughter decided
to marry, and since her mother was an obligate carrier,
she had a 1:2 risk of also carrying the disease.
Crevicular and blood neutrophil NBT tests were performed
and the results are presented in Table 5.9.
TABLE 5.9:
PERIPHERAL VENOUS BLOOD AND CREVICULAR NEUTROPHIL
NITROBLUE TETRAZOLIUM REDUCTION (PERCENTAGE POSITIVE
CELLS) IN A POSSIBLE CARRIER OF X-LINKED CHRONIC
GRANULOMATOUS DISEASE
Source Unstimulated Stimulated
Blood 2.9 (5.1) 16.7 (19.6)
Crevice 33.3 (34.1)
Figures within brackets = control
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The results did not suggest any significant deficiency in
NBT reduction.
Having married, the patient went to live in Holland,
and by arrangement specific neutrophil oxidative function
was investigated. Oxygen consumption, hydrogen
peroxide formation and NBT reduction (all blood neutrophils)
were normal. The conclusion was therefore that she was
not a carrier. (She has since had a healthy daughter.)
The younger daughter was 15 years old when first
seen for crevicular cell studies. Crevicular neutrophils
from her father, mother (identified carrier) and an
unrelated control subject were tested simultaneously.
The mean results are depicted in Fig. 5.12. The values
for the father and control subject were normal, but those
for the girl and her mother were approximately 50% of
that for the control subject and 60% that of the father.
The indication was therefore that this daughter is a
a carrier, subject to confirmation.
Conclusions
The molecular bases of the microbicidal defect in
CGD have now been largely elucidated and in the course of
this work much has been learned about the biology of
neutrophils. In fact, Segal (1981) suggested that CGD
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FIG. 5.12: Crevicular neutrophil NBT reduction values
(percentage positive cells) in three members of a
family under investigation for carrier status in CGD
(Case II). The value for a healthy control subject
is also shown.
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patients would be ideally suited to genetic engineering,
should this ever become practicable.
The crevicular neutrophil data presented from two
investigations were extremely limited, but the nature of
the data would seem to justify discussion. In the case
of the boy with diagnosed CGD in whom the history had
been classical and the mode of inheritance confirmed, the
crevicular neutrophils reflected the inactivity of those
in the peripheral blood. Unlike the blood cell
preparations where the total negative response was
striking, a very small number of crevicular cells was
positive (8 in 1,000). In comparison to normal test
results, this value is insignificant, and it is possible
that a technical artefact was responsible. It is hoped
that further studies in this family, particularly of the
mother and younger brother, will be possible.
Oral lesions are not a prominent feature of CGD, and
the limited literature has been reviewed recently
(Donowitz and Mandell, 1983). In most cases the only
feature of note is minor oral ulceration although with an
incidence not above that for the general population
(Scully, 1981; Donowitz and Mandell, 1983). There is
one recent report of a case in which ulceration and
gingivitis were severe (Allan and Straton, 1983). The
oral condition of MS was excellent and, having no
gingivitis, caries or restorations, he was far better than
the norm for his age. This may have been due to his
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mother's conscientious approach. Another factor is that
the organism principally responsible for human dental
caries is Streptococcus nutans, a hydrogen peroxide-
producing bacterium. It should therefore be possible
for CGD neutrophils to successfully kill these bacteria.
This is clearly in contrast to the situation in
neutropenia where problems are caused by there being
insufficient phagocytes. It is not known whether this
patient will develop aggressive periodontal disease in
later life, but available evidence suggests that this
should not be the case (Donowitz and Mandell, 1983).
In the family study the typical inheritance pattern
of X-linked CGD was seen, both in terms of the disease
transmission and its carriage. Two sons had died, one
in infancy, and the infection history and pathology were
classical. The other two boys had no history of
infection problems and were shown to be completely free
of any immunological disorders. The elder daughter had
normal neutrophil function as determined by NBT reduction
both in the crevice and blood, and this was verified for
blood neutrophils by more extensive tests conducted in
another laboratory (by Drs Roos and Weening, Amsterdam
and Professor van Furth, Leiden). The chance of her
being a carrier (1:2 theoretically) is thus reduced. The
younger daughter will require to be investigated
thoroughly to exclude or confirm her being a carrier.
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However, since the crevicular cell studies for the first
daughter had apparently reflected the blood picture,
then in this girl the same relationship may apply.
Crevicular neutrophil NBT reduction was similar to that
in her mother. Such a result would be consistent with
those from blood neutrophil studies in carriers (Repine
et _al. , 19 75).
Crevicular neutrophil studies may therefore prove
useful both in terms of a research application to CGD and
possibly as an adjunct to clinical diagnosis.
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DISCUSSION
The limited studies that have been described,
conducted on patients with a variety of neutrophil
disorders, have provided data from which tentative
conclusions have been drawn and possibilities for further
research suggested.
The importance of neutrophils as a primary barrier
against infection in host defence has been underlined by
the deficiency states. In severe neutropenia, whether
congenital or associated with leukaemia, infection is
likely to occur due to the quantitative defect of
phagocytes. In the dysfunctional state of CGD,
systemic infection is also seen but generally less
severely than in neutropenia and leukaemia and involving
a narrower spectrum of pathogens. The oral cavity may
also be a clinical marker of neutropenic states, but not
CGD. In neutropenia the typical oral ulceration and
severe gingivitis were present in one patient (JS), who
also presented with early destructive periodontitis
which is very rarely seen in healthy children of the same
age. His father had lost all his teeth in early adult
life due to severe periodontal disease.
Clinical problems in mucosal sites seem to be
associated mainly with a deficiency in cell numbers,
rather than of function. In the leukaemic patients
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only segmented neutrophils appeared in the exudate
washings. No blast cells were seen, and this is
consistent with the assumption that only normal functional
cells would be capable of responding to a chemotactic
stimulus. An investigation into the relationship
between the cells present and the clinical state of the
tissues in the patients could provide useful information
concerning the role of neutrophils in periodontal disease.
One study has reported finding leukaemic blast cells in
the gingival crevicular washings of children with acute
lymphoblastic leukaemia (Sonis and Sonis, 1981) but
several aspects of the methodology were open to criticism.
If immature and blast forms are incapable of migrating
from the circulation, it may leave a relatively high
concentration of these cells in the mainstream circulation,
and not in a normal equilibrium with the marginating
population. Results of differential counts from
peripheral blood may then inaccurately reflect the true
proportions of the cell types leaving the bone marrow.
Marrow biopsy would indicate the actual state of cell
production and PVB and crevice studies would indicate
the kinetics of migration.
The concept of monitoring marrow activity through
cell migration into the oral cavity was discussed nearly
50 years ago, when Allen and Dickey (1937) suggested
that salivary leucocyte counts were useful indicators of
marrow function in CML, following irradiation therapy.
300
More recently, Arnold et ad. (1977) counted salivary
cells before and after granulocyte transfusion. As was
the case in the present study, they reported the presence
of transfused cells in saliva before they appeared in the
peripheral blood. The passage of cells into saliva
with time was not monitored, nor any functional
characteristics. In the single granuolcyte transfusion
monitored in this study, neutrophils appeared relatively
quickly in the crevicular washings, but it is not known
whether this was prior to, concomitant with or following
their migration to other sites, such as the lungs. More
detailed labelling studies are required but Saverymuttu
et al. (1983) have stressed that in labelling studies
the cell function may be significantly altered by the
labelling technique itself. Nevertheless, this type of
investigation could be extended to provide more
information about the kinetics of migration in such
patients.
During transfusion in this study, the cell counts
appeared to alter markedly. Even when the number was
very low prior to transfusion, exudate fluid was
evident. This observation supported the findings of
Kowashi et al. (1980) which showed that the cellular and
fluid components of crevicular exudate are under
independent control.
The present studies have also confirmed the
convenience and validity of the gingival crevice as a
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site for study of cell migration and function. Samples
are available, completely without trauma or invasion,
of particular importance in an immunocompromised patient.
In the CGD studies both in the patient and carriers,
the crevicular cell activity accurately reflected that in
the blood neutrophils. In the case of the leukaemic
subjects, a relationship was less apparent and should be
further investigated. Parameters, easily measured in
crevicular cells, might show promise as predictors of
relapse or remission during treatment. These isolated
results hint at such a possibility. In one CML patient
(Case I), crevicular neutrophil MPO activity was normal
on several occasions following breast cancer therapy.
In two patients, one with CML (Case II), and one with
AM0L (Case IV) , crevicular MPO activity ceased some
considerable time before the patients died. In vivo
phagocytosis also decreased latterly in the young woman
with AMM0L (Case V). Cytotoxic chemotherapy appeared
to depress MPO activity in the patient with AML (Case
III), but in the long term study of one CML patient
(Case II), the crevicular neutrophil cytochemical MPO
reflected the improvement induced by the chemotherapy.
Generalisations applicable to a broad category of
patients may not be possible, since cellular activity
varies from the outset. In this type of investigation,
sequential studies in individual patients may be
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particularly appropriate. Suda et al. (1983) reported
34 out of 35 patients with AML who presented with
abnormal blood neutrophil cytochemistry, and who could
be classified into three groups according to the changes
resulting from therapy. Patterson et al. (1982)
reported one patient with AML as having abnormally high
neutrophil peroxidase activity. Recent studies with
blood neutrophils have suggested that disease and
prognosis, to some degree, may be predicted from some
functional markers. Solberg et al. (1975) showed that
decreased neutrophil bactericidal function preceded the
development of overt leukaemia in five patients. Bendix-
Hansen and Kaspersen Nielsen (1983b) found that MPO
activity had no predictive capacity, but did normalise
once therapy was controlling the leukaemia. By contrast,
another recent study showed that azurophilic granule
enzyme activity (including MPO) fell in advance of a
relapse in AML (Schofield et al., 1983). The crevicular
studies mentioned above would accord with this latter
finding.
The crevicular sampling procedure is also applicable
when few cells are available for functional studies, as
in severe neutropenia. Dale and Wolff (1971) performed
studies on neutropenic patients using the skin window
technique, but this is an invasive procedure. Also the
initial neutrophilic infiltrate in a skin window is
subsequently replaced by monocytes, a sequence which does
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not occur in the gingival crevice. Freeman and King
(1972c) described a blood NBT test suitable for
neutropenic patients and Gordon et al. (1975)
developed a test by which blood neutrophils were
concentrated by cytocentrifugation, so facilitating study
in neutropenia. Collecting sufficient crevicular cells
for study in the neutropenic states so far encountered
has presented no difficulty, with the exception of the
transfusion patient (Case IV) immediately prior to
treatment, when the crevicular counts were extremely low
(and cells appeared to be non-existent in peripheral
blood).
Summary
It has been demonstrated that collecting crevicular
neutrophils for study from patients with disorders of
neutrophil production and function is practicable. The
procedure is atraumatic and the results suggest that
further investigations should demonstrate the usefulness
of this approach both in neutrophil research and clinical




In the context of host defence, neutrophil
leucocytes provide non-specific protection against
microbial invasion, and it is often implied that their
function is less sophisticated than the specific
mechanisms of immunity. It would be more appropriate
to regard this ability to deal with a wide range of
organisms as a highly successful attribute. In a wider
perspective of cell biology, the neutrophil is highly
developed for its intended function.
The structure of a neutrophil bears little
resemblance to standard text book drawings of a 'typical
cell', which show a single nucleus and the cytoplasm
replete with many extra-nuclear organelles. The nucleus
in a mature neutrophil is multilobed and distinctive
whilst the cytoplasmic membrane structures of endoplasmic
reticulum, ribosomes and mitochondria are almost entirely
replaced by membrane structures of a different form.
These are the lysosomes and granules, all charged with the
enzymatic and biochemical means necessary to achieve the
cell's defensive objectives. This development is further
seen in a unique feature of phagocytic cells, that is the
ability to generate considerable microbicidal activity
from the progressive reduction of molecular oxygen. In
the virtual absence of mitochondria the neutrophil
produces energy equivalents (ATP molecules) from
glycolysis. It may be that those membrane structures,
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once designed for oxidative phosphorylation, have been
transformed into those now reducing oxygen by a different
pathway to superoxide and hydrogen peroxide as a basis
for the oxygen-dependent microbicidal systems.
The importance of neutrophils to defence is also
shown by the greatly increased susceptibility to infection
seen in neutrophil deficiency states, particularly those
affecting cell production. A recent report of ten cases
of septicaemia, one fatal, in seven of which recovery was
dependent on the provision of adequate granulocytes
rather than the use of antimicrobial drugs, emphasises
this role (Cohen et al., 1983). Equally relevant to
this discussion was the identity of the organisms which
caused the septicaemia. All were viridans streptococci,
which are usually regarded as commensal and present
universally in the oral cavity. The pathogenic status
arose from the absence of the normally controlling
neutrophils. The authors suggested that the portal of
entry to the circulation, ironically, may have been
mouth ulcers caused by cytotoxic chemotherapy. The oral
cavity is therefore a site of critical importance to
systemic host defence and the function of neutrophils in
one part of the mouth, the gingival crevice, has been the
subject of this study.
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Neutrophils in the Gingival Crevice and
Periodontal Disease
The presence of neutrophils in the gingival crevice
has been recognised for many years but the first
functional studies were reported comparatively recently
(Wilton et al., 1977a,b). These were limited to basic
assays of phagocytosis and killing, using Candida
albicans as the in vitro test organism. An interesting
observation noted in one paper (Wilton et al., 1977b) was
the toxicity of crevicular fluid for autologous
peripheral blood neutrophils and yet a subsequent report
described the strong opsonic activity towards oral
organisms (Wilton et al., 1983), so illustrating the
complexity of possible interactions in an inflammatory
exudate. The decreased phagocytic activity of
crevicular as compared to blood neutrophils (Wilton et a_l. ,
1977a; Scully, 1982) may be the result of an intrinsic
cellular defect or could be an acquired deficiency
produced by some component of the fluid or associated with
the physical passage of cells through connective tissues.
The results of the present study have demonstrated in vivo
phagocytosis, NBT reduction and functional MPO in
crevicular neutrophils. Whilst the crevicular cells were
more susceptible to the toxicity of NBT, and overall had
less MPO activity than autologous blood neutrophils, their
MPO activity was markedly increased by the antibiotic
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cefaclor in comparison to blood cells.
The work of Scully has demonstrated the ability of
oral neutrophils to phagocytose and kill Streptococcus
mutans, which is clearly implicated as a causative
organism in human dental caries. This activity is
enhanced by the presence of specific opsonising antiserum
(Scully and Lehner, 1979b). However, a problem that has
hardly been addressed is the ability of crevicular
neutrophils to phagocytose or kill bacteria implicated in
human periodontal disease. The basic model for such an
investigation has been the in vitro interaction between
bacterial species isolated from dental plaque and
peripheral blood neutrophils. Some of these studies
have demonstrated the ability of plaque organisms to
induce extracellular lysosomal enzyme release from
neutrophils and thus have hypothesised mechanisms of
tissue destruction (e.g. Baehni et al., 1979). Others
have demonstrated the inhibitory effects (e.g. Adamu and
Sperry, 1981) or cytotoxicity (Shurin et al., 1979;
Taichman and Wilton, 1981; Nowotny et al., 1982) of
plaque bacteria for neutrophils. While providing
useful information and indicating directions for research,
more information is needed concerning the ability of
crevicular neutrophils to adequately control potential
pathogens. The only indications of such a capability
have been from electron microscopic studies (Garant,
1976; Newman, 1980; Saglie et al., 1982).
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In the present study the correlation between MPO
activity and gingival inflammation may indicate a causal
relationship, but such a finding may result from indirect
causes coincidental to other tissue changes. It
requires further study. Myeloperoxidase has many roles
in neutrophil function and in crevicular cells one of
these must be the classical catalysis of microbicidal
oxidations. The enzyme may also interact with protease
inhibitors to enhance inflammation (Clark et ctL. , 1981) .
Proteases (Kowashi et al. , 1979) and protease inhibitors
(Peterson and Marsh, 1979) have been identified in
crevicular fluid.
The passage of cells through the gingival tissues
has been considered disruptive but there is evidence that
the transmigration of neutrophils through epithelium may
cause no irreversible damage (Milks et al., 1983).
However, the potentially destructive role of activated
neutrophils in inflammatory disease has been a popular
theme in recent years (Lanser and Saba, 1981) . The
oxygen-dependent systems have been strongly implicated as
contributing to the damage (Halliwell, 1982; Weiss and
LoBuglio, 1982). There is also a strong case for tissue
damage being caused by proteolytic enzymes, particularly
in lung injury (Blue and Janoff, 1978; Hunninghake and
Crystal, 1983). Obviously both mechanisms may operate
synergistically (Matheson et al., 1979; Clark et ax.,
1981; Turkall and Tsan, 1982). Also, a recent report
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has proposed an interesting and plausible mechanism for
joint damage in rheumatoid arthritis, in that oxygen
radicals, generated from activated synovial fluid
neutrophils, were shown to significantly alter lymphocyte
function in vitro (Niwa et a^L. , 1983) . Most of these
models have yet to be tested or applied to human
periodontal disease. In this study crevicular
neutrophils have been shown to reduce NBT and to possess
active MPO but this is not synonymous with their being
automatically agents of destruction.
Against this increasing body of evidence for a
destructive role, the clinical evidence suggests that
neutrophils in the oral cavity are protective. The
progressive, rapid soft tissue and alveolar bone
destruction seen in patients with severe cyclical
neutropenia provides convincing evidence. Another
aspect of the argument has been closely examined through
the rare disease of juvenile periodontitis or periodontosis
(Saxen, 1980) . Many reports have identified a cellular
chemotactic defect in patients with juvenile periodontitis
(e.g. Clark et al. , 1977; Genco et al. , 1980; Van Dyke
et al., 1982), and the disease is particularly marked
when the neutrophil defect is aggravated by the presence
of leucotoxic bacteria in the gingival crevice (Taichman
and Wilton, 19 81; Ginsburg et al., 19 82) . Juvenile
periodontitis may be an extreme or exaggerated form of
the condition normally seen in the majority of adults.
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The conclusion must be that crevicular neutrophils
are both protective and destructive (Miller et al., 1984).
Seen in perspective, this should be interpreted as
protective for the whole organism at the expense of
localised and quantitatively minimal tissue destruction.
That is, the price of systemic health may be periodontitis.
Crevicular Neutrophils as a Model in Clinical Research
Kanthack and Hardy (1894) were the first workers to
propose the investigation of phagocytic cells in
inflammatory exudates, but such work did not begin
seriously in human studies until the introduction of the
skin window by Rebuck and Crowley (1955). Neutrophils
exist in secretions such as colostrum and human milk,
where they are functional (Ho and Lawton, 1978;
Pickering et al., 1980), but a factor contributing to the
relative lack of studies on secretory and exudate cells
must be their inaccessibility. The gingival crevice
therefore provides a site of easy access with none of the
organisational difficulties of, for example, collecting
cells from uterine cervix washings.
This study has demonstrated that tests of crevicular
cell function may provide an additional approach to the
investigation of a patient's ability to deal with
microbial invasion. The correlation between NBT
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reduction values for blood and crevicular neutrophils
should be further investigated, since a predictive assay
of host defence potential could prove most useful.
Similarly, the sensitivity of crevicular neutrophil MPO
to antimicrobial and cytotoxic drugs, and the ease with
which cells can be harvested atraumatically, present
the possibility of repeated monitoring of disease and
treatment in severely ill patients, e.g. with leukaemia
and neutropenia. However, the characteristics of the
MPO must be more closely defined, particularly in the
light of recent work which has demonstrated the influence
of fluctuating hormone levels on salivary LPO (Cockle and
Harkness, 1983), and the evidence for the existence of
several MPO iso-enzymes (Kinkade et a].., 1983) .
Several groups of workers have described subsets of
neutrophils in peripheral blood, identified by a variety
of techniques. Crevicular cell studies may help to
resolve this intriguing possibility.
Finally, in this respect, the detection of carrier
status in CCD by such a simple technique could prove
particularly useful in children. The minimal age of
cooperation for the crevicular rinsing technique appears
to be about 2\ years, by which time the deciduous




A century ago Metchnikoff emphasised the importance
of considering both humoral and cellular components of
immunity as a whole. Despite this, experiments are
generally designed to study limited functions. The
principle of Metchnikoff's approach must be considered
in order to properly elucidate the protective and
destructive aspects of neutrophils in the gingival
crevice, especially as these relate to human periodontal
disease. Such studies will also provide information
about neutrophil function in sites of confrontation
between host and microorganisms.
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Formalin (Formaldehyde solution) 125 ml
Distilled water (Store at 4°C) 150 ml
2. Pararosanalin solution
Dissolve 1 g of pararosanalin hydrochloride in
20 ml of distilled water + 5 ml conc. HC1.
Warm gently, cool and filter.
Store at room temperature.




Distilled water up to 500 ml




Distilled water up to 500 ml
5. Ethylene glycol monomethyl ether
6. N-N dimethyl formamide
METHOD:
7. Prepare the following reagents in glass, code A-D.
WEIGH: A- 80 mg Sodium nitrite
B- 10 mg AS-D chloroacetate (deep freeze) in
bijou
C- 60 mg a-naphthyl butyrate (deep freeze) in
bijou. (This is a liquid.)
D- 20 mg Fast Blue BB (deep freeze)
Fix smears in fixative for 30 sec at 4-10°C.
Wash in water 3 times. Allow to dry (10-30
min at room temperature).
To Bijou C add 3 ml ethylene glycol monomethyl
ether.
In a Coplin jar place:
M/15 phosphate buffer, pH 6.3 38 ml
Solution C 2 ml
To Tube A add 2 ml distilled water, mix to
dissolve, then add 2 ml pararosanilin solution
- mix - after 1 min add 0.5 ml to Coplin jar.
Stain smears for 45 min in this solution at
room temperature. Wash in water 3 times.
To Tube B add 5 ml of N-N dimethyl formamide
in glass.
In a Coplin jar mix:-
M/15 phosphate buffer, pH 7.4 38 ml
Solution B 2 ml
Contents of Tube D
Stain slides for 20 min (longer if required
at room temperature). Wash well.
Counterstain in 2% methyl green for 10 min.
RESULTS
a-naphthyl butyrate esterase activity (as indicated by
red-brown granules) is as follows
STRONG - monocytes only
WEAK or NEGATIVE - myeloblasts, plasma cells,
lymphocytes, granulocytes,
megakaryocytes
Chloroacetate esterase activity (as indicated by blue
granules) is strong in the granulocyte series.
APPENDIX 2
NEUTROPHIL ALKALINE PHOSPHATASE (NAP)
(Based on method of Kaplow, 1963)
REAGENTS
1. Fixative (10% formalin in absolute methanol)
2. Naphthol AS-MX phosphate concentrate
3. Fast Blue RR
4. 2% neutral red
5. 1% aqueous light green
METHOD
N.B.: If EDTA anticoagulated blood used, prepare film
within 30 mins of collection.
1. Fix slides for 30 sec.
2. Brief rinse in distilled water.
3. Add 2 ml naphthol phosphate concentrate to 48 ml
distilled water. To this, add 1 capsule Fast Blue
RR. Mix. (Contents do not dissolve completely.)
4. Place in a clean Coplin jar containing slides.
Leave for 2 h.
5. Wash under tap for 10 min.
6. 1st counterstain: 1% aqueous light green, 3 min.
(This should be done at 4°C.)
7. Brief rinse to remove all excess stain.
8. 2nd counterstain: 2% neutral red, 10 min.
9. Rinse under tap. Allow to dry.
ACTION
This stain works on a diazo-dye coupling technique, the
alkaline phosphatase activity giving rise to colour of
varying intensity in the granules of mature neutrophils.
RESULTS
Normal value is approximately 40-150.





It is reduced in chronic myeloid leukaemia.
APPENDIX 3
NEUTROPHIL MYELOPEROXIDASE
(Benzidine Method; Kaplow, 1965)
NB: It is advisable to wear protective gloves when
handling these reagents.
REAGENTS
FIXATIVE - 10 ml of 40% formalin in 90 ml
absolute ethanol
STAIN 30% Ethanol 100 ml
Benzidine dihydrochloride 0.3 g
ZnSOi,. 7H20, 0.132M (3.8% w/v) 1.0 ml
NaC2H302-3H20 1.0 g
3% H202 0.7 ml
NaOH, 0.IN 1.5 ml
Safranin 0.2 g
The reagents must be added in the above order, mixing
well. There may be some residue. The final pH should
be 6.0 ± 0.05. The solution should be filtered and
stored at room temperature, for up to six months.
METHOD
1. Fix freshly prepared films for 60 sec at room
temperature.
2. Rinse in tap water for 30 sec.
3. Immerse in staining solution for 30 sec at room
temperature.
4. Rinse in tap water.
5. Counterstain with 1% safranin, haematoxylin or
Giemsa.
6. Rinse in tap water and air dry.
RESULT
Peroxidase-positive, azurophilic granules stain darkly.
APPENDIX 4
NEUTROPHIL MYELOPEROXIDASE
(3-Amino-9-ethylcarbazole Method; Kaplow, 1975)
REAGENTS
FIXATIVE - 40% Formalin 25 ml
Acetone 45 ml
Na2HPOi,. 20 mg ) or, ,5 in 30 ml
KH2POit 100 mg j water
Final pH -6.6
STAIN - Acetic acid, 0.02M, adjusted to
pH 5.0-5.2 with IN NaOH 50 ml
Dimethylsulphoxide 6 ml
3-Amino-9-ethylcarbazole 10 mg
0.3% H202 0.4 ml
Final pH - 5.5; filter solution before use.
METHOD
1. Fix freshly prepared films for 15 sec at room
temperature.
2. Rinse in distilled water.
3. Immerse film in stain for 2-3 min at room
temperature.
4. Wash in tap water.
5. Counterstain with haematoxylin for 10 min.
6. Wash in tap water and air dry.
RESULT
Peroxidase-positive, azurophilic granules stain rusty
brown. Nuclei stain pale blue.
APPENDIX 5
SPECTROPHOTOMETRY ASSAY OF MYELOPEROXIDASE
(Method of Klebanoff, 1965)
SPECIAL REAGENTS
1. Phosphate buffer 0.1M, pH 6.0. Dissolve 1.40 g
NaH2POIt .2H20 and 0.28 g Na2HPO<* .2H20 in 100 ml
distilled water. Check pH.
2. Hydrogen peroxide 0.01M. Add 0.1 ml 30% H202 to
88 ml distilled water. Prepare freshly for use.
3. Orthodianisidine 0.2M. Dissolve 0.0488 g in 10 ml
methanol. Prepare freshly for use.
ASSAY
1. Set the spectrophotometer to record at 460 run.
2. Set thermostat of water bath to 25°C.
3. Add 2.65 ml phosphate buffer and 0.3 ml H202
solution to a 3 cm cell.
4. To initiate reaction, add 0.05 ml orthodianisidine
solution, followed immediately by 0.05 ml
neutrophil preparation.
5. Mix well and follow the increase in optical
density at 460 nm for 5 min.
RESULT
Activity = A OD/min x 62,000 units/ml.
Once the protein (neutrophil extract) has been determined,
the activity may be reported as units/ng protein.
The lower limit of detection is taken as 0.2 units/jig
protein.
APPENDIX 6
CALCULATION OF LINEAR REGRESSION AS USED FOR CREVICULAR ON
BLOOD NBT POSITIVE VALUES IN CHAPTER 3
The purpose of this analysis is to obtain an idea of
the extent to which one parameter is related to or depends
upon another, but provides no information as to the reason
for such a relationship. The correlation coefficient can
thus be calculated and its statistical significance
determined.
Let blood values = X n = number of subjects and
Let crevice values = Y therefore values in
each group
The regression is calculated from:
Ex2 = EX2 - (EX)2 Ey2 = EY2 - (ZY)2n 2 n
EX.EY
Exy = ZXY - n
Exy
r = correlation coefficient = J £X2 _ £y2
The significance level can be obtained from published
tables, e.g. Snedecor, 1956: 174.
The 'best fit' line is determined:
Exy
b = regression coefficient or slope = Ex2
b was calculated for the male and female subjects, as well
as the total group.
To determine the plot points
Y = a + bX, where a is the intercept on the vertical
axis (when X = 0), and b is the regression coefficient.
X and Y are known,
Y = a + bX
a = Y - bX
The line can then be drawn between the two points,
APPENDIX 7
THE MANN-WHITNEY U TEST
This is a ranking test for the comparison of two
groups of data of unequal size. The method employed
below is that published by von Fraunhofer and Murray
(1976) .
ni = number of cases in the smaller group (20)
n2 = number of cases in the larger group (30)
Each value is assigned a rank, i.e. smallest 1, etc.
(For any duplicate values, the average is used.)
The value of U is then calculated. U = number of
times that a score in the group with n2 cases precedes a
score in the group with n; cases in the ranking order.
ni (ni + 1)
2
TT _ ^ ^ i X/U - nin2 + - Rx
TT. _ „ „ n2 (n2 + 1)u — n i n2 + - k2
Ri = sum of ranks in group Rx; R2 = sum of ranks in
group R2.
The correct value for U is the smaller, with the
value of the larger denoted as U'.
U = nin2 - U'
The method for determining statistical significance
depends on the sample size. For n2 greater than 20, the
distribution approaches normal so that
uTT nin2
mean = U = —i——
2
It is therefore possible to calculate Z (the normal
deviate), according to the formula:
/ (ni) (n2) (ri! + n2 + 1)~
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z = 3.4358, and p < 0 .0003.
